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ABSTRACT 
 
 
 
Safety and Efficacy of NovaSil Clay as a Dietary Supplement to Prevent 
Aflatoxicosis.  (December 2004) 
Evans Afriyie-Gyawu, B.S., Texas A&M University; MPH, Texas A&M University 
Systems Health Science Center 
Chair of Advisory Committee:  Dr. Timothy D. Phillips 
 
 
 
It is well documented that aflatoxin contamination in foods presents 
significant economic and public health burdens worldwide.  Aflatoxins, 
particularly aflatoxin B1 (AFB1), have been implicated in the etiology of disease 
and death in many parts of the world, necessitating research initiatives for 
intervention strategies designed to diminish biological exposure.  Calcium 
montmorillonite clays (e.g. NovaSil Plus, NSP) have been found to tightly bind 
and inactivate aflatoxins in the gastrointestinal tract of multiple animal species.  
In the future, the hypothesis is that this strategy may also be appropriate for 
humans.  Thus, the overall research goal was to investigate NSP suitability for 
human use through in vitro characterization followed by in vivo evaluation of 
NSP-AFB1 sorption and most importantly, safety of the clay.   
The first objective was to characterize the in vitro and in vivo sorption 
efficiency of NSP-AFB1 sorption and determine potential interactions with 
vitamin A (VA).  Isothermal analysis suggested that NSP binds AFB1 with high 
 iv
capacity, affinity, and specificity in aqueous solution and further indicated that 
NSP does not appear to interact with VA.  Subsequent short-term studies in 
Sprague-Dawley (S-D) rats and broiler chicks indicated that dietary inclusion of 
NSP (0.25%) significantly reduced AFB1 bioavailability without exerting overt 
toxicity.   
The second objective was to evaluate potential adverse effects of chronic 
ingestion of dietary NSP using male and female S-D rats in the absence of 
aflatoxins.  Although statistically significant changes to a few parameters were 
noted, the differences did not appear to be NSP- or dose-dependent, suggesting 
that NSP at dietary inclusion levels as great as 2.0% (w/w) does not produce 
overt toxicity.  Thus, this information increases the feasibility for using NSP in 
human trials in populations at high risk for aflatoxicosis. 
The third objective was to establish representative baseline data on 
human exposure to aflatoxins by collecting and quantifying urinary AFM1 in 
volunteers living in four separate communities in Ejura district of Ghana.  Results 
revealed that urinary AFM1 in the study population was substantially high (mean 
= 1,850.86 ± 274.59 pg/mg creatinine), indicating that this particular population 
was highly exposed to aflatoxins and could be used for future intervention trials.   
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CHAPTER I 
INTRODUCTION 
 
1.1  Definition/Overview of the Aflatoxin Problem  
Aflatoxins (AFs), perhaps the most well-known class of mycotoxins, are 
harmful by-products of mold growth produced primarily by the fungi Aspergillus 
flavus, A. parasiticus, and, to lesser extent, A. nominus (Kurtzman et al., 1987; 
Lopez et al., 2002).  Other common mycotoxins that are of public health, 
agricultural, and economic importance include ochratoxins, trichothecenes, 
zearalenone, fumonisins, tremogenic toxins, and ergot alkaloids (Huwig et al., 
2001; Hussein and Brasel, 2001).  Table 1 delineates some of the mycotoxins, 
the affected commodities, and health implications upon exposure.  However, the 
focus of this research is on the burden of AFs and a clay-based enterosorption 
strategy, for the prevention of aflatoxicoses in humans. 
Although members of the Aspergillus species are widely distributed, they 
thrive in regions of high temperature, high humidity, and relatively low moisture 
content in the substrate.  These conditions make the fungi well-suited to colonize 
a variety of grain and nut crops including corn, groundnut, cottonseed, and tree 
nuts (CAST, 2003).  The naturally occurring AFs, aflatoxins B1, B2, G1, and G2 
(Figure 1), which are characterized as ubiquitous, can contaminate food/feed 
  2
TABLE 1 
 
Health impact of common mycotoxins on humans and animals 
 
Mycotoxin Affected Commodity Health Impact 
Aflatoxins (B1, B2, G1, 
G2, M1, M2) 
Peanuts and peanut products, corn, 
wheat, rice, cottonseed, nuts, eggs, 
various foods, dairy products, figs 
Hepatotoxicity, bile duct hyperplasia, hemorrhage of 
intestinal tract and kidneys, carcinogenesis (liver 
tumors) 
 
Ergot alkaliods Rye, flour, forage grasses Neurotoxic, paralysis, convulsions, necrosis, 
gangrene, decreased serum prolactin levels 
 
Fumonisins Corn Leukoencephalomalacia, porcine pulmonary edema, 
linked to human esophageal cancer 
 
Ochratoxin A  Cereal grains (wheat, barley, oats, corn), 
dry beans, moldy peanuts, cheese, coffee, 
raisins, grapes, dried fruits, wine  
Tubular necrosis of kidney, porcine nephropathy, 
liver damage, teratogenesis, kidney tumors 
 
 
Patulin Apples, apple juice, wheat, moldy feed Brain and lung edema, lung hemorrhage, paralysis of 
motor nerves, antibiotic, convulsions, carcinogenesis 
 
Trichothecenes (T-2, 
deoxynevalenol, 
diacetoxyscirpenol) 
 
Corn, wheat Digestive disorders, oral lesions, hemorrhage of 
stomach, heart, intestines, lungs, bladder, kidney 
edema 
 
Zearalenone Corn, hay Estrogenic effects (e.g. edema of vulva, uterine 
enlargement), testicular atrophy, enlargement of 
mammary glands, abortion 
Adapted from the CAST report (2003) 
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Figure 1.  Chemical structures of the four naturally occurring aflatoxins B1, B2, 
G1 and G2.  The aflatoxins are produced primarily by Aspergillus flavus and 
Aspergillus parasiticus fungi, and their series nomenclature denotes a 
characteristic fluorescence emmission under UV light, that is, (B) blue and (G) 
green fluorescence. 
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sources either concurrently or separately (CAST, 1989).  Among these 
metabolites, aflatoxin B1 (AFB1) is usually the most predominant in foods/feeds, 
the most toxic, as well as the most potent hepatocarcinogen known in humans 
(Busby and Wogan, 1984; Flaherty and Payne, 1997; Lopez et al., 2002). 
AF contamination in foods/feeds has been longstanding and difficult to 
control even with good manufacturing practices because AFs are invisible to the 
naked eye, heat stable, and are not neutralized by common food processing 
techniques including drying, roasting, canning, cooking, etc (CAST, 1989; 
Phillips, 1999; Phillips et al., 2002).  The compounds are reportedly carcinogenic 
(Busby and Wogan, 1984; Wild et al., 1992; WHO-IARC, 1993), genotoxic 
(Wang et al., 1999; Smela et al., 2001), and immunotoxic (Hinton et al., 2003; 
Turner et al., 2003).  In addition, the AFs have been associated with inhibition of 
protein, enzyme, and clotting factor synthesis (Abdulrazzaq et al., 2004).  The 
toxins can also depress glucose metabolism and fatty acid and phospholipid 
synthesis.  All these effects may lead to teratogenic effects (Di Paolo, 1967) and 
mutagenicity (Ong, 1975). 
Furthermore, the presence of AFs has been found to significantly affect 
some nutrients such as vitamins A and D (Glahn et al., 1991; Pimpukdee et al., 
2004), zinc and selenium (Kalorey et al., 1996; Mocchegiani et al., 1998), and 
iron status (Dimri et al., 1994).  While this may not seriously affect many 
developed countries where an abundant and safe food supply allows tainted 
grain to simply be discarded, AF contamination remains a serious threat in many
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parts of the world where this grain is either not properly detoxified or is 
consumed for survival due to limited food supplies (McAlpin et al., 2002).   Thus, 
strategies to limit the occurrence of these compounds in grain or eliminate their 
presence in the food supply are highly desirable.  Also, intervention methods to 
diminish or prevent biological exposure of humans and animals to the AFs 
constitute a great need. 
 
1.2 Historical Background 
Aspergillus flavus was of little concern prior to the 1960s, although it was 
reported to be the cause of ear mold in corn as early as 1920 (Taubenhaus, 
1920; CAST, 2003).  However, in 1960 ingestion of contaminated peanut meal 
used in formulating livestock feeds on farms near London, England, led to a 
condition termed Turkey “X” disease that was linked to the deaths of more than 
100,000 turkey poults (Blount, 1961).  Symptoms included loss of appetite, 
followed by affects to the animal’s gait and ability to stand and, finally, death 
(Wannop, 1960).  Histopathological analysis revealed the most severely affected 
organ was the liver, but the kidneys, heart, and duodenum were also affected 
(Siller and Ostler, 1961). 
Subsequently, investigations mounted to determine the cause of this 
unprecedented disease led to the discovery, separation, and conformation of 
various AFs and their major metabolites (Newberne et al., 1966).  The two main 
series of naturally occurring AFs were categorized as B and G, identified first by 
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their blue and green fluorescent emissions, respectively (Nesbitt et al, 1962).  
Since this discovery, numerous AF metabolites have also been characterized 
and reported, including: aflatoxins M1, M2, M2a, H1, P1, P1, Q1, parasiticol, 
aflatoxicol I, aflatoxicol II, and aflatoxin B1-8,9-dihydrodiol (Phillips, 1999) (Table 
2).   
 
1.3  Physical and Chemical Characteristics 
Structurally, AFs are multi-heterocyclic compounds that contain a 
coumarin structure fused to a dihydrofurofuran (Figure 1) (Wogan, 1969).  In the 
B, M, and Q series, an additional cyclopentenone ring system is adjacent to the 
coumarin ring, whereas the G series contain a δ-lactone ring adjacent to the 
coumarin ring.  In their nomenclature, the subscript 1 denotes a vinyl ether intact 
in the terminal furan ring, while subscript 2 indicates a tetrahydrofuran ring 
(Grant, 1998).  The AF analogues with an M notation have a hydroxyl group 
attached to the carbon between the furan rings. 
AFs are heat-stable and invisible to the naked eye (Phillips et al., 2002).  
They are intensely fluorescent in ultraviolet light.  Of particular interest, AFB1 is a 
white crystalline solid with a melting point of 268-269 °C that emits a pungent 
smoke and irritating fumes upon decomposition.  The compound has a 
molecular formula of C17H12O6, a molecular weight of 312 g/mol, and is slightly 
soluble in aqueous solution where the peak absorbance in ultraviolet (UV) light 
occurs at 362 nm.  Also, AFs are soluble in methanol, acetone, and chloroform
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TABLE 2 
 
Chemical characteristics of aflatoxin metabolites 
 
Aflatoxin 
Metabolites 
Molecular 
Formula 
Molecular 
Weight 
(g/mol) 
Melting Point 
(oC) 
Molar 
Absorptivity 
(λ/nm) 
B1 C17 H12O6 312.06 268-269 21800 (362) 
B2 C17 H14O6 314.08 287-289 24000 (363) 
B2a C17 H14O7 330.08 240-DEC 20400 (363) 
G1 C17 H14O7 328.06 244-246 16100 (362) 
G2 C17 H14O7 330.07 230 19300 (365) 
G2a C17 H14O8 346.07 190-DEC 18000 (365) 
GM1 C17 H12O8 344.28 276 12000 (358) 
GM2 C17 H14O8 346.07 270-272 13020 (357) 
GM2a C17 H14O9 362.30 195-DEC 19100 (357) 
H1 C17 H14O7 330.07 - - 
M1 C17 H12O7 328.06 299 19000 (357) 
M2 C17 H14O7 330.07 293-DEC 21000 (357) 
M2a C17 H14O8 346.08 240 19300 (358) 
MP1 C16H10O7 314.08 - - 
P1 C16H10O6 298.05 >320 15400 (362) 
Q1 C17 H12O7 328.06 295 18800 (365) 
TI C17H16O6 314.08 234 14100 (332) 
TII C17H16O6 314.08 233-DEC 14100 (325) 
8,9-
dihydrodiol C17 H14O8 346.07 - - 
parasiticol C16 H14O6 302.08 233-234 9700 (325) 
 
DEC = Decomposed 
Adapted from Heathcote and Hilbert (1978), Cole and Cox (1981), and Grant (1998). 
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but slightly soluble in hydrocarbon solvents (HSDB, 2003).  Chemical 
characteristics of known AF metabolites are listed in Table 2.  Additionally, AFs 
can be degraded by ultraviolet light (Phillips et al., 1994). 
 
1.4 Occurrence of Aflatoxins 
1.4.1  Contamination of Aflatoxins in Crops 
As noted previously, aflatoxins are produced primarily by the fungi 
Aspergillus flavus, A. parasiticus, and, to lesser extent, A. nominus (Kurtzman et 
al., 1987; Lopez et al., 2002).  Although members of this genus are distributed 
worldwide, the fungi are most abundant between latitudes 26° to 35° north or 
south of the equator (Klich et al, 1994).  On the basis of these latitudes, it is 
evident that AFs occur mostly in tropical areas with hot and humid climates, 
prolonged drought stress, and insect infestation, all conditions that are favorable 
to the growth and development of molds (Schroeder, 1969; Bhatnagar et al., 
2002). 
A. flavus and A. parasiticus reportedly have overlapping ecological niches 
and, under favorable pre-harvest conditions, they can produce AFs in 
developing seeds of corn, peanuts, cotton, almond, pistachio, and other tree 
nuts (Bhatnagar et al., 2002; CAST, 2003).  However, the growth of the 
Aspergillus mold itself does not predicate the presence of the toxin, since 
production of AFs depends upon the complex interaction of many environmental 
and nutritional variables, including moisture, temperature, substrates, aeration, 
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pH, the quantity of both carbon and nitrogen sources, lipids, certain metal salts, 
and specific nutrient requirements (Ominski et al., 1994; Cary et al. 2000a; 
CAST, 2003).  For instance, the pronounced stimulatory effect of AF production 
has been linked to the level of zinc in host species, and has been cited as a 
contributing factor for the resistance of soybeans (with low levels of zinc) to AF 
contamination (Gupta and Venkitasubramanian, 1975).  In addition, some of 
these factors may affect gene expression throughout the AF biosynthesis 
pathway (Bhatnagar et al, 2003). 
The process of AF contamination by Aspergillus flavus is best 
characterized in corn.  A. flavus is a ubiquitous soil inhabitant that reproduces 
asexually by conidia (Payne, 1998).  When the conidia are conveyed to corn 
silks by wind or insects, they can grow into the corn ear shortly after pollination 
and colonize the kernel surfaces (Widstrom, 1996; Payne, 1998).  Under 
favorable environmental conditions, the fungus may directly penetrate the seeds 
and cobs or it may enter through wounds created by insects.  In either scenario, 
significant AF production and contamination do not occur until the moisture 
content of the kernel is below 32% (Payne, 1998) and continues until the grain 
moisture reaches 15% (Payne et al., 1988).  The optimal temperature for the 
growth of these fungi ranges from 36 to 38 °C (Klich et al., 1994).  In field 
studies, AF contamination in peanuts by A. flavus were maximized at 30.5 °C 
(Cole et al., 1995).  
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1.4.2  Aflatoxin M1 (AFM1) in Milk and Urine  
In addition to AF contamination in crops, AFM1, a hydroxylated metabolite 
of AFB1 is commonly detected in milk of humans and animals and in urine.  
Under favorable physiological conditions, cytochrome P450 enzyme, particularly 
CYP1A2 isoform, is reportedly responsible for oxidizing the parent compound 
(AFB1) into the AFM1 metabolite (Eaton et al., 1994; Wang et al., 1999) (Figure 
2).  In humans, AFM1 has been reported to be excreted through breast milk from 
nursing mothers in tropical countries in Africa and Asia (Somogyi and Beck, 
1993) and enhance AF-induced morbidity particularly in children with 
Kwashiorkor (Adhikari, 1994).  In dairy animals, consumption of AFB1-
contaminated rations results in dose-dependent excretion of AFM1 in milk (Neal, 
1998; Chopra et al., 1999).  Subsequently, AFM1-contamination may occur in 
dairy products such as cheese, yogurt, and ice cream (Jones, 1995).  Therefore, 
the U.S. FDA has set a limit of 0.5 ppb for AFM1 in milk; whereas, the limit for 
AFB1, the most toxic and carcinogenic of all the AFs, is 20 ppb for foods 
intended for human consumption (CAST, 2003).  This discrepancy in action 
limits is due to the fact that milk is consumed as a major source of nutrition in 
young children. 
    In addition, several reports have indicated that AFM1 is dose-dependently 
excreted in urine following dietary AFB1 ingestion (Groopman et al., 1992a; 
Hsieh and Wong, 1994; Wang et al., 1999).  Other studies have also found that 
urinary AFM1 has a dose-dependent association with increased 
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Figure 2.   Aflatoxin B1 (AFB1) metabolism and the enzymes involved.  AFB1 is activated to the reactive exo-8,9-
epoxide form by cytochrome P450 (mainly CYP1A2 and 3A4 isoforms) in the liver. The epoxide can react at the N7 
position of guanine in DNA to form the primary AFB1-N7-Gua adduct (DNA adduct).  Other metabolites such as 
aflatoxins M1, Q1, and P1 can be formed from different P450 isoforms (Eaton et al., 1994; Groopman, 1994).  
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relative risk of developing hepatocellular carcinoma (HCC) (Qian et al., 1994; Yu 
et al., 1997).  Thus, monitoring urinary AFM1 provides for a non-invasive method 
of AFB1 exposure quantification. 
 
1.5  Exposure to Aflatoxins 
Exposure to AFs occurs predominantly through ingestion of contaminated 
food/feed, although the compounds can also be absorbed through the lungs and 
skin (Leeson et al., 1995; Coulombe, 1994).  In the occupational setting, 
exposure to AFs in humans is mainly via the respiratory tract upon inhalation of 
AF-contaminated dust (Coulombe, 1994).  In fact, several studies have reported 
that AFB1 is virtually always present at higher levels in grain dust compared to 
those found in contaminated food/feed (Baxter et al., 1981; Sorenson et al., 
1981; 1984).  Generally, in many parts of Africa and the developing world 
protective gears are usually not available to farmers and communities that 
routinely process foods/feeds that may be contaminated by the AFs.  In this 
situation, not only do the people get exposed through dietary ingestion of the 
toxins, they can also be exposed through dermal and inhalation routes. 
 
1.6  Biotransformation of Aflatoxins 
AF biotransformation involves several biochemical processes including oxidation 
(most importantly, epoxidation) (Essigmann et al., 1977; Groopman, 1994), 
reduction (Wong and Hsieh, 1978), hydroxylation (Moss and Neal, 1985), and 
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conjugation (Holeski et al., 1987), and excretion of the parent compound 
(particularly AFB1) and its metabolites.  Because of the fairly lipophilic nature of 
the compounds, absorption across the membranes of the gastrointestinal (GI) 
tract is the most likely entry point for the AFs into humans and animals.  From 
the intestines, the toxins enter the liver through the hepatic portal blood supply 
(Wilson et al., 1985) and are then distributed to most soft tissues and fat 
deposits, however the majority of the toxins accumulate in the liver and kidneys 
where biotransformation occurs (Leeson et al., 1995). 
Specific processes in AF metabolism are best characterized using AFB1 
as a model compound.  Figures 2 and 3 represent some relevant 
biotransformation pathways of AFB1 as presented by Eaton et al. (1994).  In the 
liver, AFB1 undergoes metabolism by phase I metabolizing enzymes, primarily 
cytochrome P450, resulting in the formation of the AFB1-8, 9-epoxide and 
hydroxylated metabolites such as AFM1 and AFQ1 (Ramsdell and Eaton, 1990), 
and the O-demethylated AFP1 (Wong and Hsieh, 1980).  Two possible epoxides,  
AFB1-exo-8,9-epoxide and AFB1-endo-8,9-epoxide, are formed when the 
8,9 vinyl group is transformed.  The AFB1-exo-8,9-epoxide has been reported to 
be three orders of magnitude more genotoxic than the AFB1-endo-8,9-epoxide 
(Ueng et al., 1995).  Cytochrome P450 3A4 is responsible for producing the exo-
epoxide form, whereas the 1A2 isoform may produce either the endo- or exo-
epoxides.  A high concentration of the epoxide may lead to protein- and DNA-
adduct formation in the liver (Figure 3). 
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Figure 3.  Cytochrome P450 activation of aflatoxin B1 and interaction with DNA. 
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Excretion of AFB1 and its metabolites occurs primarily through the biliary 
pathway, followed by the urinary pathway.  Phase II metabolizing enzymes such 
as glutathione-s-transferase (GST) and epoxide hydrolase (EH) may convert the 
epoxide into GSH conjugates or dihydrodiols, respectively.  These products may 
then be excreted (Eaton et al., 1994), although a small portion may remain in the 
body tissues as residues (Leeson et al., 1995).  
 
1.7  Toxicity of Aflatoxins  
An abundance of scientific evidence implicates AFs, particularly AFB1, in 
the etiology of disease and death in both animals and humans (IARC, 1987).  In 
1993, WHO-International Agency for Research on Cancer evaluated the 
carcinogenic potential of certain diverse mycotoxins and identified the naturally 
occurring AFs as human carcinogens (Group I) (WHO-IARC, 1993).  In vitro 
evidence indicates that all the naturally occurring AFs (B1, B2, G1, and G2), as 
well as AFM1, produce some form of injury to DNA (Cullen and Newberne, 
1994).  For instance, AFB1 reportedly produces chromosomal aberrations and 
strand breaks, micronuclei, sister chromatid exchange, unscheduled DNA 
synthesis, and forms DNA-adducts in rodent and human cells used for in vitro 
experiments (IARC, 1987).   
Additionally, In vivo studies have shown that the liver is the predominant 
target organ for both AFB1 toxicity and carcinogenicity (Miller and Wilson, 1994).  
However, disposition and effects of this AF have been reported in several organ 
  
16
systems, including the pulmonary, renal, gastrointestinal (especially in the 
colon), nervous, reproductive, and immune systems in both animals and humans 
(Coulombe, 1994; Kolars et al., 1994; Larsson and Tjalve, 1995).  Specific AF-
related adverse effects in animal species and humans are detailed below. 
 
1.7.1 Animal Toxicity  
Since the incidence of Turkey X disease (characterized by massive 
hepatotoxicity in turkeys) in England in 1960, a number of acute dosing studies 
have been conducted to determine LD50 values for a wide range of animal 
species (CAST, 1989).  Reports generated from those studies delineated that 
the effects of AFs are species-dependent, primarily due to the dependence on 
metabolic rates, type and duration of exposure, age, dosimetry, and dietary 
quality or nutritional status (Newberne, 1986; Miller and Wilson, 1994).  For 
instance, duckling, rabbit, rainbow trout, and cats are highly sensitive to AFB1 
(Muller et al., 1970) while a variety of mouse strains were relatively resistant to 
AFB1 in carcinogenicity studies (Newberne et al., 1982).  In general, young 
animals are more susceptible than older ones to the toxic effects of AFs (CAST, 
2003).  However, Newberne (1986) reported that weanling rats are more 
sensitive than newborn and older animals (1 yr or more) to toxic effects of AFB1.  
Also, male rodents are more sensitive to the toxic and carcinogenic effects of 
AFB1 than females (Cullen and Newberne, 1994).  
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AFs have been associated with acute and chronic toxic effects, 
particularly hepatitis and hepatic cancer, in multiple animal species.  
Contamination of livestock feed with AFs often results in poor growth and feed 
conversion efficiency, increased disease susceptibility, and increased mortality 
rates (Smith and Hamilton, 1970; Jones et al., 1982; Huff et al., 1986).  For 
instance, feeder pigs can suffer weight loss, rough hair coat, anorexia, ataxia, 
tremors, coma, and death from dietary AF exposure (Coppeck et al., 1989).  In 
dairy cattle, ingestion of contaminated feed has been associated with decreased 
milk output carrying a metabolite AFM1 (Hsieh, 1985), tachycardia, and death 
(Cockcroft, 1995).  In turkeys, acute necrosis and bile duct proliferation have 
been reportedly associated with ingestion of dietary AFs (Lancaster et al, 1961).  
In dogs, acute aflatoxicosis is clinically manifested by jaundice, abdominal pain, 
edema, anorexia, GI bleeding, and death (Ngindu et al., 1982).  Also, several 
reports have indicated that, hepatic and renal injuries, GI tumors, urogenital 
system toxicity, fetotoxity, and liver cancer (i.e. HCC) are linked to dietary AFB1 
exposure in rats that ingested contaminated feed (Clifford and Rees, 1967; 
Goerttler et al., 1980; Butler and Hempsall, 1981). 
Generally, acute and chronic exposure to large doses of AFB1 can cause 
liver failure and ultimately, death of the animal, while with low doses, necrosis 
occurs (Roebuck and Maxuitenko, 1994).  Sublethal doses of AFs may lead to 
chronic toxicity and low levels of chronic exposure can result in cancer (Wogan 
and Newberne, 1967; Sinnhuber et al., 1977), primarily liver cancer in certain 
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species (Busby and Wogan, 1984).  Other effects of AFs (mainly AFB1) in 
multiple animal species include severe hypoproteinemia, hemorrhagic anemia 
and lesions, impaired blood coagulation, fatty liver, immunosuppression, 
unscheduled pathologic changes to organs, and teratogenic effects (Doerr et al., 
1974; Hayes, 1981; Cysewski et al., 1978; Robens and Richard, 1992; CAST, 
2003).    
 
1.7.2  Human Toxicity 
1.7.2.1  Acute Toxicity 
In developed countries, the levels of AF contamination in foods are 
typically too low to cause severe aflatoxicosis, however, in less developed 
countries human vulnerability can vary with age, health, quantity, and duration of 
AF exposure (U.S. FDA, 2003).  It is estimated that ingestion of 2-6 mg AF/day 
for one month can lead to acute hepatitis and death in humans (Patten, 1981).  
In humans, AF exposure is manifested primarily as an acute hepatitis and is 
usually associated with ingestion of highly contaminated foodstuffs, particularly 
corn and peanuts (Krishnamachari et al., 1975a,b; Shank, 1977; Ngindu et al., 
1982).  Patients with acute aflatoxicosis typically experience symptoms including 
jaundice, low-grade fever, GI bleeding, edema, depression, anorexia, diarrhea, 
fatty liver, ascites, and abdominal pain, and possibly, liver failure, and death 
(Ngindu et al., 1982; CAST, 2003). 
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A severe outbreak of acute hepatitis due to dietary AFs occurred in India 
in 1974.  In the outbreak, death occurred in about 25% of the patients that had 
consumed AF-contaminated corn at levels of 0.25-15 mg/kg (Krishnamachari et 
al., 1975a,b).  Liver tissues obtained from patients that died contained 
detectable AFB1 levels, which confirmed their exposure to the contaminated food 
(CAST, 2003).  Another incident, which solidified the evidence of acute toxicity in 
India, was a fatal hepatitis outbreak in Kenya that was attributed to ingestion of 
AF-contaminated maize (Ngindu et al., 1982).  Additionally, the most severe 
outbreak of AF poisoning occurred recently in Kenya and was linked to 
consumption of meals prepared from locally grown and poorly stored maize 
contaminated with AFs.  This outbreak was blamed for 125 deaths, which was 
39% of the 317 cases reported from early May to July 20, 2004.  Analysis of 31 
food samples including maize and maize products from households in the 
affected communities revealed AFB1 contamination levels as high as 8,000 ppb 
(CDC, 2004). 
Acute exposure to AFs via contaminated diets has also been linked to 
Kwashiorkor and Reye’s syndrome, both of which are of undefined etiology.  
Geographically, Kwashiorkor has been associated with the seasonal occurrence 
and distribution of AFs in foods (Hendrickse et al, 1983).  The link was shown to 
be credible because Hendrickse (1985) evaluated liver tissues taken at autopsy 
from 36 children with Kwashiorkor and found AFs to be the cause of this human 
disease.  Also, animals given dietary AFs experienced hypoalbuminemia, fatty 
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liver, and immunosuppression, which are some of the attributes of Kwashiorkor 
(CAST, 2003).  The link of Reye’s syndrome (RS) to dietary AFs, however, 
remains controversial (CAST, 2003).  Some manifestations of RS have been 
associated with AF because the toxin has been found in RS patients in some 
countries including Thailand, New Zealand, and the United States (Shank et al., 
1971; Becroft and Webster, 1972; Ryan et al., 1979).  However, cause-effect 
relationship of AFs with RS has not been adequately established (CAST, 2003). 
 
1.7.2.2  Chronic Toxicity 
The most commonly associated effect of chronic AFB1 exposure is the 
increased incidence of hepatocellular carcinoma (HCC) (Shupe and Sell, 2004), 
although lung cancer is also a risk among workers handling contaminated grains 
(Kelly et al., 1997).  HCC is reportedly the fifth most common cancer and the 
third most common cause of cancer deaths worldwide (Pisani et al., 2002).  
About 80% of the HCC cases occur in developing countries (Wild and Hall, 
2000).  Internationally, there are geographic variations; a low incidence 
occurring in the Western world including the US and countries in Western 
Europe (4 cases per 100,000 people); and a particularly high incidence of up to 
150 per 100,000 people in parts of sub-Saharan Africa, China, and South East 
Asia (Manns and Kubicka, 1997). 
Epidemiological studies conducted in Africa and Asia reveal an 
association between HCC and dietary AF content (Jaimez et al., 2000).  
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Moreover, the combination of AF with hepatitis B and C, which is prevalent in 
Asia and sub-Saharan Africa, is reportedly synergistic, increasing the relative 
risk of developing liver cancer to more than 10-fold compared with either 
exposure (Qian et al., 1994; Jackson and Groopman, 1999; Turner et al., 2000).  
In addition to the relative risk, the potency of AF in individuals infected with HBV 
(HBsAg+) is about 30-fold higher compared to that of non-infected (HBsAg-) 
individuals (Henry et al., 2002). 
Other adverse effects that have been linked to AF exposure and toxicity 
include genetic mutation (GC to TA transversions) at codon 249 of tumor 
suppressor gene p53, DNA damage, AF interaction with RNA and intercellular 
proteins, and teratogenicity (Wang et al., 1999; Smela et al., 2001; Eaton et al., 
1994).  In addition, AFs are also associated with stunting growth in children 
(Gong et al., (2002).  It is also reported that even at low levels of exposure, AFs 
can suppress the immune system (cellular and humoral) and subsequently 
increase animal susceptibility to bacterial, viral, parasitic, and other fungal 
infections (Peska and Bondy, 1994; Turner et al., 2003; Miller and Wilson, 
1994).   
 
1.8  Molecular Mechanism of Action 
1.8.1  Mutagenicity   
AFB1 is reportedly a direct acting mutagen that covalently interacts with 
DNA (Essigmann, 1977).  It is metabolized in the animal liver by the action of 
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phase I metabolizing enzymes, primarily cytochrome P450, resulting in the 
formation of the AFB1-8, 9-epoxide and other metabolites (Figure 2).  The 
cytochrome P450 enzymes are mostly concentrated in the liver but are also 
found at lower concentrations in nearly every other tissue in the body, including 
lungs and kidneys (Guengerich and Mason, 1979).  The most important 
metabolite is the AFB1-exo-8,9-epoxide, which is highly reactive and is required 
in order to damage DNA (Miller, 1978).  The exo-8,9-epoxide covalently reacts 
with DNA at the guanine residues of specific sites to form a number of adducts 
(Essigmann et al., 1983).  For instance, the C8 position of AFB1-exo-8,9-epoxide 
intercalates into DNA at the N7 position of guanine forming 8,9-dihydro-8-(N7-
guanyl)-9-hydroxy-AFB1 adduct (Gopalakrishnan et al., 1990) (Figure 3). 
This adduct can break down into two secondary DNA lesions (i.e. the 
apurinic site lesion and a more stable AFB1-formamidopyrimidine (FAPY) 
adduct) and collectively, may lead to heritable genetic alterations that can 
enhance malignant transformation of the affected cells (Smela et al., 2001).  
Although structural variations exist among the AFB1-induced DNA adducts 
formed in treated cells, the mutational profile of AFB1 is dominated by one 
genetic change: GC to TA transversion.  To date, studies in biological systems 
indicate that GC to TA transversion is the most frequently observed mutation 
induced by the chemically reactive forms of AFB1 (e.g. AFB1-epoxide or other 
electrophilic derivatives) (Smela et al., 2001).  For instance, investigations on 
AFB1 mutagenicity involving bacterial mutagenesis using an endogenous lacI 
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gene in an E. coli strain (Foster et al., 1983), ras gene of rainbow trout liver 
(Lawrence et al., 1990), lacI gene in transgenic C57BL/6 mice and Fisher 344 
rats (Gentil et al., 1992), and human liver tumors (Hsu et al., 1991; Bressac et 
al., 1991) have demonstrated the GC to TA transversion. 
 
1.8.2  Genotoxicity 
Laboratory evidence reveals that DNA damage (AFB1-N7-Gua adduct 
formation) in hepatocytes, albumin-adduct formation (Abdoulaye et al., 1999), 
decreased specific antibody production, covalent bonding between nucleic acids 
and AFB1, and cell death, occur in humans and animals upon acute or chronic 
exposure to AFB1 (Aguilar et al., 1993; Roebuck and Maxuitenko, 1994).  One of 
the most important effects of AFB1 is its mutagenic and genotoxic effect on 
tumor suppressor gene p53.  For instance, codon 249 (at the third position) of 
p53 gene is a hotspot for AFB1 modification and AFB1-induced mutation, 
specifically AGGC to AGTC (Smela et al., 2001).  In regions where AF exposure 
is high – namely, China, India, South Africa, The Gambia, Mozambique, and 
Senegal, this mutation has been detected in 44% of the total HCC cases 
examined showed a predominance of GC to TA mutations (Katiyar et al., 2000; 
Kirk et al., 2000; Yang et al., 1997; Shimizu et al., 1999) compared to 1% of the 
HCC cases in regions with low AF exposure – namely, Australia, Europe, Japan, 
and the US (Shimizu et al., 1999; Katiyar et al., 2000; Vautier et al., 1999; Boix-
Ferrero, 1999).  Further, a dose-dependent association between AFB1 ingestion 
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and codon 249 of p53 mutations has been observed in human HCC from Asia, 
Africa and North America (Hsu et al., 1991).  
In addition to the DNA damage, AFB1 has been associated with depletion 
of RNA and intercellular proteins and involvement in teratogenicity in both 
humans and animals (Wang et al., 1999; Smela et al., 2001).  Possible 
interactions with the latter involve the formation of AFB1-8,9-dihydrodiol which 
can react with protein amino groups (e.g. lysine and tyrosine) to form a Schiff 
base that can destroy the functionality of the protein (Eaton et al., 1994).  For 
instance, several studies have reported AFB1-albumin adduct in the urine and 
blood of both human and animal studies exposed to AFB1 (Sabbioni et al., 1987; 
Wang et al., 1999; 2001).  This product is particularly important in that it reveals 
exposures to AFs over a long period of time in humans and animals (Groopman, 
1994).  
 
1.8.3  Tumorigenicity 
AFB1 has also been shown to affect genes involved in tumor growth.  
Upon administration of AFB1, hepatocellular tumors in male Fisher rats 
contained an activated form of a c-Ki-ras family proto-oncogene and high 
expression of the proto-oncogenes c-H-ras and c-myc (McMahon et al., 1986; 
1987).  Proto-oncogenes stimulate growth in the normal cell, but when mutated, 
loss of function results in rapid growth characteristic of carcinogenic cells.  
Tumor suppressor genes generally antagonize this system of uncontrollable cell 
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growth.  Unfortunately, AFB1-exo-8,9-epoxide binds to guanine and causes GC 
to TA transversions in the p53 tumor suppressor gene (TSG) in human 
hepatocytes.  Thus, this mutation causes the p53 TSG to lose its physiological 
functionality, thereby making some humans and animals biologically susceptible 
to AFB1-induced liver tumorigenesis (Aguilar et al, 1993).  For instance, Herrold 
(1969) observed small intestinal tumors in 6 of 10 Syrian hamsters dosed 0.2 mg 
AFB1 ip weekly for up to 8½ months.  Also, in studying AFB1 metabolism and 
activation, Authrup et al. (1980) used cultured colon tissues from rats and 
humans and found out that these tissues were capable of activating AFB1 to 
form DNA adducts.  Similar to hepatic and pulmonary system, the main adduct 
formed in the cultured colon was AFB1-N7-Gua (Authrup et al., 1979). 
 
1.8.4  Carcinogenicity 
Chronic exposure is the most efficient method to produce AF-induced 
hepatocellular carcinoma in both humans and animals (Roebuck and 
Maxuitenko, 1994).  Thus, AFs have been identified as human carcinogens 
(Group I) by IARC with AFB1 included as a primary carcinogenic compound and 
AFM1 as a secondary carcinogenic compound (WHO-IARC, 1993).  In particular, 
AFB1 is the most potent hepatocarcinogen known in humans (Busby and 
Wogan, 1984; Flaherty and Payne, 1997; Lopez et al., 2002).  Reports have 
indicated that the carcinogenic potential of AFB1 is mediated in part by the 
mutagenic properties of one or more of the AFB1-DNA adducts.  This effect is 
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even more severe when the AFB1 exposure victim is also positive for hepatitis B 
virus (HBV) due to the synergistic association between these two carcinogens 
(Kew, 2003).  For instance, in evaluating AF exposure in HCC cases in Taiwan, 
Lunn et al. (1997) reported that people who were exposed to AFB1 alone had a 
relative risk (RR) of 17.4 (95% CL = 3.4, 90.3) of developing HCC compared to 
RR of 67.6 (95% CL = 12.2, 373.2) for those infected with HBV and chronically 
exposed to AFB1. 
As presented above, the AFB1-DNA adduct formation (DNA damage), 
mutation and activation of proto-oncogenes, and especially the mutation of p53 
TSG (GC to TA transversion) enhances carcinogenic activities in the affected 
cells or tissues.  It is reported that this mutation abrogates the normal functions 
of p53, including those in cell cycle control, DNA repair and apoptosis, thereby 
contributing to the multistep process of hepatocarcinogenesis (Kew, 2003). 
 
1.8.5  Immunosupression Related to Aflatoxin Exposure  
Besides their potent toxicity and carcinogenic character, reports indicate 
that AFs are also immunotoxic in various animal species and possibly humans 
(Marasas and Nelson, 1987; Wild and Turner, 2002; Hinton et al., 2003; Turner 
et al., 2003).  Several studies have indicated that even at relatively low 
exposures, AFs can suppress the immune system (cellular and humoral) and 
subsequently enhance animal susceptibility to bacterial, viral, parasitic, and 
other fungal infections (Miller and Wilson, 1994; Peska and Bondy, 1994; Turner 
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et al., 2003).  Most information on AF-related immunotoxicity is generated from 
studies of farm or laboratory animals.  
The effects of AFs on the immune system can be divided into two main 
categories – 1) effects of cellular responses and 2) effects on humoral factors.  
AF effects on cellular (cell-mediated) responses include reductions of a) 
phagocytosis by macrophages, b) delayed cutaneous hypersensitivity, and c) 
lymphoblastogenesis.  The toxin effects on humoral factors include reductions of 
a) concentrations of serum immunoglobulins (IgG and IgA), b) complement 
activity, and c) bactericidal activity in serum (CAST, 2003).  Suppression of the 
immune system via cell-mediated responses is particularly sensitive to AF attack 
as evidenced by reduction of thymus weight and lower numbers of peripheral T-
lymphocytes in chickens fed AFB1 (Ghosh et al., 1990), lower numbers of T-
lyphocytes in cattle (Bodine et al., 1984; Brown et al., 1981), and swine (Liu et 
al., 2002; Mocchegiani et al., 1998). 
Specifically, AFs have been shown to: impair immunoglobulins synthesis 
in chicken and mice; reduce complement levels in guinea pigs (Pier et al., 1989), 
chickens, and pigs (Kadian et al., 1988); impair phagocytosis and reduce 
locomotion and bactericidal activity of neutrophils in chickens; decrease 
monocyte locomotion and phagocytosis in rats, chickens, and rabbits; and 
reduce several factors involved in cell-mediated immunity in chickens (Kadian et 
al., 1988), guinea pigs (Pier et al., 1989), turkeys, cows, and mice (Reddy et al., 
1987).  In a separate study, the number of splenic CD4 (helper T) cells and 
  
28
interkeukin 2 production significantly decreased in mice upon treatment with 
AFB1 at a dose of 0.75 mg/kg (Hatori et al., 1991). 
In humans, however, evidence of immunosuppression by AFs is limited 
and uncertain.  In a study by Turner et al. (2003), 93% of Gambian children that 
participated tested positive for AF-albumin adducts in their sera at a range of 5-
456 pg/mg.  In that study, a multivariable analysis revealed that secretory 
immunoglobulin A (sIgA) was markedly lower in children with detectable AF-
albumin adduct compared to those with nondetectable levels.  This adduct, 
which is reflective of exposure to AFs over a long period of time, and all the 
animal studies presented above suggest that immunity in humans could also be 
impaired upon acute or chronic exposure to the AFs. 
It should be noted that immunosuppression by a toxicant (e.g. AFB1) can 
be enhanced by various mechanisms such as decreased protein and/or DNA 
synthesis (e.g. AFB1-DNA adduct or AFB1-albumin adduct), changes or loss in 
enzymatic activity, and changes in metabolism or cell cycles, which may result in 
apoptosis or necrosis.  Toxic effects on T-lymphocytes (Dugyala and Sharma, 
1996) and/or other lymphoid cells such as the cytotoxic T-cells and natural killer 
cells (Methenitou et al., 2001), which impair the function of direct or indirect 
killing of tumor cells, can have pronounced and devastating effects, especially 
during the progression phase of tumorigenesis (Raisuddin et al., 1991; Hinton et 
al., 2003). 
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1.9  Impact of Aflatoxins on Selected Nutrients    
Chronic AF exposure has been shown to affect nutritional status in 
multiple animal species.  In chickens, AFs have been shown to significantly 
reduce nutrients including vitamin A (VA) in liver (Pimpukdee et al., 2004) and 
vitamin D in plasma (Glahn et al., 1991).    VA deficiencies have been linked to 
compromised immune responses and increased disease susceptibility in poultry 
(Aye et al., 2000 a,b; Dalloul et al., 2002).  Vitamin A is vital for vision, controlling 
the differentiation program of epithelial cells in the digestive tract and respiratory 
system, skin, bone, the nervous system, the immune system, and for 
hematopoiesis (Gursu et al., 2002).  Because the nutrient induces 
lymphoproliferation to stimulate the immune system, deficiency has been shown 
to decrease specific antibody production, the number of circulating lymphocytes, 
and lymphocyte proliferation (West et al., 1991).  VA deficiency is the leading 
cause of childhood blindness in developing countries, and is a major contributor 
to childhood morbidity and mortality resulting from common infections (Fieldler et 
al., 2000). 
Iron (Fe) is reportedly essential in the body as a cofactor in several 
enzymatic and metabolic functions (Lehninger et al., 1997a).  Fe is required for 
the synthesis of the heme proteins including hemoglobin and myoglobin, 
metalloenzymes, and cytochromes (Nicholls, 1996; George-Gay and Parker, 
2003).  It is reported that Fe deficiency (FeD) is one of the most prevalent 
nutritional deficiency problems in the world.  FeD has been associated with 
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anemia, impaired cognitive development, and fitness and aerobic work capacity 
in humans (Rodgers et al., 2002).  In animals, it is reported that AFs have been 
shown to affect the physiological concentrations of Fe in the serum (Dimri et al., 
1994; Harvey et al., 1988), however its potential effects have not been evaluated 
in humans.  Further studies are warranted to evaluate the impact of AFs on Fe 
levels in humans. 
Zinc (Zn) is essential in the body as a cofactor in many enzymatic and 
metabolic functions (Lehninger et al., 1997a).  It promotes health via its role in 
immunity, cognitive development, and human capacity (Mendez and Adair, 
1999).  The WHO estimates that Zn deficiency (ZnD) affects about a third of the 
world’s population, although severe ZnD is rare (Rodgers et al., 2002).  ZnD can 
lead to reduced growth rate, skin lesions, impaired immune response, low sperm 
count, fetal abnormalities, and cognitive impairment (Chesters, 1996; Prasad et 
al., 2001).  The role of AFs in ZnD is not certain in humans but animal data 
suggest that AFs may promote the extent of ZnD, particularly during early 
childhood (Kalorey et al., 1996; Mocchegiani et al., 2001).  Further studies are 
needed to determine the extent of AF effect on Zn levels in humans since the 
impact of ZnD is very significant especially in developing countries. 
 
1.10 Regulatory and Economic Impact  
As stated above, consumption of AFB1-contaminated rations results in 
dose-dependent excretion of AFM1 in milk of dairy animals (Neal, 1998; Chopra 
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et al., 1999).  This hydroxylated metabolite of AFB1, AFM1, has been identified 
as a secondary carcinogenic compound (IARC, 1993), although it is two orders 
of magnitude less toxic than AFB1 (Hsieh, 1985).  Therefore, AFs are strictly 
regulated in many countries of the world with known standards ranging from 4 – 
50 ug/kg (ppb) food intended for human consumption.  For instance, Denmark 
and Germany have a regulatory limit of total AFs set to 4 ppb in human foods 
whereas the allowed limit is 50 ppb in Taiwan (CAST, 2003).  Also, the U.S. FDA 
has set a limit of 0.5 ppb for AFM1 in milk while that of AFB1, the most toxic and 
carcinogenic of all the AFs, is set to 20 ppb of AF for foods intended for human 
consumption (CAST, 2003).  This means that large amounts of tainted food or 
food products and milk or milk products may be discarded in developed 
countries causing substantial economic losses to farmers. 
Contamination of foods and feeds with mycotoxins is a significant 
worldwide problem.  It is estimated that about 20 - 25% of the world’s food 
crops, mainly of plant origin, are affected annually in some way by mycotoxins 
(Fink-Gremmels, 1999; Gilber and Anklam, 2003).  Since moldy grain often 
cannot be sold, farmers usually feed it to their livestock.  Consequently, the AF 
contamination in poor quality grain reduces animal productivity and decreases 
the food supply in developing nations.  The economic losses from lower animal 
production can lead to even greater poverty, which further enhances the 
conditions culpable for poor human health (Miller and Marasas, 2002). 
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Although effort to precisely calculate the economic losses due to AF 
contamination is usually a difficult task, some estimates have been made in 
several countries.  For instance, a comprehensive economic assessment 
undertaken by Lubulwa and Davis (1994) revealed that the annual social costs 
of AFs in Indonesia, Thailand, and the Philippines amounted to almost 1 billion 
U.S. dollars.  This estimate included losses to human and animal health and 
market impacts.  In a recent World Bank study (Otsuki et al., 2001), it was 
reported that compliance with an AF standard of 2 ppb could lead to an 
estimated economic loss of about $720 million (in food export only) in African 
nations.  However, in the context of the sub-Saharan regions of Africa, where AF 
levels are comparable to or worse than the situation in the three Asian nations 
mentioned above, health losses are likely to present a more severe AF-related 
impact than the economic aspect because corn is a staple in the human diets 
(Lubulwa and Davis, 1994).   
 In the U.S., the potential estimated cost of mycotoxin contamination of 
crops ranges from $418 million to $1.66 billion, with the mean estimated cost of 
about $932 million.  Additionally, the estimated costs to manage mycotoxins in 
the United States, including research and testing, are in the tens of millions of 
dollars.  Further, livestock losses and mitigation expenses could increase the 
mean estimated cost by an additional $6 million and $466 million, respectively 
(U.S. FDA, 2000; CAST, 2003).   
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1.11 Intervention Strategies for Aflatoxins 
1.11.1  Pre-harvest Intervention 
In historical context, it is important to note that the significance of pre-
harvest contamination of corn by the aflatoxigenic fungi was largely discounted 
until 1971, since AF contamination was only associated with poor post-harvest 
storage facilities and conditions (Eddins, 1930; Butler, 1947; CAST, 2003).  It is 
now known that under favorable conditions, the Aspergillus fungi can grow and 
produce AFs in developing seeds of crops in the field, particularly corn, peanut, 
and cottonseed.  The fungi have been found to be most abundant between 
latitudes 26° to 35° north or south of the equator (CAST, 2003), primarily in 
tropical areas including the sub-Saharan Africa, Asia, and South America.  As 
noted above, several studies indicate that the AF biosynthetic pathway is very 
sensitive to certain environmental, biochemical, and/or genetic influences (Gupta 
and Venkitasubramanian, 1975; Ominski et al., 1994; Cary et al. 2000a; 
Bhatnagar et al, 2003; CAST, 2003).  Results of these studies suggest that field 
strategies could be devised to perturb or disrupt the AF biosynthetic pathway, 
particularly during the interaction between AF-producing fungi and plants 
(Bhatnagar et al., 2003). 
AF production can be dramatically influenced by environmental factors 
through direct effects of the fungi or indirect effects on the crop and crop-
associated insects and microflora.  The factors, which include temperature, 
humidity, pH, and specific salts or acids common in foods/feeds, can diminish or 
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prevent AF production through direct effects on A. flavus.   For instance, at 
temperatures above 40 oC, AF production is prevented, although high 
temperature and favorable associated conditions can enhance the fungal 
colonization of the crop (Bhatnagar et al., 1994).  The direct and indirect 
environmental influences of fungal contamination on the host also include high 
temperatures and prolonged drought stress.   
During drought and high temperatures, wounded surfaces of corn kernels 
can be excellent sites for A. flavus colonization and possible AF production 
(Diener et al., 1987).  Also, these conditions can reduce the natural defenses of 
groundnuts by shutting down phytoalexin production, making the pods more 
susceptible to fungal attack (Hill et al., 1985; Cole et al., 1989).  Although 
producers have no control over these environmental conditions, proper irrigation 
schemes can help reduce or alleviate this problem if it is economically feasible 
(CAST, 1989).  For instance, a study by Cole et al. (1989) found that AF 
concentration in edible grade groundnuts grown under drought stress was high 
whereas edible grade kernels from irrigated groundnuts contained practically no 
AFs, suggesting that drought stress is a significant contributor of AF 
contamination in foods/feeds.   
Insect infestation also creates an environmental stress to crops, thus 
making them susceptible to fungal colonization and AF production.  Methods to 
reduce growth of Aspergillus fungi and production of these AFs in the field 
include the application of fungicides and insecticides.  Unfortunately, the 
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fungicidal approach has generally not been effective while crop treatment with 
insecticides during fungal contamination has shown some promising results in 
slowing the growth of the fungi (Lisker and Lillehoj, 1991).   
Another pre-harvest control measure against fungal colonization and AF 
production is to select naturally resistant plant species or breeding hybrids, 
which have desired genetic traits and may impede fungal growth and toxin 
production (Lisker and Lillehoj, 1991).   Conventional plant breeding techniques 
have made this possible by identifying a variety of corn strains (Gorman and 
Kang, 1991; Lisker and Lillehoj, 1991) and groundnuts (Mehan et al., 1986) with 
reduced susceptibility to inoculation and/or AF contamination by aflatoxigenic 
fungi.  Efforts have been made and research continues to develop AF resistant 
crops, via modifying plant genes to inhibit AF biosynthesis and withstand 
extreme temperature and moisture conditions (Minto and Townsend, 1997; 
Ehrlich et al., 1999b; Bhatnagar et al., 2003).  
 
1.11.2  Post-harvest Storage Conditions 
Post-harvest contamination occurs mainly when crop drying is delayed 
and storage conditions favor fungal growth and production of the toxins (CAST, 
2003).  Conditions that maximize AF production and subsequent contamination 
of stored grain include a relative humidity greater than 85%, air temperature 
ranging from 24 to 35 °C (optimum temperature being 30.5 °C), and a grain 
moisture content of 14-32% (Cole et al., 1995; Payne, 1998; Shephard, 2003).  It 
  
36
must be noted that slowly growing fungi may up-regulate the water content of 
the grain through metabolic mechanisms when the grain moisture falls below 
14% (Wilson and Payne, 1994).  Therefore, it is essential to allow the grain to 
mature and dry in the field.  However, if conditions do not permit the drying 
process, the grain can be dried after harvest before storage (Williams, 1991). 
Temperature also affects the moisture content in food/feed products.  
When temperatures are warm, it almost invariably increases the humidity of the 
storage facility, thereby enhancing fungal contamination.  Prevention of the 
effects of humidity can be achieved when grain is stored in buildings that allow 
proper aeration.  Usually, low and flat buildings with dimensions of the width 
approximately half of its height are recommended to enhance adequate air flow, 
keeping temperatures and moisture content in the facility relatively low (Williams, 
1991). 
Another problem that faces producers is infestation by insects, rodents, 
and/or birds which consume the stored foods and inflict damage to the 
remaining grains, making them highly susceptible to fungal attack and toxin 
production.  Control of these pests may be achieved by using storage facilities 
made with steel or concrete and elevated from the ground.  Pesticide application 
may also be used, but has not been completely effective.  In addition, pesticide 
residues have the potential to adversely affect animal and human health upon 
exposure (Williams, 1991).  As presented above, pre-harvest and post-harvest 
storage conditions are difficult to control or manage, making AF contamination 
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unavoidable in foods/feeds (Phillips, 2002).  Thus, it is imperative that effective, 
yet economically feasible decontamination or intervention strategies be devised 
for the protection of both animal and human health against the harmful effects of 
these toxic substances.  Several methods have been reviewed, all of which are 
geared towards minimizing contamination of foods/feeds and diminishing 
biological exposure of humans and animals to the AFs.  Below are some of the 
preventive strategies that are applied or under extensive scientific investigation. 
 
1.11.3  Detoxification Methods for Aflatoxins 
1.11.3.1  Physical Methods  
The first option of the AF reduction strategies is the physical removal of 
fungal-damaged kernel/seed/nut from the intact and uncontaminated product 
(Park, 2002).  This includes non-invasive methods such as cleaning, sorting, and 
handpicking (Dickens and Whitaker, 1975) that do not significantly affect the 
integrity or texture of the product.  In addition, floatation and density segregation 
methods have been useful in separating the AF-contaminated corn and peanut 
which are generally less dense compared to the undamaged grain (Cole, 1989).  
Dry-milling is useful because fungal contamination is usually concentrated on 
the outside of the kernel so that the highest AF concentrations are found in the 
germ and hull fractions.  Separation of these fractions from the rest of the grain 
allows for the removal of the majority of AFs (Trenholm et al., 1991; Park, 2002).  
Although these methods effectively reduce AF levels by 40-80%, and are 
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relatively cost-effective processes, physical removal is not effective to achieve 
complete removal of the contaminated product (Park, 2002).   
Although AFs are relatively heat-stable, thermal inactivation has been 
used to reduce toxin levels in foods and feeds.  The toxins are not completely 
destroyed when boiled in aqueous solution, autoclaved, and processed utilizing 
a variety of food/feed processing techniques (Christensen, 1977).  Several 
studies have indicated that roasting is a good method used to reduce AF levels 
in certain commodities, including oil and dry-roasted groundnuts (Peers and 
Lindsell, 1975), microwave roasted groundnuts (Luter et al., 1982), and corn and 
coffee (Conway et al., 1978; Levi, 1980).  For instance, Conway and co-workers 
reported that roasting corn at temperatures ranging from 145 to 165 oC reduced 
AFB1 levels by 40-80%.  In a recent study, the process of toasting AF-
contaminated maize samples at 285 oC reportedly reduced AF levels by a 
maximum of 81% (Mendez-Albores et al., 2004). 
 
1.11.3.2  Chemical Inactivation of Aflatoxins 
Several chemical methods of AF detoxification have also been used and 
include ammoniation, ozonation, and nixtamalization.  Ammoniation involves 
subjecting contaminated food products (e.g,. corn, peanuts, or cottonseed) to 
ammonium hydroxide or gaseous ammonia and heat to hydrolyze the lactone 
ring (Park and Price, 2001).  Several ammonia-based procedures have been 
developed and studied but the high pressure/high temperature method utilizing 
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ammonia (0.5-2.0%) under controlled conditions of moisture (12-16%), pressure 
(45-55 psi), and temperature (80-100 oC) for 20-60 min has been shown to be 
the most efficient and produces a relatively safer product (Park, 2002).  If 
ammoniation is allowed to proceed for a sufficient time period decarboxylation 
will occur and the process will form less toxic compounds (Park et al., 1988).  
Whether these compounds can exhibit toxicity in humans or animals however 
has not yet been clearly established.  However, it is reported that the 
ammoniation process subjects AF molecules to chemical modification into 
compounds possessing reduced or non-detectable toxic or mutagenic potentials.  
The same report indicated that the presence of identified AF/ammonia reaction 
products, including aflatoxin D1 and a compound with molecular weight of 206 
g/mol, in animal feeds exert no health impact on animals (Park, 2002). 
Nixtamalization, the alkaline treatment of corn as part of the process of 
making tortillas, has also been reported to significantly reduce AF levels (Ulloa 
and Herrera, 1970), although AFB1 may be reformed upon acidification (Price 
and Jorgensen, 1985), making this process inadvisable.   Ozonation may also 
reduce AF contamination (McKenzie et al., 1997).  In one study, ozonation of 
contaminated corn effectively eliminated AF toxicity in turkey poults without 
affecting the nutritional value of the feed (McKenzie et al., 1998).   
Dietary inclusion of specific chemicals or nutrients has also been shown 
effective in the reduction of AF toxicity.  As an example, inclusion of vitamin A 
has been shown to inhibit the formation of AFB1-adduct and phenobarbitol may 
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increase the rate of natural detoxification processes (Leeson et al., 1995).  In 
addition, vitamin E has also been shown to ameliorate AF-induced alterations in 
steroidogenesis in mice.   Further, it has been suggested that vitamin E may 
reduce AF toxicity by the reduction of both oxidative damage and bioavailability 
of the toxin (Verma and Nair, 2002).  In a separate study, vitamin E was found to 
possess a high affinity for AF and it acts by forming a stable association with it, 
thus reducing the bioavailability of the toxin (Odin, 1997).  Finally, dietary 
inclusion of clay minerals, which is of particular interest in this research, has 
proved effective for binding AF in the gastrointestinal tract of animals, thus 
reducing toxin bioavailability and distribution in the blood and target organs 
(Phillips et al., 1988; Phillips, 1999).  Since this detoxification method was 
discovered (Phillips et al., 1988), many scientific studies have focused on finding 
clay minerals and other sorbents for research on mycotoxin decontamination in 
foods/feeds.   
 
1.12  Clay Research 
1.12.1  Clay Mineral Structures and Chemistry 
Solid particles of soil are grouped into three categories, including sand, silt, and 
clay, based on their sizes.  Generally, the particle size of clay minerals is less 
than 2 µm, while those of silt and sand range from 0.002 – 0.05 mm and 0.05 – 
2 mm, respectively (Sylvia et al., 1997).  Minerals are divided into classes based 
on the chemical identity of the dominant anion or anionic group.  Classes of 
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major mineral groups include: sulfides, sulfosalts, oxides and hydroxides, 
halides, carbonates, nitrates, borates, phosphates, sulfates, tungstates and 
silicates (Hurlbut and Klein, 1977).  Within these classes, minerals are further 
subdivided depending upon structural similarities (Schulze, 1989).  On the basis 
of both the number of mineral types formed and their overwhelming contribution 
to total mass of the earth’s crust,  silicates are the largest class of minerals 
identified (Schulze, 1989).   
The basic structural unit for the silicates is a SiO4 tetrahedron in which 
Si4+ is located at the center and four O2- are positioned at the apices.  The 
tetrahedral structures can be linked together by sharing four O2- ions and 
together can form a variety of more complex structures including rings 
(cyclosilicates), chains (inosiliates), sheets (phyllosilicates) and three-
dimensional arrangements (tectosilicates) (Schulze, 1989).  It should be noted 
that tetrahedra (e.g. SiO4) and octahedra (e.g. Al2O3) (Figure 4) are commonly 
found as structural components in many mineral structures (Schulze, 1989). 
 
1.12.2  Phyllosilicate Clay Minerals  
The phyllosilicate clay minerals contain both tetrahedral (Figure 5) and 
octahedral sheets (Figure 6).  The tetrahedral sheets are composed of SiO4 
tetrahedra are arranged such that three O2- ions of each tetrahedron are shared 
with the three adjacent tetrahedral components.  This O2- ion arrangement 
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Figure 4.  Structural representation of the arrangements of silicon oxide 
tetrahedral and aluminum oxide octahedral basic units of phyllosilicate clay 
minerals.  The three dimensional structures were drawn using HyperChem v 7.0 
software based on AM1 energy minimized molecules.  Adapted from Schulze 
(1989). 
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Figure 5.  Structural representation of tetrahedral sheets found in phyllosilicate 
clay minerals.  Silicon oxide basic units are arranged in such a way that they 
form the tetrahedral layer. Adapted from Schulze (1989).   
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Figure 6.  Structural representation of octahedral sheets found in phyllosilicate 
clay minerals.  Metal oxide basic units are arranged to form the dioctahedral 
layer (top), in which 2 out of every 3 octahedral sites are filled by a trivalent 
cation (e.g. Al3+); and trioctahedral layer (bottom), in which 3 of every 3 
octahedral sites are occupied by a divalent cation (e.g. Mg2+).  Adapted from 
Schulze (1989). 
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Figure 7.  Structural configuration of the linkage between silicon oxide tetrahedral and aluminum oxide octahedral 
sheets forming either 1:1 or 2:1 layer lattice structures in phyllosilicate clay minerals.  Adapted from Schulze 
(1989). 
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extends in all directions at the same plane, and the oxygens involved are 
referred to as basal oxygens.  The fourth O2- ion of each tetrahedron is not 
shared with another SiO4 tetrahedron, and is referred to as the apical oxygen 
and is free to bond to other elements.  Structures in which all the apical oxygens 
of a single sheet point to the same direction are the most common but structures 
can also occur in which these oxygens point to alternate directions.  Minerals 
that contain this sheet-like structural arrangement of the SiO4 tetrahedra are 
categorized as the phylosilicates or sheet silicates (Schulze, 1989).    
 The octahedral sheet consists of two planes of hydroxyl (OH-) groups that 
form a hexagonal closest packing arrangement.  In order to neutralize the 
negative charge of this structure, cations are located in the octahedral sites 
between the layers.  There are two possible ways of filling the octahedral sites 
depending upon the valence of the cation involved.  First, a divalent cation (e.g., 
Mg2+) must fill every available octahedral space to produce a trioctahedral 
arrangement (Figure 6).  In this case three of every three octahedral sites are 
filled, giving a formula of Mg3(OH)6 or Mg(OH)2, thereby keeping the sheet 
electrically neutral since charge is balanced within the sheet.  A second 
possibility is when a trivalent cation (e.g., Al3+) fills only two of every three 
possible octahedral sites to produce a dioctahedral arrangement (Figure 6).  To 
balance the charge and keep the sheet electrically neutral, each Al3+ ion is 
effectively surrounded by three OH- ions to give a formula of Al(OH)3. 
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 In phyllosilicate minerals, the apical oxygens from the SiO4 tetrahedral 
layer can replace OH- groups from the octahedral layer and coordinate with the 
metal cation of the octahedral layer, thus linking the octahedral and tetrahedral 
layers.  The tetrahedral-octahedral bonding arrangement commonly occurs in 
one of two ways depending upon the number of tetrahedral and octahedral 
sheets involved in the layer structure.   The 1:1 layer structure occurs when one 
tetrahedral layer is bonded to one octahedral layer, and the 2:1 layer structure 
also occurs when an octahedral layer is bonded to two tetrahedral layers, one on 
each side of the octahedral layer.  Figure 7 depicts the structural configuration of 
tetrahedral and octahedral sheets in the phyllosilicate clay minerals.  Examples 
of the 1:1 layer structure type phyllosilicates include kaolinites and halloysite, 
while the 2:1 type includes talc, pyrophyllites, micas, vermiculites, smectites, and 
chlorites.  Figure 8 is an illustration of structures of selected phyllosilicate 
minerals (Schulze, 1989). 
 The phyllosilicate mineral series are grouped by the amount of 
substitution and therefore, charge per layer.  It is reported that among the 2:1 
phyllosilicates, talc and pyrophyllite have almost no substitution and therefore 
very little charge; smectites have a layer charge per formula unit of 0.25 to 0.6;  
vermiculites have 0.6 to 0.9; and micas have complete substitution, resulting in a 
charge of 1 per formula unit (Bohn et al., 1979).  Selected mineralogical 
properties for several phyllosilicate minerals are presented in Table 3.  The 
kaolinites have 1:1 layer structure and are electrically neutral.  Adjacent layers
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TABLE 3 
 
Summary of some properties of selected silicate minerals and organic matter 
 
Mineral Group Layer type General Formula 
CEC 1 
(cmol/kg) 
Surface area 
(m2/g) Expansible 
Colloidal 
activity 
Kaolinite 1:1 Al2Si2O5(OH)4 1 - 10 10 - 20 No Low 
Montmorillonite 2:1 Nax [(Al2-x Mgx)Si4O10(OH)2] 80 - 120 600 - 800 Yes High 
Vermiculite 2:1 Nax [(Mg3)(Si4-x Alx)O10(OH)2] 120 - 150 600 - 800 Yes High 
Mica 2:1 Kx [(Al4)(Si4-x Al)O10(OH)2] 20 - 40 70 - 120 No Medium 
Organic Matter 2 -- -- 100 - 300 800 - 900 -- Medium 
 
Note.  Data presented were summarized from Bohn et al. (1979). 
1 CEC denotes the cation exchange capacity range. 
2 Properties for organic matter are shown for comparative purposes 
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Figure 8.  Structural representation of common phyllosilicate minerals. 
Adapted from Schulze (1989). 
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                           Figure 8 (Continued). 
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are held together by electrostatic bonding between the basal oxygens of the 
tetrahedral sheet and the OH- ions of the octahedral sheet.  Kaolinite is a 
common mineral in the soil and in fact, is the most common member of the 1:1 
type phyllosilicates.  These minerals have very little isomorphous substitution in 
either the tetrahedral or the octahedral sheets, thereby making their cationic 
exchange capacity and surface areas very low.  The dioctahedral smectites are 
the most common in soils among the smetitic group of minerals.  These 
smectites are very important minerals in soils found in temperate regions due to 
their high surface area and adsorptive capabilities.  One property that is relevant 
is the fact that smectites swell upon wetting and shrink upon drying.  Of 
particular significance to this research, it must be noted that the optimum 
swelling properties smectites are primarily due to the interlayer charge after 
substitution.  Other phylosilicate minerals include chlorites, palygorskite, and 
sepiolite, which are also 2:1 layer structures (Schulze, 1989).   
By virtue of industrial applications, the phyllosilicate clays are unique in 
that they have been integrated into various production processes.  Reports have 
indicated that kaolinites are widely used in ceramic industry and serves as a filler 
and coating for paper.  Similarly, vermiculite, which becomes very light and 
porous when heated, is used as filler for concrete in building and also serves as 
a thermal and sound insulator.  Montmorillonites have been employed in industry 
as decolorizing agents and for filtration of water and food products (Millot, 1979).  
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The functionality of this class of minerals is a result of the distinctive structural 
and chemical properties of silicate layers.   
NovaSil Plus (NSP), a calcium montmorillinite (CM) clay, is a 2:1 layer-
lattice phyllosilicate clay.  These 2:1 types of clay consist of layers containing 
one octahedral alumina sheet between two tetrahedral silica sheets.  Structural 
morphology of the 2:1 layer-lattice dioctahedral montmorillonite clays shows that 
SiO4 tetrahedra are linked together, with each tetrahedron sharing three O2- ions 
with three adjacent tetrahedra.  This arrangement extends in all directions to 
form a plane of basal oxygens.  Al3+ ions are octahedrally coordinated with SiO4 
sheets, in the center of clay platelets, a surface characteristic that limits the 
bioavailability of Al (Phillips et al., 2002).  The montmorillonites are a subclass of 
smectites that contain isomorphic substitution in the octahedral sheets, resulting 
in a general formula of Nax[(Al2-xMgx)Si4O10(OH)2].  These clays are naturally 
abundant and have surface areas as high as 800 m2/g, making them ideal 
sorbent materials (Borchardt, 1989) (Table 3). 
 The clay minerals possess a characteristic negative surface charge on 
their platelets.  This phenomenon results from either isomorphic substitution of 
cations within the platelet surface, or dissociation of H+ ions from the hydroxyl 
groups attached to Si and Al atoms at the broken edges of clay platelets. The 
negative charge is attributed to isomorphic substitution results from the naturally 
occurring replacement of a Si or Al atom by a cation of similar geometry, but of 
lower charge (e.g. Mg2+ for Al3+ or Al3+ for Si4+).  This phenomenon produces a 
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net negative charge, which is distributed across the platelet.  Overall, the 
negative charge on 2:1 clays results primarily from the isomorphic substitution 
and, to a lesser extent, dissociation of H+ ions from the hydroxyl groups. The 
negative charge is generally neutralized by cations (e.g., Na+ and Ca2+) attracted 
into the interlayer regions (Huebner et al, 1999).  Interlayer cations are subject to 
formation of layers of hydration, thus water enters the interlayer regions of the 
clay and causes it to swell (Bohn et al., 1979).  The interlayer region and other 
surface characteristics have been established to be especially important in the 
binding efficacy of NS for AFs (Grant and Phillips, 1998).  
 
1.12.3  Sorption of Ligands onto Clay Surfaces 
A systematic, quantitative, and qualitative means of investigating 
adsorption is very essential when analyzing sorption processes and comparing 
effectiveness of sorbent materials.  One simple approach is the single-
concentration sorption method, a procedure that measures the sorption of one 
concentration of sorbate (or ligand) by one concentration of sorbent in aqueous 
solution that allows for rapid screening of large sample numbers (Phillips et al., 
1988).  More importantly, complete isothermal analysis reportedly measures 
surface adsorption using a fixed concentration of sorbent, coupled with a range 
of initial ligand concentrations at a constant temperature (Kinniburgh, 1986). 
The isothermal procedure was originally developed for the purpose of 
examining adsorption of a gas to a homogenous solid surface, with the 
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assumption that the sorbent surface contains a finite number of sorption sites 
(Langmuir, 1916).  The mathematical equation introduced by Langmuir relates 
the amount of ligand bound to that unbound at equilibrium and incorporates 
capacity (Qmax) and affinity (Kd) parameters.  The Qmax provides an estimated 
maximum amount of ligand that could be adsorbed by a given weight of the 
sorbent under optimum experimental conditions, while the Kd is an equilibrium 
constant which depicts the sorbent affinity for the ligand.  Several mathematical 
equations have been developed to model isothermal data after the introduction 
of the Langmuir equation (LM).  These equations include Freundlich, Langmuir-
Freundlich, generalized Freundlich, Multi-Langmuir, and Toth (Kinniburgh, 
1986).  For instance, the Freundlich equation utilizes a generalized K to 
establish a computational relationship between the amount bound and that left in 
solution at equilibrium, and it incorporates an n variable to evaluate the deviation 
of an isothermal curve from a linear sorption isotherm.  The LM equation is most 
applicable to a single ligand adsorbing to a single type of site on a particular 
sorbent, whereas the Langmuir-Freundlich, Freundlich, generalized Freundlich, 
and Toth equations are applicable to heterogeneous solid surfaces.  Multi-
Langmuir equation has also been used to model heterogeneous adsorption by 
the addition of Langmuir equations to delineate different sites (Langmuir, 1916). 
The shapes of isotherm curves are generally categorized into four main 
types, designated H (high affinity), L (Langmuir), S (sigmoidal), and C (constant 
partion), representing different adsorption mechanisms (Giles et al., 1960, 
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1974a,b; Kinniburgh, 1986).  Both the H and L isothermal shapes are 
characterized by initial steep concave slopes.  The shape of the H type isotherm 
curve is generally shows a much sharper initially elevation at low concentrations 
of the ligand and it plateaus quickly, an indicative of a high initial affinity and 
rapid saturation of the binding site(s).  However, the shape of the L type 
isotherm curve demonstrates a more gradual initial rise before plateaus, which 
also indicates saturation of binding site(s).  The S isotherm shape is exemplified 
by very little initial ligand binding, followed by a steep concave elevation and 
then a plateau.  Basically, this shape suggests that the adsorption process is 
contingent upon the ligand concentration, thus, the presence of initially bound 
ligand enhances the affinity of other molecules to bind as well.  When saturation 
point is reached, the isotherm shape begins to plateau.  Lastly, the shape of the 
C type isotherm denotes a constant partition process.  In this case, the isotherm 
shape demonstrates linearity in the sorbent-ligand interactions and hence the 
ligand concentration sorbed increases continuously as its concentration in the 
aqueous phase also increases.  Analysis of these isotherm shapes compared to 
standard isothermal curves supplies a great deal of information to be able to 
predict the adsorption mechanism involved in the binding process (Grant and 
Phillips, 1998; Lemke, 2000). 
Thermodynamic parameters, such as Qmax and Kd, may also be used to 
estimate the effectiveness and affinity of a sorbent and allow comparison 
between sorbent materials (Grant and Phillips, 1998).  From these isotherm 
  
57
equations, Kd values can be used to calculate the Gibbs standard free energy 
change of adsorption (∆Goads) and the enthalpy of adsorption (∆Hads) (Fischer 
and Peters, 1970; Stumm et al., 1992), giving information about the adsorption 
mechanism, particularly, physisorption or chemisorption.  Physisorption involves 
weak associations which include van der Waals, dipole-dipole, induced dipole, 
and hydrogen bonding.  Chemisorption implies a chemical reaction or sharing of 
electrons between the adsorbent and the adsorbate.  Physisorption is described 
as having an enthalpy of <20 kJ/mol, while chemisorption is generally >20 
kJ/mol (Gu et al., 1994). 
 
1.13  Geophagy in the Historical Context 
The use of clay by humans and animals is not a recent phenomenon.  
Geophagy, the deliberate consumption of soil, in particular clay minerals, alone 
or with food, has been recorded from traditional human societies on all 
continents for centuries, especially among pregnant women (Johns and 
Duquette, 1991; Abrahams and Parsons, 1996; Geissler et al., 1999; Carretero 
et al., 2002).  This practice is also widespread throughout the animal kingdom 
including mammals, birds, and reptiles. (Diamond, 1999; Gilardi et al., 1999; 
Wilson, 2003).   
Although critics view it as a maladaptive or compulsive behavior driven by 
cravings, consumption of certain clays is reported to have medicinal values and 
can be beneficial to both humans and animals (Johns and Duquette, 1991; 
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Krishnamani and Mahaney, 2000; Mahaney and Krishnamani, 2003).  The 
potential health benefits of geophagy (although ill-defined in the scientific 
literature) may include the enterosorption and decreased bioavailability of toxic 
chemicals and hazardous microbes from contaminated food and water.  
Possible explanations, regarding geophagy, include the belief that the practice 
may provide essential minerals (Johns and Duquette, 1991) and/or may detoxify 
the body of poisonous substances (Gilardi et al., 1999).  Specifically, Peruvian 
macaws consume clay after ingestion of seeds and unripe fruits high in alkaloids 
(Diamond, 1999).  In humans, clays have been used therapeutically as laxatives 
and antidiarrhetics and consumption has been associated with the sorption of 
toxins, bacteria, and viruses (Carretero et al., 2002).  
Although many types of clay and zeolitic minerals are routinely added to 
animal feeds for various purposes, it is important to note that not all clays are 
beneficial.  In particular, inclusion of clinoptilolite in an AFB1-contaminated diet 
resulted in severe liver pathology in pregnant rats that was not observed in the 
presence of AFB1 alone, suggesting the sorbent may be involved in either 
nutrient sequestration or metabolism of the AFB1 on catalytic surfaces of the 
clay (Mayura et al., 1998).  Nonselective or versatile sorbents may bind 
enzymes and critical nutrients, and may release sorbed contaminants, making 
prolonged use inadvisable.  This presents a great challenge particularly during 
prenatal development because mothers and fetuses are highly prone to 
nutritional deficiencies.  For instance, a previous research found that the 
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hemoglobin, hematocrit, and red blood cell levels in rats fed high levels (20%) of 
kaolin in the diet throughout the gestation period were significantly reduced 
compared to controls, indicative of kaolin-related maternal anemia, and pups 
borne to these rats had lower birth weights (Patterson & Staszak, 1977).  
Therefore, it is essential to completely evaluate the safety of any potential 
additive prior to routine inclusion in animal feeds or humans diets. 
 
1.14  Detoxification by Clay-Based Enterosorption Method  
The use of non-nutritive materials to adsorb or covalently bind AFs has 
been a method of current interest for AF decontamination.  In particular, the use 
of calcium montmorillonite clays (e.g. NovaSil) to tightly sorb and inactivate 
AFB1 in the gastrointestinal tract of various animal species has shown significant 
promise in the prevention of aflatoxicoses.  Several studies have demonstrated 
that inclusion of NovaSil (NS), an anti-caking agent previously used in animal 
feeds, protected multiple animal species from the adverse effects of AFs 
including: rodents (Mayura et al., 1998), chickens (Phillips et al., 1988; Kubena 
et al., 1990a), turkeys (Kubena et al., 1991), dogs (Bingham, 2003), swine 
(Lindermann et al., 1993), lambs (Harvey et al., 1991a), goats (Smith et al., 
1994), and dairy cattle (Harvey et al., 1991b) (Table 4).  In addition, the clay (at 
1.0% level in feed) reduced AFM1 levels in milk without altering the nutritional 
quality or causing overt toxicity itself (Ellis et al., 1990; Harvey et al., 1991) 
(Table 4).   
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TABLE 4 
 
In vivo studies with dietary NovaSil (NS) or NSP1 for mycotoxin prevention: Efficacy and selectivity 
 
Animals Mycotoxin 
in Feed 
% NS/NSP in 
Feed (duration) 
NS/NSP 
Toxicity 
Major Effects of NS/NSP Reported References 
chickens AFs 0.5 (28 d) None Growth inhibition diminished; gross hepatic 
changes prevented; decreased mortality 
 
Phillips et al., 1988 
chickens AFs/OTA 0.5 (21 d) None Decreased growth inhibitory effects; no 
effect against ochratoxin A  
 
Huff et al., 1992 
chickens AFs/TTC  0.25/0.37/0.8 
(21 d) 
None Diminished growth inhibition; no effect 
against trichothecenes (e.g. T-2 toxin) 
 
Kubena et al., 1990b 
chickens None 0.5/1.0 (14 d) None NS did not impair utilization of riboflavin, 
vitamin A, Mn; slight reduction of Zn 
 
Chung et al., 1990 
Turkeys AFs 0.5 (21 d) None Decreased mortality rates 
 
Kubena et al., 1991 
Rats AFs 0.5 (21 d) None Significant prevention of maternal and 
developmental toxicity 
 
Mayura et al., 1998 
Pigs  AFs 0.5 (42 d) None Diminished growth inhibition 
 
Lindermann et al., 
1989 
Pigs  AFs 0.5/2.0 (28 d) None Decreased growth inhibition; prevented 
serum effects and hepatic lesions 
 
Harvey et al., 1989 
Dogs AFs 0.5 (48 hr) None Significantly reduced bioavailability of AFs 
and excretion of AFM1 in urine. 
 
Bingham, 2003 
Lambs AFs 2.0 (42 d) None Diminished growth inhibition and 
immunosuppresion 
 
Harvey et al., 1991a 
Diary Cows AFs 0.5/1.0 (28 d) None Reduced the levels of AFM1 in milk Harvey et al., 1991b 
 
Note.  1NSP = NovaSil Plus ; AFs = Aflatoxins; TTC = Trichothecenes ; OTA = Ochratoxin A
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NovaSil, at an inclusion level as low as 0.5% in the AF-contaminated diet 
of sensitive animal species (i.e., young chickens, turkeys, swine, lambs, and 
rats), effectively reduced the health manifestations of aflatoxicosis (Phillips et al., 
1995).  In a previous research, NS effectively reduced the acute effects of AFB1, 
as evidenced by the reduction of AFM1 (a dose-dependent biomarker of dietary 
AFB1 exposure) levels in urines of AF-exposed rats (Sarr et al., 1995).  It is 
hypothesized that the edge sites, basal surfaces, and mainly the interlayer 
surfaces of NS interact with the β-dicarbonyl system of AFB1 in a chemisorption 
process (Phillips et al., 1995).  With this arrangement, the toxin can remain 
tightly sequestered as substantiated by previously reported thermodynamic 
results in which NS-AFB1 binding interaction yielded estimated ∆Hads and ∆G°ads 
values of –40 KJ/mol and –29 KJ/mol, respectively (Grant, 1998).  Specificity of 
NS for AFs has been well-characterized in several animal studies.  For instance, 
NS was shown to be ineffective for sorption of diacetoscirpenol (DAS) (Kubena 
et al., 1993), ochratoxin A (OA) (Huff et al., 1992), or T-2 toxin (Kubena et al., 
1990b) in chicks, or of deoxynivalenol (DON) in pigs (Patterson et al., 1993).  
However, when a combination of each of these mycotoxins with AF was tested 
in these same studies, NS effectively protected against aflatoxicosis, suggesting 
specificity of this clay for AFs. 
NovaSil Plus (NSP), a new calcium montmorillonite (CM) clay, which is 
structurally similar to NS, and currently available as an anti-caking agent in 
livestock feeds, has demonstrated high efficacy for AF binding.  In a previous 
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study, male Fisher-344 rats (fed diets containing 0.5% NSP) were administered 
NSP equivalent to 0.5% of the estimated maximum daily intake (30 g) of feed 
concomitantly with AFB1 (dissolved in corn oil) as previously described (Mayura 
et al., 1998).  Results in the study indicated that NSP significantly protected the 
rats as evidenced by a 95% reduction of urinary metabolite aflatoxin M1 (AFM1) 
levels compared to rats dosed without NSP (Bingham, 2003).  In a separate 
study using dogs, Bingham (2003) found that dietary inclusion of 0.5% NSP also 
protected the animals by reducing the AFM1 levels an average of 48.4% 
compared to dogs fed diet containing no NSP.  In another study, concentrations 
as high as 2% NSP in the diet throughout pregnancy produced neither maternal 
nor fetal toxicity in Sprague-Dawley (S-D) rats, and did not affect metal 
bioavailability in a variety of tissues (Wiles et al., 2004).  Therefore, NSP clay 
may be a good candidate that can be considered for a carefully designed, short-
term feasibility studies in humans.  However, further in vitro and in vivo (short-
term and long-term) analytical studies must be conducted to evaluate and 
predict potential adverse effects of the clay itself in animal models, which is the 
overriding basis of this work. 
 
1.15  Research Objectives 
AF contamination in foods/feeds has been longstanding and difficult to 
control even with good manufacturing practices because AFs are invisible to the 
naked eye, heat stable, and are not neutralized by common food processing 
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techniques (CAST, 1989; Phillips, 1999; Phillips et al., 2002).   While this 
problem may not pose significant threats to most developed countries owing to 
their extensive commodity screening, regulations, and monitoring programs, AF 
contamination in food and feed products remains a serious burden in many parts 
of the world especially where insufficiency of food supplies presents a major and 
persistent impediment to improvements in food safety (McAlpin et al., 2002; 
Shephard, 2003).  Thus, intervention strategies to diminish or prevent biological 
exposure of humans and animals to the AFs have warranted a highly desirable 
pursuit.  However, any intervention method must satisfy the following conditions 
for it to be successful particularly in developing nations: it must be practical, 
safe, economically feasible, culturally acceptable, environmentally benign, and 
sustainable in order to be successful in the prevention of health problems 
associated with AF contamination.  For instance, concerns have been raised as 
to whether or not NSP has the ability, or lack thereof, to interact with nutrients 
such as vitamin A (VA) in vitro or in vivo in the presence or absence of AFB1. 
Currently, the NSP, a new CM clay, has demonstrated high efficacy for AF 
binding in animals and shows promise for application to the human diet.   
Therefore, the objectives of this research were to:   
1) Characterize the in vitro and in vivo sorption efficacy of NSP for AFB1 and 
potential interaction with VA.  Determine sorption affinity and capacity of 
NSP for AFB1 and VA and characterize the thermodynamics of the AFB1-
NSP interaction in vitro in order to predict in vivo activities.  Investigate 
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the sorption of AFB1 by NSP in Sprague-Dawley (S-D) rats, as measured 
by the AFM1 metabolite in urine.  Determine the minimal effective dietary 
inclusion level of NSP that can protect broiler chicks from the effects of 
AFs and hepatic VA depletion.   
2) Evaluate potential adverse effects of chronic (6.5 months) ingestion of 
NSP in the diets of male and female S-D rats based on measurements of 
feed intake, change in body weights, terminal organ weights, complete 
blood counts and leukocyte differentials, typical serum biochemical 
parameters, selected trace metals in tissues, and qualitative organ 
histology.  
3) Establish representative baseline data on human exposure to AFs by 
collecting and analyzing AFM1 in urine samples from volunteers in 
Ghana.  Determine localities with high dietary aflatoxin exposure, which 
will eventually be the populations of choice for the clay-based intervention 
studies in the country.   
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CHAPTER II 
IN VITRO AND IN VIVO CHARACTERIZATION OF NOVASIL 
CLAY: AFB1 AND VITAMIN A INTERACTIONS 
 
2.1  Introduction 
Aflatoxins (AFs), naturally occurring metabolites of Aspergillus spp. that 
are produced primarily by Aspergillus flavus and Aspergillus parasiticus, have 
been shown to be acutely toxic, carcinogenic, mutagenic, teratogenic, and 
immunosuppressive to mammalian species (Busby and Wogan, 1984; Miller and 
Wilson, 1994; Pestka and Bondy, 1994; Turner et al., 2003; 2004; Glahn et al., 
1991). Specifically, B1, B2, G1, and G2, are considered human carcinogens 
(group 1) by IARC (WHO-IARC, 1993). Among these, AFB1 is the most 
predominant metabolite and the most potent hepatocarcinogen (Busby and 
Wogan, 1984; Flaherty and Payne, 1997; Lopez et al., 2002).  
AF contamination of livestock feed often results in poor growth and feed 
conversion efficiency, increased disease susceptibility, and increased mortality 
rates (Smith and Hamilton, 1970; Jones et al., 1982; Huff et al., 1986). The 
impact of AFs on micronutrient status is also a major concern, specifically the 
association between dietary AF exposure, vitamin A (VA) deficiency, and 
disease susceptibility. In a recent study, dietary exposure to AFB1 in growing 
barrows resulted in a reduction of serum VA levels, suggesting that AF exposure 
may exacerbate VA deficiencies (Harvey et al., 1994). In addition, VA 
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deficiencies have been linked to compromised immune responses and 
increased disease susceptibility in poultry (Aye et al., 2000 a,b; Dalloul et al., 
2002). 
The inclusion of non-nutritive enterosorbents to sequester AFs in 
contaminated feeds is both practical and economically feasible for large-scale 
detoxification of contaminated feedstuffs. Calcium montmorillonite clays such as 
parent NovaSil (NS) and currently available NovaSil Plus (NSP) are commonly 
added to animal feeds as anticaking agents. NS has been shown to diminish the 
adverse effects of AFs in multiple animal species including rats (Abdel-Wahhab 
et al., 2002; Mayura et al., 1998), chickens (Phillips et al., 1988; Kubena et al., 
1990b), turkeys (Kubena et al., 1991), pigs (Lindermann et al., 1993), lambs 
(Harvey et al., 1991a), dairy goats (Smith et al., 1994a), and dairy cows (Harvey 
et al., 1991b).  In addition, NS has been shown to effectively reduce AFB1 
exposure in the gastrointestinal tract as evidenced by a reduction of AFM1 (a 
dose-dependent biomarker of dietary AFB1 exposure) levels in the urine of rats 
dosed with AFB1 (Sarr et al., 1995).  Previous research has shown that the 
inclusion of 0.5% of NS in AF-contaminated diets of animals effectively reduced 
the symptoms of aflatoxicosis (Phillips et al., 1995) and did not interfere with 
nutritional utilization in chicks (Chung et al., 1990).  However, the efficacy and 
minimal effective dose of NSP that is sufficient to protect chicks from 
aflatoxicosis, as well as the potential for NSP interaction with important vitamins, 
such as vitamin A (VA), have not been reported. 
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In this research, the major objectives were to: 1) determine the sorption 
affinity and capacity of NSP for AFB1 and VA and characterize the 
thermodynamics of the AFB1-NSP interaction in vitro; 2) investigate the potential 
of NSP to reduce exposure of AFB1 in Sprague-Dawley rats, as measured by 
the AFM1 metabolite in urine; and 3) determine the minimal effective dietary 
inclusion level of NSP that will protect broiler chicks from the effects of 
aflatoxicosis and hepatic VA depletion. 
 
2.2  Materials and Methods 
2.2.1  Chemicals and Reagents 
 For all experiments, purified water (ddH2O) was prepared by processing 
deionized water through a Milli-QUF+ water purification system.  All solvents were 
HPLC grade. VA (retinol, 95% purity), cetylpyridinium (CP) chloride, AFB1, and 
AFM1 were purchased from Sigma Chemical Co. (St. Louis, MO). Activated 
carbon (AC) was purchased from Aldrich Chemical Co. (Milwaukee, WI). NSP 
and low-pH montmorillonite (LPHM) were obtained from Engelhard Chemical 
Corp. (Iselin, NJ). 
 
2.2.2  Sorbent Preparation 
Both NSP and LPHM were sieved to ≤45 µm prior to use. Heat-collapsed 
NSP (col-NSP) was prepared by first heating the clay at 200 °C for 30 min and 
then increasing the temperature to 800 °C for 1 hr. CP-exchanged organoclays 
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were prepared according to methods previously reported (Lemke et al., 1998). 
Briefly, LPHM was washed in H2O (100 ml/g of clay) for 120 hr while shaking. 
Afterwards, the suspension was centrifuged and the supernatant was discarded.  
The washed clay was resuspended in H2O (100 ml/g clay), and CP was added 
based on the estimated cation exchange capacity (CEC) for LPHM (1 CEC, 90 
cmolcharge/kg of LPHM, obtained from Engelhard Corp.). The clay was 
exchanged for 24 hr, centrifuged, and the supernatant was again discarded.  
Unexchanged organic cations were removed by washing in H2O for an additional 
24 hr. The washed clay was centrifuged and the supernatant discarded before 
the clay was dried, ground, and sieved to a particle size of <45 µm. 
 
2.2.3  AFB1 Sorption Studies with NSP Clay 
The efficiency of AFB1 sorption by NSP was evaluated over various 
equilibration time periods and pH ranges. A 100 µg sample of the sorbent was 
added to a 5 µg/ml solution of AFB1 was agitated at 1000 rpm at 25 °C for 5, 10, 
15, and 30 min, and 1, 2, 4, and 24 hr. After shaking, samples were centrifuged 
at 800 x g for 10 min, and residual AFB1 in the supernatant was measured by 
UV-visible spectrophotometry (362 nm; ε= 21,865 M–1cm–1) with Beckman DU-
65 scanning UV-visible spectrophotometer. Based on these results, a minimum 
of at least 2 hr was selected as an appropriate equilibration time period and was 
used to evaluate the effect of sorption at pH 2, 7, and 10. All solutions were 
adjusted to the corresponding pH value with either HCl or NaOH prior to 
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shaking.  The samples and controls were agitated at 1,000 rpm for 2 hr at 25 °C. 
After shaking, the samples were centrifuged at 800 x g for 10 min, and the 
supernatants were analyzed for AFB1 content as stated above. 
 
2.2.4  Isothermal Analysis of Vitamin A and AFB1 with NSP    
Isothermal analyses were conducted based on previously described 
methodology (Grant, 1998; Grant and Phillips, 1998; Lemke et al., 1998; 
Huebner et al., 1999; Pimpukdee, 2000). Briefly, stock solutions of VA (10 
µg/ml) and AFB1 (8 µg/ml) were prepared in purified water (pH 6.5 ± 0.2) and 
verified by UV-visible spectrophotometry (absorbance at 292 nm ε = 6634 M– 1 
cm–1 and 362 nm ε= 21,865 M–1 cm–1, respectively).  Test samples using 5 ml 
aliquots were prepared in triplicate containing VA ranging from 0.5 to 10 µg/ml or 
AFB1 ranging from 0.4 to 8 µg/ml made by diluting the stock solutions with 
ddH2O.  Respective sorbent suspensions (2 mg/ml) were prepared then 
vortexed for 1 min and 50 µl portions were added to the dilutions.  Controls 
consisted of ddH2O alone, ddH2O + 10.0 µg VA/ml or 8 µg AFB1/ml, and ddH2O 
+ 50 µl sorbent suspension.  The tubes were capped, agitated at 1,000 rpm for 2 
hr (VA) or 24 hr (AFB1) at 25 °C in the absence of light, then centrifuged at 800 x 
g for 30 min at 25 °C.  Residual VA or AFB1 in supernatant was measured by 
UV-visible spectrophotometry. CP-LPHM and AC were used as positive controls 
for the VA isotherms since they have been shown to be effective for organic 
compounds such as VA (Paune et al., 1998; Srinivasan and Fogler, 1990a,b).  In 
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the case of AFB1, the procedure was repeated with 15 and 37 °C in order to 
evaluate the thermodynamic parameters of AFB1-sorbent interactions, 
specifically, to estimate the enthalpy of sorption (∆Hads) of AFB1 on the surface 
of the test sorbent. Isothermal data was transferred to Table Curve 2D v3 and fit 
to appropriate models based on shape, r2 and standard deviation.  Estimates of 
the capacity values (Qmax) and the distribution constants (Kd) for each sorbent 
were calculated using various equations (Table 5). Enthalpy of sorption (∆Hads) 
was determined using the van’t Hoff equation (eq 1, Table 5) by substituting 
individual Kd values at different temperatures into the equation.  The Gibbs free 
energy change of adsorption (∆Goads) of NSP-AFB1 reaction was calculated 
using eq 2 (Table 5) with the Kd value from the isotherm conducted at 25 oC. 
 
2.2.5  Biomarker Determination of AFB1 Exposure in Rats 
Four-month old male Sprague–Dawley rats (Harlan, Houston, TX) were 
randomly assigned to 1 of 3 treatment groups (3 rats/group).  Treatment groups 
consisted of: 1) basal feed in the absence of clay; 2) basal feed containing 
0.0625% NSP; 3) basal feed containing 0.25% NSP.  Water and feed (Teklad 
rodent diet 8604; Harlan Feeds, Madison, WI) were provided ad libitum.  On day 
6 of the study, each rat was weighed and dosed with 1 mg/kg (bw) AFB1 
(dissolved in corn oil) by gavage as previously described (Sarr et al., 1995).  
Additionally, rats in treatment groups 2 and 3 were dosed with an NSP 
equivalent of either 0.0625% or 0.25% (based on the estimated maximum daily   
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TABLE 5 
 
Equations used for plots and calculations in NSP-AFB1 adsorption 
 
 
 
 
 
 
 
 
 
 
 
 
 
Isotherm Model Equationa 
Langmuir Model (LM) q = Qmax  [(KdCw)/(1 + KdCw)]                         
Multi-Langmuir Model (MLM) q = Qmax1[(KdCw)/(1 + KdCw)] + Qmax2[(KdCw)/(1 + KdCw)] + ….
Toth Model (TM) q = Qmax  [(KdCw)/{1 + (KdCw)n}1/n]                   
Freundlich Model (FM) q = K(Cw)n                                                       
Generalized-Freundlich Model (GFM) q = Qmax  ((KdCw)/(1 + KdCw))n                       
Langmuir-Freundlich Model (LFM) q = Qmax  [(KdCw)n/(1 + (KdCw)n)]                    
Equations used for Thermodynamic Calculations 
van’t Hoff equation ∆Hads  =   -R ln (Kd2/Kd1)/{(1/T2) – (1/T1)}      ……  (1)  
Gibbs free energy change of Adsorption 
at Equilibrium ∆G
o
ads 
  =  -RT ln Kd                                      ……   (2) 
Rearrangement of Langmuir Model  Kd        =   q/(Qmax - q)Cw                               ……   (3) 
Note. q = concentration of AFB1 adsorbed (mol/kg), Qmax = maximum capacity of clay (mol/kg), Kd = 
distribution constant, Cw = equilibrium concentration of AFB1 (mol/L).  n = exponent, K = distribution 
constant. T = temperature (Kelvin) and R = gas constant.
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intake of feed (30 g)) concomitantly with the toxin as previously described 
(Mayura et al., 1998).  Each rat was placed in a metabolism cage and urine was 
collected over the entire 48 hr time period following dosing. Urine volumes were 
recorded and samples were frozen at –80 °C in cryogenic vials prior to AFM1 
quantification.  
 
2.2.6  Urinary AFM1 Analysis 
AFM1 in urine was quantified by HPLC following immunoaffinity cleanup 
based on procedures previously described by Groopman et al. (1992b) with 
modifications by Wang et al.(1999) and Sarr et al. (1995). Briefly, a 1 ml aliquot 
of urine was eluted through a Aflatest P® immunoaffinity column (Vicam, 
Watertown, MA) at a flow rate of approximately 0.3 ml/min.  After elution, the 
column was rinsed with 5 ml PBS and AFs were then eluted with 1 ml 
dimethylsulfoxide (DMSO):PBS (1:1).  
Quantitative measurements of AFM1 were performed by HPLC with 
fluorescence detection utilizing a 250 mm x 4.6 mm LiCrospher RP-18 
endcapped column with pore size 100 Å and particle size 5 µm (Alltech 
Associates, Deerfield, IL).  The mobile phase contained 22% ethanol buffered 
with 20 mM ammonium formate (pH 3.0).  Chromatographic separation of AFs 
was achieved by isocratic elution of the mobile phase for a total run time of 35 
min (flow rate 1.0 ml/min) and injection volume of 50 µl.  AFM1 quantification 
was based on peak area and retention time as compared to external standard. 
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2.2.7  Preparation of Poultry Diets 
AFs were produced through the fermentation of rice by Aspergillus 
parasiticus NRRL 2999 as described by Kubena et al. (1990a). Briefly, 
fermentation was carried out in 2.5 L fernbach flasks containing 50 g of white 
rice (free of preservatives). Water (25 ml) was added to each flask and rice was 
autoclaved then shaken to break up clumps. Each flask was inoculated with 1 ml 
of an Aspergillus spore suspension then shaken on a platform shaker at 220 to 
240 rpm at 15 °C for 24 hr. Ten ml of water was added at 48 hr.  The initial 
temperature of the rice fermentation was increased from 15 °C to 21 °C after 24 
hr of incubation and then to 28 °C after 48 hr. Incubation was continued for a 
total of 5 d and during the fermentation process, grains were kept separated to 
prevent excessive hyphae formation.  After incubation, the rice was autoclaved, 
dried, then ground into a powder. The total aflatoxin content of the rice powder 
was initially measured by spectrophotometry (Nabney and Nesbitt, 1965) as 
modified by Wiseman et al. (1967) and consisted of approximately 79% AFB1, 
16% AFG1, 4% AFB2, and 1% AFG2.  The rice powder was incorporated into a 
corn-soybean meal basal diet (free of detectable mycotoxin contamination) to 
provide 5 mg AFB1/kg diet as confirmed by HPLC methods (Hutchins and 
Hagler, 1983).  The basal diet contained no antibiotics, coccidiostats, growth 
promoters, or inorganic sorbents and met or exceeded the levels of critical 
nutrients recommended by the National Research Council (1994). 
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2.2.8  Experimental Design for the Broiler Chick Study  
 One-day-old male broiler chicks (Peterson x Hubbard) were obtained 
from a commercial hatchery. Chicks were reared in wire-floored brooding cages, 
with continuous fluorescent illumination and forced ventilation at the USDA/ARS, 
Southern Plains Agricultural Research Center (College Station, TX). Chicks 
were individually weighed, wing-banded, and randomly distributed to the 
different treatment groups consisting of four replicates of six chicks per dietary 
treatment group (pen). Chicks were grouped by the following dietary treatments: 
1) basal feed (BF) free of toxins (control); 2) BF containing 0.5% NSP; 3) BF 
containing 5 mg AFB1/kg; 4) BF containing 0.125% NSP + 5 mg AFB1/kg; 5) BF 
containing 0.25% NSP + 5 mg AFB1/kg; and 6) BF containing 0.5% NSP + 5 mg 
AFB1/kg.  Broilers were provided with water and feed ad libitum for the duration 
of the study (3 weeks).  Body weights of chicks and feed consumption were 
measured weekly and chick mortalities were recorded as they occurred.  After 
termination of the study, liver and kidney weights were recorded and were 
evaluated as relative organ weight changes (g/100 g bw). Random liver samples 
(3/pen) were also collected and stored at –75 °C in preparation of hepatic VA 
level determination. Control birds were evaluated via necropsy by scientists and 
an attending veterinarian for underlying diseases. No evidence of preexisting 
problems was observed.   
 
 
  
75
2.2.9  Hepatic Vitamin A (Retinol) Determination   
A 1 g portion of liver was mixed with 100 mg butylated hydroxytoluene 
and 25 g silica gel. The mixture was ground in a mortar, then extracted with 30 
ml hexane:acetone (1:1) for 30 min with agitation.  Afterwards, 10 ml ddH2O was 
added to the mixture, which was then vortexed for 30 sec and centrifuged at 
1,000 rpm for 15 min at 4 °C.  Ten ml of the hexane fraction was removed from 
the mixture and dried under nitrogen.  The oily residue was resuspended in 3 ml 
of saturated KOH, incubated for 30 min at 65 °C, then re-extracted with 
hexane:water (5:1) and centrifuged at 1,000 rpm for 15 min at 4 °C. The 
resulting hexane fraction was again removed and dried under nitrogen, and 
resuspended in methanol:ammonium acetate (9:1; pH 5.6) prior to analysis.  
Quantitative measurements of VA were performed by HPLC with 
photodiode array detection methods (325 nm) utilizing an ODS column (4.5 x 
150 mm) maintained at 30°C.  The mobile phase consisted of a gradient elution 
of 40 mM ammonium acetate buffer (pH 5.6):methanol (40:60) for 12 min 
followed by 100% methanol elution for 4 min, then ammonium acetate 
buffer:methanol (40:60) for 9 min (flow rate of 1 ml/min).  Injection volume was 
20 µl with a total run time of 25 min.  VA was quantified based on retention time 
and peak area as compared with an external retinol standard.  
 
 
 
  
76
2.2.10  Statistical Analysis  
Data were subjected to analysis of variance using the General Linear 
Models procedure to establish differences between means. Means showing 
significant differences in ANOVA were compared using Fisher’s protected least 
significant difference procedure (Snedecor and Cochran, 1967). All statements 
of differences were based on a significance of p < 0.05. 
 
2.3 Results 
2.3.1 Sorption of AFB1 with NSP Clay In Vitro 
 
Initial sorption studies indicated that removal of AFB1 from aqueous 
solution occurred rapidly (within 5 min) and an equilibrium state was achieved 
within 2 hr (data not shown). Using this 2 hr equilibration time period, isothermal 
analysis of AFB1 sorption by NSP was further shown to be pH-dependent. At pH 
7 and 10, NSP exhibited greater sorption than at pH 2 (Figure 9).  Experimental 
data for removal of AFB1 from aqueous solution by NSP at pH 7 and 25 °C were 
fit to various isotherm equations to select the most comprehensive model (Table 
6).  Considering the Qmax, Kd, n, and the residuals, the Langmuir Model (LM) and 
Toth Model (TM) were determined to be most appropriate for modeling AFB1 
sorption on NSP.  However, the LM had a much higher F-value making it a 
better model than TM (Table 6).  Based on this set of data, the LM was selected 
for quantitative and qualitative analysis of the binding affinity (Kd) and capacity 
(Qmax) of NSP for AFB1.  The average Qmax values (± SEM) for AFB1 sorption
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Figure 9.  Isotherm analysis of AFB1 sorption by NSP at pH 2, 7, and 10 at 25 oC.  Samples and controls were 
agitated at 1,000 rpm (25 °C) for 2 hr, centrifuged, and supernatants were analyzed for residual AFB1 utilizing UV-
visible spectrophotometry. Data represent means (± SD) from three independent experiments. 
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TABLE 6 
Summary of isotherm fit parameters of AFB1 adsorption by NSP 
AFB1 Sorption at 25 oC (pH 7) 
Isotherm 
Model 
(Qmax) ± SE 
(mol/kg NSP) Kd ± SE (x10
5) Exponent (n) r2 F-value Residual (Runs) 
LM 0.456 ± 0.007 7.479 ± 0.498 NA 0.996 2814.27 3 
TM 0.488 ± 0.021 8.957 ± 1.152 0.811 0.997 1830.19 5 
FM N/A N/A 0.311 0.960 239.42 2 
LFM 0.119 ± 0.093 6.646 ± 0.705 0.896 0.997 1587.78 5 
GFM 0.462 ± 0.009 5.806 ± 1.535 0.867 0.997 1379.30 3 
MLM1 0.341 ± 1.797 0.118 ± 0.825 NA 0.998 1718.92 5 
MLM1 0.401 ± 0.044 9.512 ± 1.521 NA 0.998 1718.92 5 
 
Note. 1Two sets of data were obtained for MLM.   NA = not applicable. LM = Langmuir Model, TM = Toth Model, 
FM = Freundlich Model, LFM = Langmuir-Freundlich Model, GFM = Generalized- Freundlich Model, MLM = Multi-
Langmuir Model. 
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Figure 10.  Isothermal analysis and enthalpy of sorption (∆Hads) plots for AFB1 by NSP 
at 15 °C, 25 °C, and 37 °C.  A. Isotherm plots for NSP-AFB1 sorption. Data were fit with 
Langmuir model (LM). Curve fits are displayed as solid lines, and experimental data as 
average points.  B. Enthalpy of sorption plots based on isothermal analysis.  ∆Hads was 
calculated using the van’t Hoff equation (see inset). Data show average enthalpy values 
derived from observed experimental data and estimated values based on LM data. 
∆Hads =  -R ln (Kd2/Kd1)    
               (1/T2) – (1/T1) 
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onto NSP at 15 °C, 25 °C, and 37 °C were 0.420 ± 0.013 mol/kg, 0.456 ± 0.007 
mol/kg, and 0.379 ± 0.001 mol/kg, respectively (Figure 10A). Similarly, the 
average Kd constants were determined to be 1.18 x 106, 7.48 x 105, and 3.61 x 
105, respectively.  Sorption was shown to be exothermic and spontaneous with 
an average enthalpy (∆Hads) equal to -49.2 kJ/mol (Figure 10B) and Gibbs free 
energy change of adsorption (∆Goads) equal to -33.5 kJ/mol. From the LM, the 
maximum observed concentration of AFB1 sorbed onto NSP was calculated to 
be 0.437 mol/kg, 96% of the Qmax of 0.456 mol/kg. In contrast, isothermal 
analysis of col-NSP indicated that the Qmax and Kd were 0.0267 mol/kg (94% 
less than unmodified NSP) and 2.06 x 102 (99% less than unmodified NSP) 
(Figure 11). 
 
2.3.2  Interaction of NSP with Vitamin A In Vitro 
In isothermal analyses experiments, NSP exhibited negligible interactions with 
VA, whereas CP-LPHM and AC (positive controls) both showed high affinity 
binding for the ligand (Figure 12).  However, only AC appeared to have a 
saturable binding site for VA.  Data for VA sorption were best fit to the 
Freundlich Model (FM) with Kd (± SEM) equal to 1.59 x 102 ± 1.50 x 102 for NSP-
VA interactions and 6.44 x 104 ± 1.24 x 104 for CP-LPHM-VA interactions. The 
shapes of the data plots suggest sorption occurs primarily by partition 
processes.  In contrast, AC-VA isotherm data were fit best to the LM showing a 
Qmax of 0.552 ± 0.027 and a Kd value of 4.15 x 105 ± 0.89 x 105.   
  
81
 
Adsorption of AFB1 by NSP vs Col-NSP at 25 oC
0.0
0.1
0.2
0.3
0.4
0.5
0.0E+00 5.0E-06 1.0E-05 1.5E-05 2.0E-05 2.5E-05
Equilibrium Concentration of AFB1 (mol/L)
A
FB
1 
A
ds
or
be
d 
(m
ol
/k
g)
NSP col-NSP
 
 
Figure 11.  Comparison of isotherm sorption plots for AFB1 on NovaSil PLUS 
(NSP) vs. collapsed NSP (col-NSP) surfaces at 25 oC (pH 7).  Isotherm data 
were fitted to the Langmuir Model.  The solid lines show the curve fits while the 
experimental data are represented by the average data points ± SEM. 
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Figure 12. Comparison of isotherm plots for vitamin A sorption onto NSP, CP-
LPHM, and AC surfaces at 25 oC (pH 7). AC Isotherm data were fit to Langmuir 
Model while CP-LPHM and AC data were fit to Freundlich Model. The solid lines 
show the curve fits while the experimental data are represented by the average 
data points ± SEM. 
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Figure 13.  Total AFM1 in urine over 48 hr of rats dosed 1.0 mg/Kg (bw) AFB1. 
Values represent data for 3 rats ± SEM. *Indicates significant reduction of AFM1 
levels in rats dosed with the toxin and treated with NSP versus untreated 
controls.   
 
 
 
 
 
*
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2.3.3  Analysis of Urinary Biomarker AFM1 in Rats 
AFM1 was used as a biomarker indicative of AFB1 exposure.  In control 
animals dosed with 1.0 mg/kg (bw) AFB1 in the absence of clay, the average 
concentration (± SEM) of AFM1 was 2511.2 ± 380.0 ng/ml of urine.  Those 
animals exposed to AFB1 and NSP showed lower AFM1 levels.  Co-exposure to 
0.0625% NSP decreased AFM1 in urine to 1555.3 ± 397.6 ng (38%) and 0.25% 
NSP decreased the biomarker to 719.2 ± 196.5 ng (71%) (Figure 13).  
 
2.3.4  Feeding Studies using Broiler Chicks 
 In the feeding study, consumption of AFB1-contaminated diet in the 
absence of NSP resulted in significantly decreased feed consumption (FC) in 
broiler chicks (Table 7). Treatment with NSP ranging from 0.125 to 0.5% NSP 
showed protection from these effects, although not to the extent of untreated 
controls.  Compared to the controls, AFB1 reduced the FC by 30% while 
reductions in the presence of the clay with the toxin were 9.8% (0.25% NSP), 
13.0% (0.50%NSP), and 15.7% (0.125% NSP (Table 7).  Also, dietary exposure 
to NSP alone and at the greatest amount used in the study (0.5%) did not 
significantly affect feed consumption.   
In addition to feed consumption, dietary exposure to 5 mg/kg AFB1 
significantly affected body weight gain (Table 8).  In chicks fed diets containing 5 
mg/kg AFB1, body-weight gains were reduced by 19% after 21 d, although 
significant reductions were apparent after only 7 d.  Exposure to 0.5% NSP in
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TABLE 7 
Effects of dietary NSP inclusion either alone or in combination with AFs on average feed 
consumption and feed:gain ratios in broiler chicks 
 
Treatment Group 
AFB1 
(mg/kg) NSP (%) 
Feed Consumption1 
 (g) 
% Reduction of 
FC from control Feed:Gain Ratio
1 
0 0 1369.0 ± 45.7a 0.0 1.628 ± 0.058a 
0 0.500 1275.8 ± 38.5a 6.8 1.535 ± 0.029a 
5 0 957.8 ± 183.1b 30.0 1.480 ± 0.117a 
5 0.125 1153.8 ± 103.4ab 15.7 1.483 ± 0.084a 
5 0.250 1235.0 ± 54.2ab  9.8 1.460 ± 0.050a 
5 0.500 1191.5 ± 22.9ab 13.0 1.538 ± 0.073a 
 
 
 
 
 
Note.  1Data are reported as the mean ± SEM of four replicate pens of six broiler chicks each 
per treatment group.  a,b Mean values with no common superscript differ significantly (p ≤
0.05). FC = feed consumption. 
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TABLE 8 
Effects of dietary NSP inclusion either alone or in combination with AFs on temporal  
body weight gains in broiler chicks 
 
 
 
 
 
Treatment Group Body Weight Gain1 (g) 
--------------- Days --------------- AFB1 
(mg/kg feed) 
NSP 
(%) 1-7 8-14 15-21 1-21 
% Reduction from 
Control  (21 days) 
0 0 145 ± 2.9a 265 ± 13.0ab 446 ± 13.2a 866 ± 12.7a 0 
0 0.500 132 ± 5.9a 287 ± 11.0a 418 ± 26.1a 839 ± 42.6a 3 
5 0 126 ± 9.6a 229 ± 18.5b 338 ± 22.7b 699 ± 38.5b 19 
5 0.125 138 ± 4.7a 264 ± 8.9ab 390 ± 31.2ab 791 ± 43.5ab 9 
5 0.250 144 ± 6.1a 284 ± 6.9a 427 ± 12.0a 854 ± 22.7a 1 
5 0.500 136 ± 3.4a 290 ± 8.9a 385 ± 30.5ab 816 ± 37.6a 6 
1Data are reported as the mean ± SEM of four replicate pens of six broiler chicks each per treatment group. 
a,bMean values with no common superscript differ significantly (p ≤ 0.05). 
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the absence of AFB1 did not significantly decrease body weight gain as 
compared to those animals consuming diets without clay.  Throughout the study, 
chicks consuming diets containing AFs in the absence of NSP had significantly 
lower gains in body weight and the inclusion of NSP prevented growth inhibition 
with varying levels of effectiveness.  After 21 d of continuous exposure to AFs, 
body weights of chicks fed diets containing either 0.25 or 0.50% NSP did not 
significantly differ from controls.  However, this effect was not apparent in those 
chicks consuming only 0.125% NSP.  No significant differences were observed 
for feed:gain ratios among treatment groups and controls (Table 7). 
 A clear dose-response relationship was observed for protection from the 
effects of AFB1 exposure on liver and kidney weights with various dietary levels 
of NSP (Table 9). Dietary inclusion of AFB1 caused significant increases in both 
relative liver and kidney weights in broiler chicks (Table 9).  In chicks exposed to 
the greatest amount of NSP (0.5%), neither relative organ weight was 
significantly different from those animals consuming the control diet. The relative 
liver weights of chicks maintained on diets containing either 0.5% NSP in 
addition to 5.0 mg/kg AFB1 were comparable to untreated controls, whereas 
levels of only 0.25 or 0.125% NSP failed to show significant protection in 
comparison to AFB1 controls. A similar trend was observed for relative kidney 
weights. 
 Hepatic VA in broiler chicks was significantly reduced in those animals 
consuming diets containing 5.0 mg/kg AFB1 (Figure 14).  Further, co-exposure 
  
88
 
TABLE 9 
Effects of dietary NSP inclusion either alone or in combination with AFs on  
relative organ weights in broiler chicks 
 
 Treatment Group 
Relative Liver Weight1 
(g/100g bw.) 
Relative Kidney Weight1 
(g/100g BW) 
Control Feed 2.99 ± 0.15b 0.441 ± 0.034bc 
0.5% NSP 2.82 ± 0.14b 0.371 ± 0.023c 
AFB1 (5.0 mg/kg feed) 3.87 ± 0.49a 0.589 ± 0.055a 
0.125% NSP + AFB1 3.54 ± 0.32ab 0.547 ± 0.046ab 
0.25% NSP + AFB1 3.12 ± 0.03ab 0.503 ± 0.024ab 
0.5% NSP + AFB1 2.81 ± 0.16b 0.449 ± 0.024bc 
1Data are reported as the mean ± SEM of four replicate pens of three broiler chicks each 
per treatment group.  a,b,c Mean values with no common superscript differ significantly (p ≤
0.05). 
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Figure 14.  Dose response effects of dietary NSP addition on hepatic vitamin A in broiler chicks.  Data are shown 
as the means ± SEM of four replicate pens of three broiler chicks each per treatment group.  *Indicates that 
average hepatic VA content of chicks exposed to AFB1 control was significantly reduced compared to all the other 
treatments. 
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to NSP ranging from 0.125 to 0.5% in the diet showed complete protection, 
particularly at 0.25% level of NSP, from the effects of AFB1 on hepatic VA.    
 
2.4  Discussion  
The present study characterized the sorption of AFB1 and evaluated the 
potential interaction with VA by NSP, a calcium montmorillonite clay that is 
commonly added to animal feeds as an anti-caking agent. Overall, the in vitro 
data suggests that NSP selectively provides the capacity and affinity for AFB1 
equivalent to or greater than that previously reported for NS, another calcium 
montmorillonite anti-caking agent (Grant and Phillips, 1998).  In both cases, 
calculation of thermodynamic parameters suggests strong sorption of AFB1 
(Figure 10B).  However, the estimated enthalpy of sorption for NSP (-49.2 
kJ/mol) was higher than values previously reported for NS (-40 kJ/mol), 
suggesting a tighter binding to the clay (Grant and Phillips, 1998). Based on 
∆Hads, the adsorption of AFB1 to the surface of either sorbent is characterized as 
chemisorption, a chemical reaction and/or sharing of electrons between the 
chemical and the sorbent surface that is indicated by enthalpy values > -20 
kJ/mol (Gatta, 1985).  This suggests a stronger association between the toxin 
and ligand, predicting a greater efficiency as an enterosorbent. The variability of 
∆Hads in these experiments may reflect multiple binding mechanisms and/or sites 
as well as the heterogeneity of the clay mineral (Figure 2B).  For the col-NSP, 
isothermal analysis indicated that the capacity (Qmax) and affinity (Kd) were 94% 
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and 99% less than unmodified NSP, respectively.  This evidence is similar to 
Grant’s report on NS and suggests that a large portion of AFB1 binding to NSP 
occurs within the interlayer region (and Ca2+ ions) of the clay (Grant, 1998). 
 NSP interaction with VA was negligible in vitro, predicting a lack of 
interaction with the nutrient in vivo (Figure 12).  Sorbents used as positive 
controls were CP-LPHM, a hydrophobic organoclay, and AC because they have 
been shown to be effective for organic compounds such as VA (Paune et al., 
1998; Srinivasan and Fogler, 1990a,b).  Both showed high affinity for VA under 
these conditions.  The FM was used to fit data for NSP- and CP-LPHM-VA 
interactions and C-type isotherm curves were observed, indicating partition 
processes - involving weak associations such as van der Waals, dipole-dipole, 
induced dipole, and hydrogen bonding (Gu et al., 1994). However, this model 
was not appropriate for fitting the AC-VA data.  The LM showed an H-type curve, 
suggesting a saturable site for VA sorption that is indicated by the presence of a 
plateau. This is important because the data show that not all sorbents are 
appropriate for intervention of the AF problem in animals and/or humans. 
 Based on the prevalence in urine and the dose-dependent linearity 
observed with dietary AFB1 ingestion, AFM1, an oxidative metabolite of AFB1, 
was selected as a biomarker of exposure (Groopman et al., 1992a; Hsieh and 
Wong, 1994).  Previous research indicated that 0.5% NS in the diet was 
sufficient to reduce AFM1 in the urine of Fisher 344 rats by 58% following a 
single 1 mg/kg (bw) AFB1 gavage dose (Sarr et al., 1995).  At an identical 
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dietary inclusion level, NS reduced the urinary metabolite in Sprague-Dawley 
rats exposed to a single 2 mg/kg (bw) AFB1 gavage dose by 76% (Mayura et al. 
1998).  In this study, inclusion of 0.25% NSP reduced AFM1 in the urine of 
Sprague-Dawley rats following a 1 mg/kg (bw) AFB1 dose by 71% (Figure 13), 
suggesting that NSP is perhaps more efficient than NS in reducing the 
bioavailability of AFB1 in the gastrointestinal tract.    
In broiler chicks, the health manifestations of AFB1 exposure were 
expressed as reduced weight gains, increased liver and kidney weights, and 
decreased feed consumption. These effects are in agreement with those 
previously reported (Huff et al., 1986; Kubena et al., 1990a, 1993b).  The feed 
consumption of broiler chicks exposed to AFB1 in the presence of NSP was 
greater than for those consuming diets that did not contain the sorbent, although 
not as great as in the untreated controls.  Of the 3 treatment levels tested in this 
study, dietary inclusion of 0.25% NSP was the most effective in reducing the 
negative impact of AFB1 on body weight gains (95%). At inclusion levels of 0.5 
and 0.125%, NSP lessened the AFB1-dependent decrease in body weight gain 
by 68 and 53%, respectively. Based on both feed consumption and body weight 
gain, 0.25% NSP appeared to be the most effective in broiler chicks exposed to 
5 mg/kg in the diet.  
 The liver is considered to be a target organ for AFs and the effects are 
typically expressed as an increase in weight (Huff et al., 1986). Renal toxicity 
has also been linked to AF in some animals including swine (Sisk and Carlton, 
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1972) and rabbits (Clark et al, 1982).  In this study, exposure to 5 mg/kg AFB1 in 
the absence of sorbent significantly increased the relative liver weights in broiler 
chicks.  The relative liver weights of birds treated with NSP (0.5% and 0.25%) 
plus 5 mg/kg AFB1 were not only comparable to controls, but were also 
significantly lower when compared to birds treated with AFB1 alone.  These data 
indicate that NSP effectively protected chicks from AFB1 hepatotoxicity at levels 
as low as 0.25%.  Also, relative kidney weights were reduced to levels 
comparable to the controls in the presence of 0.5% NSP in diet of chicks 
exposed to 5 mg/kg AFB1.  A similar protective effect by NS against AFB1 was 
observed on relative kidney weights and was consistent with previously 
published reports (Kubena et al., 1990a, 1993b).  
  VA is vital for vision, controlling the differentiation program of epithelial 
cells in the digestive tract and respiratory system, skin, bone, the nervous 
system, the immune system, and for hematopoiesis (Gursu et al., 2002). VA also 
induces lymphoproliferation which results in a stimulated immune system. A 
deficiency can decrease specific antibody production, the number of circulating 
lymphocytes, and lymphocyte proliferation (West et al., 1991).  In a previous 
report, camels with aflatoxicosis had about half of retinol (VA) levels found in the 
plasma of healthy camels (Abbas and Ali, 2001).  However, it was not clear if VA 
deficiency predisposed the camels to aflatoxicosis or the AFs induced the VA 
deficiency. Also, potential for interaction between nutrients (such as VA) and 
ingested clay minerals had been unclear until this study was conducted.  
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Importantly, this study indicated that NSP does not significantly alter hepatic VA 
content at the levels tested (0.125, 0.25, and 0.5%) against a dietary inclusion 
level of 5 mg AFB1/kg. These results are in agreement with isothermal 
measurements, suggesting negligible interactions between NSP and VA in the 
presence or absence of the AFB1.  Thus, in the presence of NSP, the overall 
health and immune defenses of AF-challenged broilers would not be 
compromised by VA deficiency since the sorbent does not interact with VA. 
 Overall, in vitro and in vivo results suggest that NSP strongly binds AFB1 
from the gastrointestinal tract, but does not interfere with VA levels, indicative of 
strong specificity.  Also, in a study by Wiles et al (2004), concentrations as high 
as 2% of dietary NSP neither produced maternal or fetal toxicity in pregnant rats, 
nor significantly affected the bioavailability of selected trace metals in a variety of 
tissues. 
This clay-based application, when used in combination with other good 
management practices, may be a valuable tool for the development of an 
integrated approach to the preventive management of mycotoxin-contaminated 
commodities.  Due to the observed strong specificity for AFB1 sorption, NSP 
may also be a viable candidate for studies designed to prevent AF exposure in 
humans. However, long-term animal studies are required to comprehensively 
evaluate any hidden potentials for toxicity prior to the initiation of human 
feasibility studies.  Future research is needed to identify other sorbents to 
effectively sorb other mycotoxins found in food and feed. Also, studies are 
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needed to evaluate NSP and other sorbents for potential interactions with other 
nutrients such as Fe, Zn, Ca, K, vitamins E, D, K, etc. 
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CHAPTER III 
DIETARY INCLUSION OF NOVASIL: IN VITRO ANALYSIS, 
SUBCHRONIC AND CHRONIC TOXICITY EVALUATION IN 
SPRAGUE-DAWLEY RATS 
 
3.1  Introduction 
Aflatoxins (AFs) are common foodborne mycotoxins that have been 
identified as a result of Aspergillus growth in grains, such as peanuts, corn, 
cottonseed, and tree nuts (CAST, 2003).  The compounds are carcinogenic 
(Wild et al., 1992; WHO-IARC, 1993a,b), genotoxic (Wang et al., 1999; Smela et 
al., 2001), and immunotoxic (Hinton et al., 2003; Turner et al., 2003).  In 
addition, the presence of AFs has been found to significantly reduce hepatic 
vitamin A in animals, including broiler chicks (Pimpukdee et al., 2004). 
Importantly, vitamin deficiency is a common cause of blindness, especially in 
developing countries (Fieldler et al., 2000). 
The naturally occurring AFs (e.g., B1, B2, G1, and G2) are characterized as 
ubiquitous and can contaminate food/feed sources either separately or 
concurrently (CAST, 1989).  Among the naturally occurring AFs, aflatoxin B1 
(AFB1) is the most predominant, and the most potent hepatocarcinogen known 
in humans (Flaherty and Payne, 1997; Lopez et al., 2002).  It is estimated that 
ingestion of 2-6 mg AF/day for one month can lead to acute hepatitis and death 
in humans (Patten, 1981).  In the U.S., a 20 ppb action level for AFs in foods 
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intended for human consumption has been set, however, a recent outbreak of 
AF poisoning in Kenya was linked to consumption of foods containing levels as 
high as 8,000 ppb (CDC, 2004).  Because these toxins can affect both animal 
and human health, effective (yet economically feasible) intervention strategies 
are imperative. 
Several intervention strategies have been previously reviewed and 
include diverse physical, chemical, and biological methods (Phillips, 1999; 
Phillips et al., 1994, 2002).  One practical approach of current interest is the 
inclusion of non-nutritive clay minerals in contaminated food and feed to bind 
AFs in the gastrointestinal tract, thus reducing toxin bioavailability and 
distribution to the blood and target organs (Phillips, 1995, 1999). 
The dietary consumption of clay (known as geophagy) is not a new 
phenomenon. It has been observed among both animals and humans on all 
continents for centuries (Carretero et al., 2002).  The potential health benefits of 
geophagy (although ill-defined in the scientific literature) may include the 
enterosorption and decreased bioavailability of toxic chemicals and hazardous 
microbes from contaminated food and water.  
For example, a naturally-occurring calcium montmorillonite clays (e.g. 
NovaSil and NovaSil Plus) that is routinely added to feeds as an anti-caking 
agent, has been used as a novel dietary intervention to decrease external 
exposure to aflatoxins.  NovaSil (NS) and NovaSil Plus (NSP) in the diet has 
resulted in significant protection from the adverse effects of AFs in multiple 
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animal species, including pregnant rodents (Mayura et al., 1998), chickens 
(Phillips et al., 1988; Kubena et al., 1990a; Pimpukdee et al., 2004), turkeys 
(Kubena et al., 1991), swine (Lindemann et al., 1993), lambs (Harvey et al., 
1991a), goats (Smith et al., 1994), and dairy cattle (Harvey et al., 1991b). 
In addition, no observable adverse effects have been reported in 
numerous short-term animal studies utilizing NSP clay for the prevention of 
aflatoxicosis. In particular, a study in which Sprague-Dawley (S-D) rats ingested 
the clay at dietary concentrations as high as 2% throughout pregnancy showed 
neither maternal nor fetal toxicity, and did not show significant trace metal 
bioavailability in a variety of tissues (Wiles et al., 2004).  
Importantly, the potential effects of NSP clay following chronic dietary 
ingestion have not been established. These include weight gains and feed 
conversions, common hematological and serum biochemical parameters, 
histology, and nutrient levels (e.g., vitamins A and E, Fe and Zn). Thus, the 
objective of this study was to evaluate the potential adverse effects of sub-
chronic and chronic dietary inclusion of NSP in S-D rats to predict the safety of 
this product for future use in human populations burdened by AF contamination.   
 
3.2 Materials and Methods 
3.2.1  Chemical Reagents 
For all experiments, purified water (ddH2O) was prepared by processing 
deionized water through a Milli-QUF+ purification system (Millipore, Benford, MA).  
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Novasil clay was kindly provided by the Engelhard Chemical Corporation (Iselin, 
NJ).  All-trans retinol (>95% purity) and α–tocopherol (>95% purity), normal 
human serum, tetrahydrofuran (THF), ascorbic acid, PBS, and butylated 
hydroxytoluene (BHT) were purchased from Sigma-Aldrich (St. Louis, MO).  
Individual stock standard solutions of all-trans-retinol (4.34 µg/ml) and α-
tocopherol (32.8 µg/ml) were prepared in absolute ethanol and stored at -20 °C.  
Concentrations were calculated based on absorbance values in ethanol at 325 
nm (all-trans-retinol) and 292 nm (α-tocopherol) wavelengths. Dilutions were 
performed immediately prior to use.  HPLC grade acetone, acetonitrile (ACN), 
and methanol (MeOH) were obtained from Burdick and Jackson (Muskegon, 
MI). Ethanol was obtained from Anachemia (Rouses Point, NY).  HPLC grade 
ammonium acetate (AA) was purchased from Fisher (Fair Lawn, NJ).   
 
3.2.2  Quantification of PCDD/PCDF in NSP Clay 
 
Polychlorinated dibenzo-p-dioxin/furan analysis was performed by 
Columbia Analytical Services, Inc. (Houston, TX).  Procedures followed the 
United States Environmental Protection Agency (USEPA) methods for sample 
preparation, cleanup, and analysis with high resolution capillary column gas 
chromatography/high resolution mass spectrometry (USEPA Method 1613b).  
The 17 USEPA priority compounds analyzed included: 2,3,7,8-tetrachloro-
dibenzo-p-dioxin; 1,2,3,7,8-pentachlorodibenzo-p-dioxin; 1,2,3,4,7,8-hexachloro-
dibenzo-p-dioxin; 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin; 1,2,3,7,8,9-hexa-
chlorodibenzo-p-dioxin; 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin; octachloro-
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dibenzo-p-dioxin (OCDD); 2,3,7,8-tetrachlorodibenzo-p-furan; 1,2,3,7,8-penta-
chlorodibenzo-p-furan; 2,3,4,7,8-pentachlorodibenzo-p-furan; 1,2,3,4,7,8-hexa-
chlorodibenzo-p-furan; 1,2,3,6,7,8-hexachlorodibenzo-p-furan; 1,2,3,7,8,9-hexa-
chlorodibenzo-p-furan; 2,3,4,6,7,8-hexachlorodibenzo-p-furan; 1,2,3,4,6,7,8-
heptachlorodibenzo-p-furan; 1,2,3,4,7,8,9-heptachlorodibenzo-p-furan; and octa-
chlorodibenzo-p-furan. 
  
3.2.3  Feed Preparation and Experimental Design  
Five to six week old male (102 to 163 g) and female (79 to 135 g) 
Sprague-Dawley (S-D) rats were purchased from Harlan (Houston, TX) and 
maintained on feed (Teklad rodent diet 8604, Harlan, Madison, WI) and water ad 
libitum.  All animals were housed in a climate-controlled environment 
(temperature 22 to 25 °C) that was artificially illuminated (12 hr dark/12 hr light) 
and free from chemical contamination. After a short acclimation period, the 
animals were randomly divided into treatment groups receiving 1 of 5 dietary 
formulations containing basal rodent feed with various concentrations of NS 
ranging from 0 to 2% (w/w).  Diets consisted of:  1) absolute control (Abs), 2) 
0.25% NSP, 3) 0.5% NSP 4) 1.0% NSP, and 5) 2.0% NSP.  Dietary clay 
concentrations were based on the highest level previously allowed (2.5% w/w) 
by the Association of American Feed Control Officials (AAFCO) for use in 
pelleting processes and as an anti-caking agent in non-medicated livestock 
feeds (Ferrario and Byrne, 2000).  Each treatment group consisted of 13 male 
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and 13 female rats, with the exception of the 0.5% NS group which contained 12 
males and 14 females.  Animals were inspected daily for general appearance, 
behavioral changes and signs of morbidity and mortality.  Feed consumption 
was recorded daily for the first month and every fourth day thereafter.  Body 
weights were measured initially then once per week throughout the course of the 
study. Necropsy and histopathological evaluations were conducted on 30 
animals (3 rats/sex/group) at 90 d and at 28 weeks for the remaining 100 
animals (10 rats/sex/group).  After 28 weeks, final body weights were recorded 
and blood was drawn via cardiac puncture under isoflurane anesthesia. 
Following euthanasia at both time points, tissues of interest (liver, kidneys, 
lungs, heart, brain, spleen, tibia, uterus and ovaries) were removed and 
assessed for anatomic abnormalities.  Wet weights were recorded at both 
termination time points and portions of all tissues were fixed in 10% formalin for 
subsequent histological analysis.  A portion of skin (including hair) and the 
gastrointestinal tract were also collected and fixed in the same manner.   
 
3.2.4  Hematological and Serum Biochemical Parameters 
Hematological and serum biochemical parameters were analyzed by the 
Clinical Pathology Lab, Texas Veterinary Medical Diagnostics Lab (TVMDL) 
(College Station, TX).  Hematological analysis of collected whole blood samples 
was conducted using a Cell-Dyn 3500 counter (Abbott Laboratories, Abbott 
Park, IL) and included red blood cell (RBC) count, hemoglobin (Hb) 
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concentration, percent corpuscular volume (PCV), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC), and white blood cell (WBC) count.  Leukocyte differential 
counting was performed manually from microscopic examination of blood 
smears and included nuetrophils, lyphocytes, monocytes, and eosinophils.  
Serum biochemical parameters were assessed using a Hitachi 911 (Roche 
Laboratories, Indianapolis, IN) and included total protein (TP), albumin (ALB), 
calcium (Ca), phosphorous (P), glucose (GLUC), blood urea nitrogen (BUN), 
creatinine (CRT), total bilirubin (T-BIL), alkaline phosphatase (ALP), creatine 
kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase (ALT), 
globulin (GLOB), A/G ratio, gamma glutamyl-transferase (GGT), amylase 
(AMYL), and cholesterol (CHOL).  In addition, serum micronutrients iron (Fe) 
was also quantified using a Hitachi 911.  Also, serum zinc (Zn) levels were 
analyzed using a Perkin Elmer Analyst 100 (PerkinElmer, Shelton, CT). 
 
3.2.5  Serum Vitamins A and E Analysis  
Serum vitamins A and E were extracted under yellow light following 
previously described methodology (Ruperez et al, 2004).  Briefly, rat serum (50 
µl) was mixed with 150 µl ethanol:chloroform (3:1, v/v) in a 1.5 ml 
microcentrifuge tube, vortexed for 1 min, allowed to stand for 5 min, and 
vortexed for an additional 1 min.  Samples were then centrifuged at 13,200 x g 
for 8 min at 4 °C and the supernatant was analyzed by HPLC.  
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3.2.6  Hepatic Vitamin A & E Analysis  
Liver vitamins A & E were extracted following a modification of 
procedures described by Hosotani and Kitagawa (2003).  Briefly, 0.2 g liver was 
mixed with 10 ml 1X PBS containing 1% ascorbic acid.  The mixture was 
homogenized for 5 min on ice under reduced light.  Following homogenization, 
100 µl of ddH2O was added to 50 µl of homogenate, and the mixture was 
vortexed for 20 s.  For protein precipitation, 300 µl of ethanol:chloroform (3:1, 
v/v) containing 0.01% BHT was added and the mixture was vortexed for 1 min.  
Hexane (600 µl) was added and the solution was vortexed for 1 min and then 
centrifuged at 13,200 x g for 10 min at 4 °C.  Following centrifugation, the 
hexane layer was removed and the sample was dried using a CentriVap Cold 
Trap (Labconco, Kansas City, MO).  The residue was reconstituted in 200 µL of 
mobile phase A - ACN: THF: MeOH: AA (85:5:5:5, v/v/v/v), 50 µl of which was 
used for the HPLC analysis. 
 
3.2.7  HPLC Analysis Procedures  
HPLC analysis of VA and VE was performed using previously reported 
methodology (Burri et al., 2003) with minor modifications using a Thermo 
Finnigan Liquid chromatograph with a P4000 pump, an AS3000 autosampler 
with a 100 µl loop, and a UV6000 LP photodiode array detector (Thermo 
Separation Products, Riviera Beach, FL). For serum VA and VE, 
chromatographic separation was achieved with a Microsorb 100-5 C18 column 
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with 150 mm × 4.6 mm ID and 5 µm particle size (Varian, Palo Alto, CA) using 
mobile phase A (ACN:THF:MeOH:AA at 85:5:5:5, v/v/v/v); and mobile phase B 
(ACN:THF:MeOH:AA at 55:35:5:5, v/v/v/v) under a flow rate of 1 ml/min with an 
injection volume of 50 µl.  The elution profile consisted of 95% A and 5% B for 
the first 5 min, followed by a gradient to 5% A and 95% B over 13 min.  
Afterwards, conditions were maintained for 2 min and then the column was 
washed with 95% A and 5% B for 8 min.  The total run time was 28 min.  
Analysis of hepatic VA and VE was conducted using a Zorbax Eclipse XDB-C18 
column with 250 mm × 4.6 mm ID and 5 µm particle size (Agilent, Palo Alto, 
CA).  The elution profile consisted of 95% A and 5% B for the first 5 min, 
followed by a gradient to 5% A and 95% B over 13 min.  Afterwards, conditions 
were maintained for 10 min and then the column was washed with 95% A and 
5% B for 8 min.  The total run time was 36 min.  Quantification of both vitamins 
was based on comparison of peak areas and retention times to reference 
standards.  In the case of liver analysis, final vitamin concentrations were 
adjusted based on individual tissue weights. 
 
3.2.8  Histopathology   
Formalin-fixed tissues (liver, kidney, heart, lungs, brain, stomach, 
intestine, skin, uterus and ovaries) were processed and embedded in paraffin.  
The tissues were sectioned at 5 µm and stained with hematoxylin and eosin 
(H&E) for microscopic examination.  Severity of microscopic changes was 
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graded as:  0, normal; 1, minimal change; 2, mild change; 3, moderate change; 
or 4, severe change. 
 
3.2.9  Statistics 
All experimental data was subjected to ANOVA utilizing the General 
Linear Models procedures to establish differences among treatment groups with 
variable means. Means were compared using Tukey’s multiple comparison 
procedure and considered significant at p ≤ 0.05.  
 
3.3 Results 
3.3.1  Quantification of PCDD/PCDF in NSP Clay  
Of the 17 USEPA priority PCDDs/PCDFs, only OCDD (2.34 parts per 
trillion, ppt) was present above the limits of detection (LOD = 1.02 ppt) in NSP.  
Based on this value, the toxic equivalent (TEQ) of this contaminant was 
calculated to be 0.000234 in the clay.  
 
3.3.2  Feeding Study 
Throughout the study, all animals with the exception of 2 males remained 
healthy and active with no noticeable behavioral changes.  One male rat (0.25% 
NSP) exhibited dark discharge from the left eye on day 92 that disappeared 
within 3 days and an ulceration was observed on the right hind limb of a second 
male rat (absolute control) on day 132 that healed within 1 week.   
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TABLE 10 
 
Total feed consumption (TFC), total body weight gain (TBWG), and feed conversion efficiency (FCE) in S-D 
rats following the dietary ingestion of 0 - 2.0% NSP for 28 weeks 
 
Treatment Group (% NSP) Total Animals TFCa (g) TBWGa (g) FCEa 
Males 
Abs. control 10 4305.5 ± 55.3 339.2 ± 8.8 12.74 ± 0.24 
0.25% 10 4286.4 ± 66.6 341.9 ± 5.5 12.55 ± 0.21 
0.5% 9  4581.9 ± 149.5   350.7 ± 11.4 13.11 ± 0.35 
1.0% 10  4688.5 ± 199.9   349.9 ± 12.7 13.41 ± 0.34 
2.0% 10  4622.2 ± 177.2 348.0 ± 7.2 13.28 ± 0.40 
Females 
Abs. control  10 3102.4 ± 82.7 156.4 ± 7.9 20.07 ± 0.64 
0.25% 10 3204.1 ± 84.6 164.5 ± 7.0 19.70 ± 0.70 
0.5% 11 3185.5 ± 68.4 160.4 ± 4.4 19.95 ± 0.53 
1.0% 10 3195.8 ± 68.1 173.9 ± 7.1 18.59 ± 0.67 
2.0% 10 3212.0 ± 50.5 172.4 ± 6.9 18.89 ± 0.79 
 
aData represent mean values (± SEM) of 10 animals/sex/group with the exception of the 0.5% NSP treatment 
which contained 9 males and 11 females.  
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Figure 15.  Mean cumulative weekly feed consumption of male (M) and female 
(F) S-D rats fed diets containing 0 - 2% NSP for 28 weeks.  
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Figure 16.  Mean body weight (g) of male (M) and female (F) S-D Rats fed diets 
containing 0% - 2% NSP for 28 weeks. 
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Figure 17.  Mean cumulative feed conversion efficiency (± SEM) calculated as 
the ratio of cumulative feed consumption to the cumulative body weight gain of 
female S-D rats with dietary inclusion levels of 0-2% NSP over 28 weeks.  
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Figure 18.  Mean cumulative feed conversion efficiency (± SEM) calculated as 
the ratio of cumulative feed consumption to the cumulative body weight gain of 
male S-D rats with dietary inclusion levels of 0-2% NSP over 28 weeks. 
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There were no statistically significant differences between rats (within 
each sex) consuming treated versus untreated diets with regard to: total feed 
consumption (TFC), cumulative feed consumption (CFC) - calculated as the sum 
of feed consumption from initiation to each additional week, body weight (BW), 
total body weight gain (TBWG), feed conversion efficiency (FCE) - measured as 
TFC/TBWG, and cumulative feed conversion efficiency (CFCE) - calculated as 
the sum of FCE from initiation to each additional 4 week period throughout the 
study (Table 10 and Figures 15, 16, 17, and 18).  However, FCE increased over 
the course of the study in both sexes in treated and untreated animals, and this 
increase was independent of the amount of NSP added to the diet (Figures 17 
and 18). 
At necropsy on day 90 and day 196, there were no obvious gross 
abnormalities in the major organs of interest (liver, kidneys, lungs, heart, brain, 
spleen, tibia, uteri and ovaries) in NSP-treated rats. In addition, the relative 
organ weight (ROW) for these organs (data on day 90 not shown), measured as 
the ratio of wet organ weight (WOW) to final body weight (FBW) was not 
significantly different in rats consuming treated versus untreated diets (Table 
11).  Histopathological evaluation of H&E stained sections of the major organs 
showed no substantial differences between animals consuming NSP-containing 
diets and untreated controls at 90 d (Tables 12 and 13) or 28 weeks (Table 14 
and 15).  Any lesions present were interpreted as background lesions and were 
of similar incidence and severity in NSP-treated and control animals. 
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TABLE 11 
 
Relative organ weights of S-D rats following the dietary addition of 0 - 2.0% NSP for 28 weeks   
 
Treatment Group Organ 
Abs. control 0.25% 0.5% 1.0% 2.0% 
Males 
Brain (x103) 3.75 ± 0.07 3.85 ± 0.06 3.72 ± 0.08 3.78 ± 0.11 3.78 ± 0.10 
Heart (x103)  2.95 ± 0.05 2.88 ± 0.06 2.98 ± 0.07 2.79 ± 0.06 2.90 ± 0.05 
Kidneys (x103) 5.95 ± 0.16 5.83 ± 0.13 5.91 ± 0.12 5.77 ± 0.12 5.75 ± 0.16 
Liver (x102)  3.31 ± 0.10 3.28 ± 0.09 3.27 ± 0.10 3.22 ± 0.07 3.25 ± 0.09 
Lungs (x103)  3.36 ± 0.08 3.60 ± 0.09 3.68 ± 0.12 3.44 ± 0.09 3.28 ± 0.14 
Spleen (x103)  1.67 ± 0.06 1.78 ± 0.07 1.74 ± 0.04 1.76 ± 0.05 1.75 ± 0.06 
Tibia (x103)  1.67 ± 0.02 1.65 ± 0.02 1.63 ± 0.02 1.70 ± 0.04 1.71 ± 0.03 
Females 
Brain (x103)  6.17 ± 0.13 6.07 ± 0.13 6.19 ± 0.10 6.02 ± 0.14 5.92 ± 0.09 
Heart (x103)  3.20 ± 0.05 3.37 ± 0.06 3.26 ± 0.07 3.28 ± 0.11 3.24 ± 0.07 
Kidneys (x103)  6.00 ± 0.11 5.91 ± 0.10 5.84 ± 0.12 5.63 ± 0.10 5.84 ± 0.07 
Liver (x102)  2.94 ± 0.05 2.83 ± 0.04 2.85 ± 0.04 2.90 ± 0.05 2.83 ± 0.06 
Lungs (x103)  4.72 ± 0.15 4.89 ± 0.14 4.64 ± 0.12 4.58 ± 0.09 4.65 ± 0.11 
Spleen (x103)  2.06 ± 0.08 1.98 ± 0.09 2.02 ± 0.06 1.99 ± 0.04 1.91 ± 0.09 
Tibia (x103)  2.05 ± 0.12 1.93 ± 0.06 1.98 ± 0.07 2.03 ± 0.05 2.09 ± 0.05 
Uterus/ovaries (x103)  2.47 ± 0.18 2.35 ± 0.10 2.76 ± 0.19 2.70 ± 0.24 2.64 ± 0.17 
 
Note.  Data are reported as mean values (± SEM) for 10 animals/sex/group with the exception of the 0.5% NSP 
treatment which contained 9 males and 11 females.  
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TABLE 12 
 
Histological findings for male S-D rats following the dietary ingestion of 0 - 2.0% NSP for 90 days 
 
Treatment group Control 0.25% 0.5% 1.0% 2.0% 
 Incidence (group mean severity) 
Liver      
   Focal inflammation   0 0 2 (1.0) 0 0 
Kidney      
   Focal interstitial inflammation/fibrosis 2 (1.5) 1 (1.0) 2 (1.0) 1 (1.0) 2 (1.5) 
   Focal cortical tubular epithelial hyperplasia 3 (1.7) 3 (1.3) 3 (1.7) 2 (1.5) 3 (1.7) 
   Focal tubular dilatation with protein casts 3 (1.7) 3 (1.3) 3 (2.0) 2 (1.5) 2 (2.5) 
Heart       
   Focal non-suppurative interstitial inflammation 2 (1.0) 0 1 (1.0) 0 0 
Lungs      
   Focal peribronchiolar alveolar vacuolated macrophages 0 1 (1.0) 0 0 1 (1.0) 
   Focal peribronchiolar arteriolar mineralization 0 0 1 (1.0) 0 0 
Brain 0 0 0 0 0 
Stomach  0 0 0 0 0 
Intestine (duodenum, jejunum, ileum, and colon) 0 0 0 0 0 
Skin 0 0 0 0 0 
 
Note.  Group mean severity was calculated by adding severity scores 1-4 (see Methods) for animals with lesions and dividing 
by the number of animals with lesions.  Tissue samples examined were obtained from 3 male rats per treatment. 
 
 
 
 
  
112
TABLE 13 
 
Histological findings for female S-D rats following the dietary ingestion of 0 - 2.0% NSP for 90 days 
 
Treatment group Control 0.25% 0.5% 1.0% 2.0% 
 Incidence (group mean severity*) 
Liver      
   Focal inflammation   0 0 0 1 (1.0) 0 
Kidney      
   Focal interstitial inflammation/fibrosis 1 (1.0) 1 (1.0) 1 (2.0) 1 (2.0) 1 (1.0) 
   Focal cortical tubular epithelial hyperplasia 2 (1.0) 1(1.0) 1 (1.0) 1 (2.0) 1 (2.0) 
   Focal tubular dilatation with protein casts 0 0 0 1 (1.0) 1 (1.0) 
Heart       
   Focal non-suppurative interstitial inflammation 0 1 (1.0) 0 0 0 
Lungs      
   Focal peribronchiolar alveolar vacuolated macrophages 0 1 (1.0) 0 0 0 
   Focal peribronchiolar arteriolar mineralization 0 0 0 0 0 
Brain 0 0 0 0 0 
Stomach       
Intestine (duodenum, jejunum, ileum, and colon) 0 0 0 0 0 
Skin 0 0 0 0 0 
 
Note.  Group mean severity was calculated by adding severity scores 1-4 (see Methods) for animals with lesions and dividing 
by the number of animals with lesions.  Tissue samples examined were obtained from 3 female rats per treatment. 
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TABLE 14 
 
Histological findings for male S-D rats following the dietary ingestion of 0 - 2.0% NSP for 28 weeks 
 
Treatment group Control 0.25% 0.5% 1.0% 2.0% 
 Incidence (group mean severity) 
Livera      
   Focal inflammation   4 (1.0) 3 (1.0) 3 (1.0) 5 (1.0) 3 (1.0) 
   Basophilic focus of hepatocellular alteration 0 0 1 (1.0) 0 0 
Kidneya      
   Focal interstitial inflammation/fibrosis 10 (1.2) 10 (1.1) 10(1.1) 10(1.2) 10 (1.1) 
   Focal cortical tubular epithelial hyperplasia 10 (2.0) 10 (2.2) 10 (2.1) 10 (2.0) 10 (1.8) 
   Focal tubular dilatation with protein casts 10 (1.6) 10 (1.8) 10 (2.1) 10 (1.7) 9 (1.9) 
   Mineralization 3 (1.0) 3 (1.0) 2 (1.0) 3 (1.0) 4 (1.0) 
Heart (focal non-suppurative interstitial inflammation)b 0 1 (1.0) 0 0 0 
Lungsb      
   Focal peribronchiolar/perivascular/subpleural vacuolated macrophages 2 (1.5) 2 (2.0) 2 (1.5) 2 (1.0) 2 (2.0) 
   Focal peribronchiolar arteriolar mineralization 0 0 0 1 (1.0) 1 (1.0) 
   Focal peribronchiolar/perivascular eosinophil accumulation 0 0 1 (1.0) 0 1 (1.0) 
   Focal osteosis 0 0 0 0 1 (1.0) 
Brainb 0 0 0 0 0 
Stomachb       
   Focal gland dilation and epithelial attenuation) 1 (1.0) 1 (2.0) 0 0 0 
Intestine (duodenum, jejunum, ileum, and colon)b 0 0 0 0 0 
Skinb 0 0 0 0 0 
 
Note.  Group mean severity was calculated by adding severity scores 1-4 (see Methods) for animals with lesions and dividing 
by the number of animals with lesions.  aTissue samples examined were obtained from 10 rats per treatment except the 0.5% 
group that contained 9 animals.  bTissue samples examined were obtained from the first three animals of each group. 
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TABLE 15 
 
Histological findings for female S-D rats following the dietary ingestion of 0 - 2.0% NSP for 28 weeks 
 
Treatment group Control 0.25% 0.5% 1.0% 2.0% 
 Incidence (group mean severity) 
Livera      
   Focal inflammation   5 (1.0) 6 (1.0) 6 (1.0) 2 (1.0) 7 (1.0) 
   Basophilic focus of hepatocellular alteration 0 0 0 0 0 
Kidneya      
   Focal interstitial inflammation/fibrosis 5 (1.0) 8 (1.1) 7 (1.0) 5 (1.0) 7 (1.0) 
   Focal cortical tubular epithelial hyperplasia 6 (1.0) 7 (1.4) 8 (1.3) 7 (1.1) 8 (1.3) 
   Focal tubular dilatation with protein casts 6 (1.0) 9 (1.3) 8 (1.1) 9 (1.1) 9 (1.2) 
   Mineralization 1 (1.0) 1 (1.0) 0 2 (1.0) 2 (1.0) 
Heart (focal non-suppurative interstitial inflammation)b 0 0 0 1 (1.0) 0 
Lungsb      
   Focal peribronchiolar/perivascular/subpleural vacuolated macrophages 0 2 (1.5) 0 1 (1.0) 2 (1.0) 
   Focal peribronchiolar arteriolar mineralization 0 0 0 0 0 
   Focal peribronchiolar/perivascular eosinophil accumulation 0 0 0 0 0 
   Focal osteosis 0 0 1 (1.0) 0 0 
Brainb 0 0 0 0 0 
Stomachb       
   Focal gland dilation and epithelial attenuation) 1 (1.0) 1 (1.0) 0 0 0 
Intestine (duodenum, jejunum, ileum, and colon)b 0 0 0 0 0 
Skinb 0 0 0 0 0 
Ovary (paraovarian cyst)b 0 0 0 0 0 
Uterusb 0 0 0 0 0 
 
Note.  Group mean severity was calculated by adding severity scores 1-4 (see Methods) for animals with lesions and dividing 
by the number of animals with lesions.  aTissue samples examined were obtained from 10 rats per treatment except the 0.5% 
group that contained 11 animals.  bTissue samples examined were obtained from the first three animals of each group.    
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Analysis of whole blood samples showed no significant differences in 
hematological parameters between rats fed diets containing NSP compared to 
untreated controls in either males or females with the exception of males 
consuming 0.25% NSP which showed a significantly higher mean MCH (18.6 ± 
0.2 pg) (Table 16).  There was no evidence of hemoparasites.  Erythrocytosis or 
anemia was not observed in the treated compared to untreated animals as 
evidenced by the RBC count and hemoglobin levels.  RBC morphology was 
normal for most rats, although some exhibited polychromasia (Table 17).   
Poikilocytosis was observed in 1 female consuming 0.5% NSP and 1 male 
consuming 0.25% NSP in the diet, while anisocytosis was present in only 1 
absolute control male.  No evidence of leukocytosis or leukopenia was detected 
between the treated and the control groups in both males and females. 
Microscopic examination of the blood samples revealed that the WBCs in all rats 
were normal and morphologically similar.  All other hematological parameters 
assessed in this study were normal. 
Serum biochemical analysis indicated that Ca was slightly increased in 
the 0.5% (10.79 ± 0.13 mg/dl) and 2.0% (10.83 ± 0.12 mg/dl) NSP-treated 
females compared to absolute controls (10.31 ± 0.09 mg/dl) (Table 18).  All 
other parameters were unchanged between NSP-treated and untreated groups 
within both sexes.  
 Serum and hepatic vitamin A (VA) and vitamin E (VE) and serum Fe and 
Zn were also analyzed.  Serum and hepatic VA and VE levels were unchanged 
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TABLE 16 
 
Hematology of S-D rats following the dietary ingestion of 0 - 2.0% NSP for 
28 weeks   
 
Treatment Group Hematological 
Parameter Abs. 
control 0.25% 0.5% 1.0% 2.0% 
Males 
WBC/ul 5840 ± 713 6180 ± 637 5667 ± 464 8120 ± 369 5365 ± 704
Neutrophils (%) 14.1 ± 3.0 14.1 ± 3.3 14.1 ± 2.7 10.3 ± 1.6 13.9 ± 2.3
Lymphocytes (%) 83.2 ± 2.9 81.9 ± 3.5 83.6 ± 3.1 87.2 ± 1.8 83.7 ± 2.6
Monocytes (%) 1.8  ± 0.2 1.8 ± 0.5 1.4 ± 0.2 1.0 ± 0.0 1.3 ± 0.3
Eosinophils (%) 2.3 ± 0.5 3.2 ± 0.7 2.3 ± 0.7 2.4 ± 0.4 2.5 ± 0.8
RBCs/ul (x106)     7.5 ± 0.1 7.4 ± 0.1 7.5 ± 0.1 7.5 ± 0.1 7.5 ± 0.1
Hb (g/dl) 13.4 ± 0.2 13.6 ± 0.1 13.6 ± 0.2 13.6 ± 0.1 13.5 ± 0.2
PCV (%) 39.5 ± 0.4 39.9 ± 0.3 40.4 ± 0.5 40.0 ± 0.4 39.7 ± 0.5
MCV (fl) 52.6 ± 0.5 54.3 ± 0.6 53.7 ± 0.3 53.6 ± 0.6 53.0 ± 0.4
MCH (pg) 17.8 ± 0.2  18.6 ±0.2* 18.1 ± 0.1 18.2 ± 0.2 18.0 ± 0.1
MCHC (g/dl) 33.9 ± 0.3 34.2 ± 0.2 33.7 ± 0.2 33.9 ± 0.3 34.0 ± 0.2
Females 
WBC/ul 3930 ± 431 4250 ± 487 3936 ± 356 3950 ± 452 3411 ± 486
Neutrophils (%) 17.7 ± 2.6 13.5 ± 1.7 13.0 ± 2.7 13.9 ± 1.1 14.0 ± 2.7
Lymphocytes (%) 79.7 ± 2.9 83.4 ± 2.1 85.0 ± 2.8 78.4 ± 6.6 82.8 ± 3.1
Monocytes (%) 1.2 ± 0.2 2.3 ± 0.5 1.3 ± 0.3 1.0 ± 0.0 1.8 ± 0.6
Eosinophils (%) 2.2 ± 0.6 3.1 ± 0.7 1.9 ± 0.2 1.8 ± 0.3 2.2 ± 0.4
RBCs/ul (x106) 6.5 ± 0.1 6.4 ± 0.1 6.5 ± 0.1 6.2 ± 0.1 6.5 ± 0.1
Hb (g/dl) 12.4 ± 0.2 12.4 ± 0.2 12.6 ± 0.1 12.3 ± 0.2 12.5 ± 0.2
PCV (%) 36.5 ± 0.6 36.1 ± 0.5 37.2 ± 0.5 35.7 ± 0.5 36.5 ± 0.7
MCV (fl) 56.4 ± 0.6 56.8 ± 0.5 57.1 ± 0.5 57.2 ± 0.3 56.3 ± 0.5
MCH (pg) 19.1 ± 0.2 19.5 ± 0.2 19.4 ± 0.2 19.7 ± 0.1 19.3 ± 0.1
MCHC (g/dl) 33.9 ± 0.2 34.3 ± 0.1 33.9 ± 0.1 34.4 ± 0.1 34.3 ± 0.1
 
Note.  Data are reported as mean values (± SEM).   
*Indicates statistical significance compared to untreated controls (p < 0.05). 
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TABLE 17 
 
Morphological evaluation of red blood cells of S-D rats following dietary ingestion of 0 - 2.0% NSP for 28 
weeks 
 
Cell Morphology 
Treatment Group Total Samples 
Normal Polychromasiaa Poikilocytosis Anisocytosis 
Males  
Abs. control 10 3 6 - 1 (rare) 
0.25% 10 4 5 1(few) - 
0.5% 9 3 6 - - 
1.0% 10 6 4 - - 
2.0% 10 6 4 - - 
Females 
Abs. control 10 6 4 - - 
0.25% 10 6 4 - - 
0.5% 11 6 4 1 (rare) - 
1.0% 10 5 5 - - 
2.0% 9 4 5 - - 
 
Note. Data represent the number out of total samples in which the selected morphological characteristic was 
observed.  aPolychromatophilic cells were “rare or few” in all the samples in which they were identified.  
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TABLE 18 
 
Terminal serum biochemical parameters in S-D rats following the dietary 
addition of 0 - 2.0% NSP for 28 weeks   
 
Treatment Group 
Test Abs. 
control 0.25% 0.5% 1.0% 2.0% 
Males 
TP (g/dl) 5.91 ± 0.09 5.92 ± 0.04 5.99 ± 0.03 5.90 ± 0.06 5.91 ± 0.07
ALB (g/dl) 3.40 ± 0.09 3.53 ± 0.09 3.48 ± 0.08 3.51 ± 0.07 3.49 ± 0.09
Ca (mg/dl) 10.25 ± 0.15 10.51 ± 0.08 10.67 ± 0.12 10.50 ± 0.09 10.56 ± 0.07
P (mg/dl) 5.83 ± 0.18 5.70 ± 0.22 5.71 ± 0.27 5.45 ± 0.17 5.24 ± 0.15
GLUC 258.6 ± 6.3 283.1 ± 15.2 287.9 ± 9.9 264.1 ± 14.6 271.3 
BUN (mg/dl) 22.65 ± 0.86 22.68 ± 0.64 21.57 ± 0.50 22.27 ± 0.42 22.53 ± 0.52
CRT (mg/dl) 0.26 ± 0.02 0.30 ± 0.00 0.29 ± 0.01 0.28 ± 0.01 0.29 ± 0.01
T-BIL (mg/dl) 0.10 ± 0.00 0.10 ± 0.00 0.10 ± 0.00 0.10 ± 0.00 0.10 ± 0.00
ALP (U/l) 104.6 ± 2.7 106.2 ± 4.5 111.7 ± 8.5 110.6 ± 4.2 119.6 ± 3.9
CK (U/l) 1455 ± 1002 376 ± 57 3358 ± 2903 994 ± 617 318 ± 35
AST (U/l) 127.0 ± 17.4 87.3 ± 7.9 142.8 ± 49.2 134.6 ± 26.7 94.2 ± 6.3
ALT (U/l) 64.3 ± 3.9 58.9 ± 2.3 71.4 ± 9.2 70.2 ± 6.8 59.8 ± 2.9
GLOB (g/dl) 2.51 ± 0.08 2.39 ± 0.11 2.51 ± 0.08 2.39 ± 0.12 2.42 ± 0.09
A/G Ratio 1.37 ± 0.06 1.51 ± 0.09 1.40 ± 0.07 1.52 ± 0.11 1.47 ± 0.08
GGT (U/l) <3.0 <3.0 <3.0 <3.0 <3.0
AMYL (U/l) 2671 ± 89 2633 ± 87 2759 ± 120 2457 ± 74 2532 ± 113
CHOL 120.0 ± 10.1 112.6 ± 11.7 109.8 ± 6.6 102.7 ± 9.7 107.7 ± 12.4
Females 
TP (g/dl) 5.96 ± 0.09 5.96 ± 0.09 6.01 ± 0.10 6.06 ± 0.10 6.24 ± 0.10
ALB (g/dl) 4.05 ± 0.08 4.05 ± 0.07 4.10 ± 0.06 4.06 ± 0.06 4.17 ± 0.09
Ca (mg/dl) 10.31 ± 0.09 10.51 ± 0.05 10.79 ± 0.13* 10.62 ± 0.11 10.83 ± 
P (mg/dl) 4.81 ± 0.29 5.21 ± 0.20 4.87 ± 0.27 4.99 ± 0.13 4.91 ± 0.28
GLUC 223.7 ± 7.3 218.5 ± 2.9 218.5 ± 9.5 211.0 ± 5.0 212.4 ± 4.3
BUN (mg/dl) 20.96 ± 0.78 21.14 ± 0.73 20.69 ± 0.78 20.38 ± 1.05 20.27 ± 0.52
CRT (mg/dl) 0.32 ± 0.01 0.33 ± 0.02 0.34 ± 0.02 0.35 ± 0.03 0.33 ± 0.02
T-BIL (mg/dl) 0.11 ± 0.01 0.11 ± 0.01 0.17 ± 0.06 0.10 ± 0.00 0.10 ± 0.00
ALP (U/l) 96.9 ± 7.7 93.8 ± 5.7 94.5 ± 6.9 103.5 ± 9.5 100.5 ± 8.3
CK (U/l) 1019 ± 781 5455 ± 2362 3525 ± 1760 3676 ± 1939 1333 ± 595
AST (U/l) 147.0 ± 37.9 268.2 ± 72.6 314.0 ± 104.8 179.5 ± 43.1 130.1 ± 20.6
ALT (U/l) 73.0 ± 6.4 77.1 ± 8.5 243.2 ± 158.5 66.3 ± 8.7 67.8 ± 7.2
GLOB (g/dl) 1.91 ± 0.03 1.91 ± 0.05 1.91 ± 0.06 2.00 ± 0.08 2.07 ± 0.05
A/G Ratio 2.13 ± 0.06 2.13 ± 0.07 2.16 ± 0.06 2.05 ± 0.08 2.02 ± 0.06
GGT (U/l) <3.0 <3.0 <3.0 <3.0 <3.0
AMYL (U/l) 1703 ±  52 1690 ± 35 8665 ± 6937 1639 ± 64 1713 ± 85
CHOL 100.3 ± 6.7 91.3 ± 4.9 88.9 ± 3.3 95.6 ± 6.1 94.6 ± 3.4
 
Note.  Data are reported as mean values (± SEM) of 10 animals/sex/group with the 
exception of the 0.5% NSP treatment which contained 9 males and 11 females.  
*Indicates statistical significance compared to untreated controls (p < 0.05). 
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TABLE 19 
 
Analysis of vitamin A (VA), vitamin E (VE), Fe, and Zn in liver and serum of S-D rats following the dietary 
ingestion of 0 - 2.0% NSP for 28 weeks   
 
Treatment Group Selected 
Parameter  Abs. control 0.25% 0.5% 1.0% 2.0% 
Male 
aSerum VA (µg/L) 567.4 ± 24.8 571.2 ± 17.4 532.3 ± 18.4 542.3 ± 21.8 561.7 ± 20.9
bHepatic VA (µg/g) 28.7 ± 3.2 28.4 ± 2.6 27.4 ± 0.9 27.3 ± 1.3 28.9 ± 1.7
aSerum VE (µg/L) 13391 ± 1220 13217 ± 1309 11561 ± 478 11822 ± 1221 12042 ± 1315
bHepatic VE (µg/g) 395.3 ± 2.8 393.4 ± 3.7 384.6 ± 5.0 407.1 ± 3.4 393.2 ± 2.4
aSerum Fe (µg/dl) 136.7 ± 8.9 153.3 ± 8.7 131.1 ± 12.2 179.6 ± 12.4* 150.8 ± 4.9
aSerum Zn (mg/L) 1.29 ± 0.04 1.37 ± 0.04 1.35 ± 0.05 1.38 ± 0.06 1.22 ± 0.05
Female 
aSerum VA (µg/L) 254.1 ± 6.0 229.4 ± 8.3 247.5 ± 9.9 302.1 ± 10.7* 287.9 ± 13.2
bHepatic VA (µg/g) 60.4 ± 3.9 61.0 ± 4.6 61.5 ± 4.7 51.3 ± 5.1 53.5 ± 5.7
aSerum VE (µg/L) 14535 ± 1168 13574 ± 568 13804 ± 628 14675 ± 1018 15731 ± 715
bHepatic VE (µg/g) 482.1 ± 14.2 471.2 ± 1.7 468.9 ± 13.3 469.4 ± 16.1 480.9 ± 41.7
aSerum Fe (µg/dl) 321.0 ± 13.7 309.0 ± 18.1 344.1 ± 24.0 337.0 ± 22.5   344.1 ± 27.4
aSerum Zn (mg/L) 1.05 ± 0.03 1.11 ± 0.03 1.16 ± 0.04 1.11 ± 0.04 1.11 ± 0.06
 
aData are reported as mean values (± SEM) of 10 animals/sex/group with the exception of the 0.5% NSP treatment which 
contained 9 males and 11 females.  bData represent mean values (± SEM) of 3 randomly selected liver samples.  
*Indicates statistical difference compared to untreated controls (p < 0.05).  
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with dietary inclusion of NSP at all treatment levels with the exception of a slight 
increase in VA in the 1.0% NSP-treated females (302.1 ± 10.7 µg/L) compared 
to untreated controls (254.1 ± 6.0 µg/L). Serum Fe and Zn levels were also 
unaffected by the dietary inclusion of up to 2.0% NSP except in 1% NSP-treated 
males which showed increased Fe levels (179.6 ± 12.4 µg/dl) in comparison to 
untreated control animals (136.7 ± 8.9 µg/dl) (Table 19).  There was no trend 
toward dose-dependency observed in either case.  
 
3.4  Discussion 
In this study, the potential for adverse effects resulting from chronic 
dietary ingestion of up to 2% (w/w) of NSP clay was evaluated in S-D rats.  
Previously, evaluation of up to 96 compounds in various animal species found 
no significant added benefit to repeat-dose animal tests of greater than 6 months 
duration; hence, 28 weeks was chosen as sufficient for this study (Lumley and 
Walker, 1985a, 1986; Lumley et al, 1992).  Based on standards set by the 
International Conference on Harmonization (ICH) of Technical Requirements for 
Registry of Pharmaceuticals for Human Use this constitutes a chronic study 
(D’Arcy and Harron, 1992) whereas the 90 d termination was a subchronic pilot 
study.  
At termination, mean TFC, CFC, BW, TBWG, FCE, and CFCE of all the 
NS-treated groups were not statistically different from the controls in either sex.  
However, FCE, measured as the ratio of TFC to TBWG, increased as the study 
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progressed, suggesting impairment of feed utilization with age (Figure 17 and 
18).  However, comparison between NSP-treated rats and untreated controls 
suggested that this was not NSP-dependent.  In addition, no NSP-dependent 
gross or histopathological changes or differences in relative organ weights were 
observed, further suggesting that NSP is not overtly toxic.  There was a single 
basophilic focus of hepatocellular alteration in one or two sections of liver from 
one treated rat (in the 0.5% group).  Such foci may occur spontaneously as a 
background lesion in rats.  They may represent progenitor lesions from which 
hepatocellular neoplasia may arise.  However, the incidence of spontaneously 
occurring basophilic foci is generally much lower than in the liver of rodents 
treated with carcinogens (Cattley and Popp, 2002).  In this case, the single 
basophilic focus is most likely a spontaneous occurring, background lesion as it 
is present in only 1 of 2 sections of the liver from 1/80 treated rats and it is not in 
the higher dose groups (1% and 2%). 
Analysis of whole blood samples showed no significant differences in 
hematological parameters between rats fed diets containing NSP compared to 
untreated controls in either males or females with the exception of males 
consuming 0.25% NSP which showed a significantly higher mean MCH over 
their untreated counterparts (Table 16).  However, this difference was not dose-
dependent and therefore, was not attributed to the dietary inclusion of the NSP.  
In addition, the RBC counts were not affected and no NSP-related morphological 
differences were detected in RBCs, suggesting that NSP ingestion is unlikely to 
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produce hemolytic, hemorrhagic, or other forms of anemia, or to affect RBC 
physiology or metabolism (George-Gay and Parker, 2003).  Further, WBCs and 
leukocyte differentials were found to be quantitatively and morphologically 
similar between NSP-treated and untreated animals and were considered 
normal in all treatment groups.  This suggests that NSP is unlikely to impair 
immunity or inflammatory processes, lead to increased incidence of infections, 
or cause alterations to bone marrow (Goodnough et al., 1999; George-Gay and 
Parker, 2003). 
In terms of serum biochemical analysis, Ca was the only parameter found 
to be altered by NSP ingestion, with increases in females upon dietary inclusion 
levels of either 0.5 or 2.0% (Table 18).  Because this was apparent only in 
females and in a manner that was independent of NSP dose, it is unlikely that 
NSP was the source of these changes. Overall, analysis of the serum 
biochemical parameters used in this study suggests that NSP ingestion (at 
dietary inclusion levels up to 2.0% w/w) does not adversely affect biochemical or 
physiological processes. 
VA is vital for visual acuity, controlling the differentiation program of 
epithelial cells in the digestive tract and respiratory system, skin, bone, the 
nervous system, the immune system, and for hematopoiesis (Gursu et al., 
2002).  VA deficiency is the leading cause of childhood blindness in developing 
countries, and is a major contributor to childhood morbidity and mortality 
resulting from common infections (Fieldler et al., 2000).  Dietary AFs (5 ppm) 
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have been shown to reduce hepatic VA concentrations in broiler chicks 
(Pimpukdee et al., 2004).  In the same study, inclusion of 0.25% NSP to the AF-
contaminated diet not only protected the animals against aflatoxicosis, but also 
preserved the hepatic VA.  Dietary NSP alone (0.5%) did not affect VA levels.  
VE is an essential antioxidant for various biochemical functions including normal 
reproduction, muscle development, and resistance of RBCs to hemolysis 
(Lehninger et al., 1997b) and has been associated with prevention of cancer and 
heart disease (Packer, 1993).  Previous studies have suggested that this 
antioxidant may reduce AF toxicity via reduction of both oxidative damage and 
bioavailability of the toxins (Odin, 1997).  In this study, serum and hepatic VA 
and VE levels remained unchanged with dietary inclusion of NSP at treatment 
levels ranging from 0 to 2.0% with the exception of a slight increase in VA in 
1.0% NSP-treated females (Table 19).  The fact that the same effect was not 
observed in the 2.0% group or across both sexes suggests that this elevation 
was not NS-dependent. 
Fe and Zn are also essential in the body as cofactors in several 
enzymatic and metabolic functions (Lehninger et al., 1997a).  Fe is required for 
the synthesis of heme proteins including hemoglobin and myoglobin, 
metalloenzymes, and cytochromes (Nicholls, 1996; George-Gay and Parker, 
2003).  Zn deficiency can lead to reduced growth rate, skin lesions, impaired 
immune response, low sperm count, fetal abnormalities, and cognitive 
impairment (Chesters, 1996; Prasad et al., 2001).  In addition to VA and VE 
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levels, serum Fe and Zn levels were unaffected by the dietary inclusion of up to 
2.0% NSP except in 1.0% NSP-treated males which showed increased Fe 
levels.  Like the increase observed in VA, it is unlikely that this increase is NSP-
dependent because Fe levels in animals ingesting 2.0% NSP were unaffected.   
PCDD/PCDF congeners are ubiquitous environmental contaminants.  Upon 
exposure, they bioaccumulate in fatty animal tissues and subsequently can be 
highly toxic to humans (Startin et al., 1990; Schecter et al., 1997; Jensen, 2001).  
In 1997, use of ball clay as an anti-caking and pelleting agent in animal feeds 
was discontinued because it was found to contain high levels of these 
contaminants (Headrick et al, 1999).  Studies attributed the source of 
contamination in chicken products to the use of this ball clay in chicken feed 
(Ferrario and Byrne, 2000; Headrick et al, 1999). Ball clay consists primarily of 
poorly defined crystalline kaolinite, while the clay used in this study (NSP) is a 
smectite (Ferrario and Byrne, 2000).  For purposes of comparison, OCDD was 
detected at 205,663 ppt in the ball clay source from which the animals were 
contaminated.  In contrast, analysis of 17 USEPA priority dioxins/furans 
confirmed that the NSP clay used in this study was not contaminated with high 
levels of any of these pollutants.  In fact, OCDD (2.34 ppt) was the only 
contaminant present above the limits of detection (LOD = 1.02 ppt), 
approximately 0.001% of the amount detected in ball clay. According to the 
World Health Organization (WHO), OCDD exhibits the least toxicity among the 
priority PCDDs with a Toxic Equivalency Factor (TEF) of 0.0001 (developed by 
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WHO, reported by Van den Berg et al., 1998).  Based on the measurement 
value, the toxic equivalent (TEQ) of this contaminant in NSP was calculated to 
be 0.000234, in comparison to the TEQ of 21 that was calculated for the same 
contaminant in ball clay (Ferrario and Byrne, 2000).   
Nonselective sorbents may bind enzymes and critical nutrients, and may 
release sorbed contaminants, making prolonged use inadvisable.  In previous 
research, concentrations as high as 2% NSP in the diet throughout pregnancy 
produced neither maternal nor fetal toxicity in S-D rats, and did not affect metal 
bioavailability in a variety of tissues (Wiles et al., 2004).  In this study, prolonged 
(28 weeks) dietary inclusion of 0 to 2.0% NSP in S-D rats did not appear to 
affect TFC, CFC, BW, TBWG, FCE, CFCE, generally accepted hematological 
and serum biochemical parameters, or selected micronutrients (VA, VE, Fe and 
Zn).  Although statistically significant changes in some parameters were noted, 
these differences did not appear to be NSP-related or dose-dependent, 
suggesting that NSP at a dietary inclusion level as high as 2.0% (w/w) does not 
produce overt toxicity.  Importantly, this information increases the feasibility for 
use of NSP clay in the diet of humans to reduce foodborne exposure to 
aflatoxins and improve liver cancer management in high risk populations. 
 
 
. 
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CHAPTER IV 
ASSESSMENT OF ACUTE AFLATOXIN EXPOSURE IN A 
GHANAIAN POPULATION PRIOR TO INTERVENTION WITH 
NOVASIL CLAY 
 
4.1 Introduction 
Aflatoxins (AFs) are a group of structurally similar, highly toxic fungal 
metabolites produced primarily by Aspergillus flavus and A. parasiticus, 
frequently identified in corn, groundnuts, cottonseed, and tree nuts (Bhatnagar et 
al., 2002; Lopez et al., 2002; CAST, 2003).  The fungi have been found to be 
most abundant between latitudes 26° to 35° north or south of the equator, 
primarily in tropical areas including Ghana and other parts of Africa.  Conditions 
that favor AF production and subsequent contamination of grain in these areas 
include a temperature of 30.5 °C, relative humidity of greater than 85%, and a 
grain moisture content of 14-32% (Cole et al., 1995; Payne, 1998; Shephard, 
2003).  
Unfortunately, the basic dietary staples that are produced and consumed 
by rural populations in Ghana and other West African countries are poorly 
handled and stored and therefore are frequently contaminated by toxigenic fungi 
and AF (Jolly et al, 2004).  For example, analysis of randomly selected 
groundnut samples obtained from twelve major markets across Ghana revealed 
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AF contamination ranging from 5.7 to 22,168 ppb (Awuah and Kpodo, 1996).  In 
a separate study, samples of kenkey (a corn-based product) exhibited AF 
contamination that ranged from 6.15 to 196.1 ppb with a mean concentration of 
50.55 ppb (Jesperson et al., 1994). 
AFs, particularly AFB1, have been found to be acutely toxic, carcinogenic, 
mutagenic and immunosuppressive. They also cause death and disease in 
mammalian species (WHO-IARC, 1993; Miller and Wilson, 1994; Pestka and 
Bondy, 1994; Turner, 2003).  In addition, dairy animals consuming AFB1-
contaminated rations can excrete aflatoxin M1 (AFM1), a hydroxylated metabolite 
of AFB1, in milk and subsequently taint other dairy-based products such as 
cheese and ice cream (Phillips et al., 1994; Neal, 1998; Chopra et al., 1999).  In 
humans, AFM1 secreted in mother’s milk may enhance the morbidity of children 
with kwashiorkor or malnutrition. Kwashiorkor is characterized by severe protein 
deficiency and a variety of symptoms including hypoalbuminemia, retarded 
growth, changes in skin and hair pigmentation, diarrhea, loss of appetite, 
nervous irritability, edema, anemia, fatty liver, and immunosuppression. It is 
often accompanied by infection and vitamin deficiencies (Hendrickse et al., 
1983; Hendrickse, 1991; Adhikari, 1994).  In developing countries, where 
foodborne exposure to AF is significant, studies have reported a dose-
dependent association between AFM1 in the urine and an increased relative risk 
of developing hepatocellular carcinoma (HCC) (Qian et al., 1994; Yu et al., 
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1997).  Thus, there is a critical need for practical interventions or therapies to 
ensure the health of humans burdened by AF contamination of food. 
Trials are ongoing in the U.S. to assess the feasibility of NS clay for use 
as a potential enterosorbent of AF in humans. Future work is planned to 
investigate the effectiveness of this approach for reducing aflatoxin exposure in 
high risk populations in Ghana, West Africa using AFM1 in the urine as a 
molecular biomarker (Groopman et al 1992a; Hsieh and Wong, 1994).  The 
objective of this study was to quantitate this biomarker in humans from four 
communities in the Ejura district of Ghana in order to establish baseline AF 
exposure levels prior to NS clay intervention studies. 
 
4.2 Materials and Methods 
4.2.1 Chemicals and Reagents 
Aflatoxin M1 (AFM1) and creatinine measurement kits were purchased 
from Sigma Chemical Co. (St. Louis, MO) and Sigma Diagnostics, Inc. (St. 
Louis, MO), respectively.  Preparative Aflatest P monoclonal antibody columns 
were purchased from Vicam (Watertown, MA).  All solvents were HPLC grade.  
Purified water (ddH2O) was prepared by processing deionized water through a 
Milli-QUF+ purification system (Millipore Corp., Bedford, MA).   
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4.2.2 Urine Collection 
Approximately 120 ml of the first urine in the morning was collected from 
91 volunteers in four communities in the Ejura district of Ghana at designated 
community health centers.  This district was selected because the communities 
are predominantly agricultural and the main crops include maize, groundnuts, 
and other cereal-based products.  The study subjects consisted of males and 
females with ages ranging from 19 to 86 years.  The investigative team 
contacted and recruited the volunteers through the district health director and 
the chief of each community.  Each participant signed an informed consent prior 
to recruitment.  All samples were kept cool during transport to the Kwame 
Nkrumah University of Science and Technology Medical Center where three 4.5 
ml aliquots of urine from each volunteer were pipetted into 5 ml cryogenic vials 
(Corning Glass Works, Corning, NY).  All samples were stored at -80 °C prior to 
shipment to Texas A&M University (TAMU).  Upon arrival, all samples were 
stored at -80 °C before AFM1 analysis.     
 
4.2.3 Extraction of AFM1 from Urine 
AFM1 in urine was quantified by high performance liquid chromatography 
(HPLC) following immunoaffinity cleanup of samples.  Affinity chromatography 
cleanup procedures and HPLC analysis were based on methodologies 
described by Groopman et al. (1992b), with modifications by Sarr et al. (1995) 
and Wang et al. (1999).  Urine samples were centrifuged at 500 x g for 5 min to 
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remove particulate matter.  Five milliliters of supernatant was adjusted to an 
acidic pH with 0.5 ml of 1.0 M ammonium formate (pH 4.5), and increased to a 
final volume of 10 ml with ddH2O.  Samples were vortexed and loaded onto a 1-
ml preparative Aflatest P monoclonal antibody column (Vicam, Watertown, MA) 
at a flow rate of approximately 0.3 ml/min (Wang et al 1999).  The column was 
washed twice with 5 ml of phosphate-buffered saline (pH 7.4) and once with 10 
ml of ddH2O to remove nonspecifically bound analytes.  AFs were eluted with 2 
ml of 80% methanol and evaporated to dryness under nitrogen.  The eluates 
were re-suspended in a solution consisting of 100 µl of 80% methanol and 100 
µl of 20 mM of ammonium formate (pH 3.0).  Samples were analyzed by HPLC. 
 
4.2.4 AFM1 Quantification by HPLC Methods 
HPLC analysis was conducted using a Waters HPLC system (Waters 
Corporation, Milford MA) with fluorescence detection capabilities. A 250 mm x 
4.6 mm LiCrospher RP-18 endcapped column with pore size 100 Å and particle 
size 5 µm (Alltech Associates, Deerfield, IL) was employed for chromatographic 
separation.  The mobile phase consisted of 22% ethanol, buffered with 20 mM 
ammonium formate (pH 3.0).  Chromatographic separation of aflatoxins was 
achieved by isocratic elution of the mobile phase.  Samples were injected (100 
µl) on the column at a flow rate of 1.0 ml/min.  AFM1 quantification was based on 
peak area and retention time compared to the standard peak (LOD = 0.01 
ng/ml).  Urinary concentrations of AFM1 metabolites were expressed two 
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different ways: ng/ml urine to view the actual toxin levels in each urine without 
considering the dilution factor, and pg/mg creatinine to correct for individual 
sample dilution variations. 
  
4.2.5 Quantitative Analysis of Urinary Creatinine 
Measurement of creatinine (CRT) was conducted using a creatinine 
measurement kit (Sigma Diagnostics, St. Louis, MO) based on the 
manufacturers enclosed instructions (Sigma Diagnostics, 1997).  Positive and 
negative controls consisted of 0.3 ml CRT standard (3 mg/dl creatinine) and 0.3 
ml ddH2O, respectively.  Alkaline picrate solution (APS) was prepared by mixing 
CRT color reagent (0.6% picric acid, sodium borate and surfactant) with sodium 
hydroxide solution (5:1, v/v), both of which were included in the kit.  Urine 
samples were diluted 10 to 15 fold in water depending on the concentration of 
the urine and 3.0 ml of APS was added to each 0.3 ml aliquot.  The resulting 
solutions were vortexed and allowed to stand at 25 °C for 8 to 12 min.  Initial 
absorbance (AI) values were taken for standard (ST) and sample (SA) solutions 
in comparison to controls using a UV/visible spectrophotometer at 500 nm.  
Following initial absorbance measurements, 0.1 ml acid reagent (a mixture of 
sulfuric and acetic acid) was added to each test tube, the mixture was vortexed, 
and allowed to stand 5 min at 25 °C.  Absorbance (AF) measurements were 
again taken against control solutions and recorded as the final absorbance (AF). 
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Urinary CRT concentration (mg/dl) was calculated using the following equation:   
    Urine CRT (mg/dl) = [(AI of SA – AF of SA) / (AI of ST – AF of ST)]*3.  
 
4.3 Results 
4.3.1  Urinary Concentrations of AFM1 
Urinary levels of AFM1 metabolite were quantified for 91 study volunteers 
in the Ejura district of Ghana.  AFM1 was found to be present above the limits of 
detection (LOD = 0.01 ng/ml) in 83 (91.2%) of the 91 samples.  Values ranged 
from 0.01 to 17.24 ng/ml urine with a mean value (± SEM) of 1.47 ± 0.31 ng/ml 
urine.  In 8 (8.8%) samples, AFM1 was not found above the limits of detection. 
Of the 83 samples that contained detectable levels of AFM1, 22 (26.5%) were 
found to contain low to moderate levels of AFM1 (0.01 to 0.17 ng/ml), 59 (71.1%) 
contained moderate to very high levels (0.18 to 5.26 ng/ml), and 2 (2.4%) were 
considered to be extremely high (16.77 to 17.24 ng/ml).  Figure 19 illustrates 
representative chromatograms of urinary AFM1 detected by the HPLC methods. 
 
4.3.2  AFM1 Standardized to Urinary Creatinine Levels  
To correct for individual variations in hydration status AFM1 was 
standardized to urinary CRT levels.  CRT concentrations in the 91 study 
participants ranged from 11.35 to 182.83 mg/dl and a mean (± SEM) of 68.21 ± 
3.96 mg/dl.  Based on this correction factor, the levels of AFM1 in the urine  
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Figure 19.  Representative HPLC fluorescence chromatographs of aflatoxin M1 (AFM1) detected in urine samples 
collected from 91 study participants in the Ejura district of Ghana.  Of the 91 urine samples, 83 (91.2%) tested 
positive for AFM1.  A. Represents samples with low to moderate levels of M1.  B. Represents samples with 
moderate to very high levels of M1.  C. Represents samples that had extremely high levels of M1. 
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Figure 20.  Diagramatic representation of aflatoxin M1 (AFM1) concentrations in 
urine samples (standardized to creatinine (CRT) levels) obtained from study 
participants in four communities in the Ejura district of Ghana. 
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samples ranged from less than 25.59 to 11,562.36 pg/mg CRT with a mean (± 
SEM) of 1,850.86 ± 274.59 pg/mg CRT (median = 475.81 pg/mg) (Figure 20).   
 
4.4 Discussion 
The objective of this study was to establish baseline data for human 
exposure to AFs in four communities in the Ejura district of Ghana.  Urinary 
AFM1 has been shown to be a dose-dependent biomarker for dietary AFB1 
exposure (Groopman et al., 1992; Wang et al., 1999).  In this study, 91.2% of 
samples tested positive for AFM1.  This is comparable to previous research 
showing the presence of AFM1 in 88.9% of urine samples analyzed in a Chinese 
population consuming high levels of AF in the diet and at high risk for liver 
cancer (Wang et al., 2001).  Based on urine volumes, AFM1 ranged from less 
than 0.01 to 17.2 ng/ml with a mean of 1.5 ng/ml.  These results are comparable  
to those reported by Qian et al. (1994) in China (0.17 to 5.2 ng/ml) and with an 
average of 4.2 ng/ml found in Zimbabwe (Nyathi et al 1987).  In the present 
study, the data were grouped into three concentration categories based on the 
previous report by Qian et al. (1994). These authors reported that AFM1 levels 
ranging from 0.17 to 5.2 ng/ml urine were associated with a 4-fold increased 
relative risk of incidence of HCC.  Levels of AFM1 were categorized as low to 
moderate if samples contained 0.01 to 0.17 ng/ml urine, moderate to very high 
for samples that contained 0.18 to 5.26 ng/ml urine, and extremely high for 
samples with AFM1 concentrations > 5.26 ng/ml urine. 
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However, because urine production is influenced largely by individual 
hydration status (Masi et al., 2004), AFM1 levels in this study were further 
standardized based on creatinine production in individual study participants.  
Although this is a common method of standardization for a variety of urinary 
toxins and hormones (Greenberg, 1989; Wang et al., 1999), creatinine 
production is influenced by muscle mass and varies between ethnic groups 
(James et al., 1988; Goldwasser et al., 1997; Masi, 2004).  Controlling for 
muscle mass in creatinine measurements was unrealistic under these study 
conditions and hence homogeneity was assumed.  However, all participants in 
this study were black Ghanaians, eliminating ethnicity/race as a potential 
confounder. 
Upon creatinine standardization, urinary AFM1 ranged from less than 26 
to 11,562 pg/mg creatinine with a mean value of 1,851 ± 275 pg/mg creatinine.  
Approximately one-third of study participants had AFM1 levels greater than the 
mean value and considerably larger than those reported in China where AFM1 
levels ranged from less than nondetectable to 144.8 pg/mg creatinine (Wang et 
al. 1999). 
Although urinary AFM1 is dependent on several factors (e.g., sample size, 
diet, extent of aflatoxin exposure, methods of urine collection and aflatoxin 
analyses, urine concentration, genetic susceptibility to aflatoxins, health, and 
individual nutritional status) (Jolly et al., 2004), the levels of AFM1 in this study 
were found to be substantially high, indicating that this particular study 
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population is highly exposed to AFs.  Regrettably, medical records in this district 
provide little to no information on diseases and deaths associated with liver 
problems and in these regions of Ghana, AF-related health problems are not 
considered a high priority for therapy. Thus, the identification of this high risk 
population will facilitate human trials to assess the ability of NS clay to reduce 
biomarkers of AF exposure and promote the management of human 
aflatoxicosis in Ghana. 
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
 
The aflatoxins (AFs) represent the major class of mycotoxins produced by 
Aspergillus species of fungi.  They are a group of structurally similar, highly toxic 
fungal metabolites that frequently occur in foods (e.g. corn and groundnuts) and 
are  strongly implicated in the etiology of disease and death in humans and 
animals (CAST, 2003).  Among the AFs, aflatoxin B1 (AFB1) is usually the most 
predominant in foods/feeds, most toxic, and the most potent hepatocarcinogen 
in humans (Busby and Wogan, 1984; Bhatnagar et al., 2002; Lopez et al., 2002).  
The AF occurrence in food/feed has been described as an unavoidable problem 
and difficult to control even with good manufacturing practices.  This is because 
the AFs are invisible to the naked eye, heat stable, and not neutralized by 
common food processing techniques, (CAST, 1989; Phillips et al., 2002).  Food 
contamination with AF remains a serious burden in many parts of the world and 
is a serious impediment to improving food safety, especially in areas where food 
supplies are scarce (McAlpin et al., 2002; Shephard, 2003). 
Previous studies have demonstrated that calcium montmorillonite clays 
(e.g. NovaSil or NS and NovaSil Plus or NSP) in the diet can significantly protect 
multiple animal species against the insults associated with AFs (Phillips et al., 
1988; 1994; 1999).  Unfortunately, comparable studies in humans have not yet 
been published.  Therefore, the overall goal of this research was to investigate 
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the suitability of NSP for human use through in vitro characterization followed by 
in vivo evaluation of AFB1 sorption and parent clay safety.  To address this 
concern, the main objectives for this research were to:   
1) Characterize the in vitro and in vivo sorption efficacy of NSP for AFB1 and 
evaluate potential interactions with vitamin A (VA).     
2) Evaluate the potential adverse effects of chronic ingestion of NSP in the 
diets of male and female Sprague-Dawley (S-D) rats. 
3) Establish representative baseline data for human AF exposure in four 
communities in the Ejura district of Ghana.   
The first objective of this research was to characterize the in vitro and in 
vivo sorption efficiency of NSP for AFB1 and to evaluate potential interactions 
with VA.  Specifically, these studies were designed to 1) determine the sorption 
affinity and capacity of NSP for AFB1, 2) characterize the thermodynamics of the 
AFB1-NSP interaction in vitro; 3) investigate the sorption of AFB1 by NSP in S-D 
rats through quantification of urinary AFM1, and 4) determine the minimal 
effective dietary inclusion level of NSP that can protect broiler chicks from the 
effects of aflatoxicosis and hepatic VA depletion.   
Isothermal analysis was used to show that NSP had high affinity, 
capacity, and specificity for AFB1 and did not appear to interact with VA in 
aqueous solution.  The shape of the NSP-VA isotherm curve was the C-type 
with negligible affinity value, which represents a constant partition process of 
binding with no saturable site for the nutrient VA.  On the other hand, the shape 
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of the isothermal curve for NSP was the L-type, indicating saturation of a real 
binding site in the clay (Giles et al., 1960).   
Further, NSP may have an equivalent or greater capacity and affinity for 
AFB1 than that previously reported for NS, an earlier and closely related product 
(Grant and Phillips, 1998).  Although the binding capacity (Qmax) value (± SEM) 
of NSP (0.456 ± 0.007 mol AFB1/kg sorbent) and that previously reported for NS 
(0.461 ± 0.015 mol AFB1/kg sorbent) for AFB1 sorption were comparable, the 
affinity (Kd) parameter of NSP (7.48 x 105) was more than 6-fold higher than that 
reported by Grant and Phillips (1998) for NS (1.21 ± 105).  This evidence 
suggests that both clays may have the same binding capacity but NSP exhibits 
tighter binding compared to NS.  In both cases, calculation of thermodynamic 
parameters suggested strong sorption of AFB1.  However, the estimated 
enthalpy of sorption for NSP (-49.2 kJ/mol) was higher than values previously 
reported for NS (-40 kJ/mol), suggesting a tighter toxin binding onto NSP clay 
(Grant and Phillips, 1998).  Based on ∆Hads values, the adsorption of AFB1 to the 
surface of either sorbent is characterized as chemisorption, a chemical reaction 
and/or sharing of electrons between the ligand and the sorbent surface that is 
indicated by enthalpy values > -20 kJ/mol (Gatta, 1985).  Therefore, since NS 
has shown protection against AFs in the gastrointestinal (GI) tract of multiple 
animals, the prediction is that NSP may also bind AFB1 in the GI tract of animals 
with high efficacy, thus providing protection from aflatoxicosis.   
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Additionally, this in vitro evidence indicates that NSP can selectively sorb 
the AF without interfering with the physiological levels of VA in vivo.  Also, the 
use of isothermal analysis for VA serves as a useful model to investigate 
potential NSP interactions with other important nutrients such as vitamin E, iron, 
and zinc.  Future in vivo studies will include measurements of nutrients such as 
VA, VE, Fe, and Zn in AF-sensitive animals (i.e., young chickens, turkeys, 
swine, lambs, and rats) ingesting NSP.   
On the basis of its prevalence in urine and the dose-dependent linearity 
observed with dietary AFB1 ingestion, AFM1, an oxidative metabolite of AFB1, 
was selected as a biomarker of exposure (Groopman et al., 1992a; Hsieh and 
Wong, 1994).  Previous research has indicated that 0.5% NS in the diet of 
Fisher 344 rats was sufficient to reduce urinary AFM1 levels by 58% following a 
single gavage dose of 1 mg/kg (bw) AFB1 (Sarr et al., 1995).  However, in the 
current study, S-D rats fed only half the amount of NSP (0.25%) showed a 
greater reduction (71%) of the metabolite following the same AFB1 dose.  
Although the two studies used different animal strains, the results suggest that 
NSP is at least equivalent to, if not more efficient, than NS in reducing the 
bioavailability of AFs in the GI tract.  Therefore, this 48 hr study serves as a 
useful model to quickly evaluate the in vivo sorption of diverse sorbents for their 
ability to sorb AFs or other mycotoxins in future studies in animals.  Notice that 
the in vitro and in vivo characteristics of NSP suggest that NSP, which is the one 
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currently available in animal feeds, is a highly efficient binder for AFs and hence 
could also be applied to reduce biological exposure to AFs in humans.   
 In addition to reducing urinary AFM1 in rats, dietary inclusion of 0.25% 
NSP was also shown to effectively reduce (95%) the negative health 
manifestations associated with AFB1 consumption in broiler chicks (e.g., 
reduced weight gains, increased liver and kidney weights, and decreased feed 
consumption).  Importantly, at dietary inclusion levels as great as 0.5%, NSP 
protected from AFB1-dependent hepatotoxicity without affecting hepatic VA 
levels.  This lack of interaction is important because VA deficiency is the leading 
cause of childhood blindness in developing countries, and is a major contributor 
to childhood morbidity and mortality resulting from common infections (Fieldler et 
al., 2000).  In addition, VA has been reported to prevent or delay carcinogenesis 
induced in animals by chemicals such as AFB1 (Sporn and Newton, 1981; 
Frayssinet and La-farge-Frayssinet, 1989), and therefore, VA has been 
considered a potential inhibitor of human cancer (Kummet and Meyskens, 
1983).  Specifically, it is reported that VA appears to have an exceptional ability 
in rat liver microsomes to suppress AFB1 metabolic activation (Firozi et al., 
1987) and to modulate DNA-AFB1 adduct formation (Bhattacharya et al., 1984).  
Also, VA deficiency has been shown to enhance liver microsomal activity for 
AFB1 activation (Bhattacharya et al., 1989).  With all these effects of VA, the 
clay-based intervention strategy would be counter productive if NSP affects the 
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physiological levels of this nutrient.  Therefore, VA was used as a model for 
future investigations regarding nutritional analysis in AF prevention studies.  
Nonselective sorbents may bind enzymes and critical nutrients, making 
prolonged use inadvisable.  Therefore, any clay intended for human 
consumption must show high specificity for the toxin of interest, without 
interfering with normal physiological functions or nutrient utilization.  For 
example, in a previous study, inclusion of a common zeolite known as 
clinoptilolite (0.5% w/w) in an AFB1-contaminated diet enhanced the occurrence 
of preneoplastic lesions in the liver of pregnant rats.  These lesions were not 
observed in the presence of AFB1 or clinoptilolite alone (Mayura et al., 1998).  
Unlike NS clay, zeolites are nonselective in their action like carbon.  In this same 
study, NS clay protected adults and developing fetuses from the effects of AFs 
and did not produce changes in the liver like clinoptilolite.  Taken together, the 
results obtained for studies outlined in the first objective (in vitro and in vivo) 
indicate that NSP strongly and specifically sorbs AFB1 without interfering with 
hepatic VA.  Thus, in future studies, NSP added to the diet at up to 0.5% would 
not be expected to compromise health nor would the clay be expected to non-
specifically sorb VA.  
Previous research in pregnant rats indicated that concentrations as great 
as 2.0% NSP in the diet throughout gestation did not result in either maternal or 
fetal toxicity, and did not significantly affect the bioavailability of a variety of trace 
metals in selected tissues (Wiles et al., 2004).  However, the effects of chronic 
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ingestion of NSP remain unpublished.  Therefore, the second objective of our 
research was to evaluate the potential adverse effects of chronic ingestion of 
NSP in the diets of male and female S-D rats.   
Studies addressing the second objective showed that feed consumption, 
body weight gain, feed conversion efficiency, and relative organ weights in male 
or female S-D rats were not affected by dietary NSP concentrations as great as 
2% over 6.5 months, suggesting that the clay did not produce overt toxicity upon 
chronic ingestion.  In addition, no observable NSP-dependent gross anatomical 
or histopathological changes to major organs were observed, and there were no 
NSP-dependent changes to common diagnostic hematological or serum 
biochemical parameters, further confirming a lack of overt toxicity.  Specifically, 
red blood cell (RBC) count was not affected and there were no NSP-related 
morphological differences detected in RBCs in NSP-treated versus untreated 
groups, suggesting that NSP ingestion is unlikely to produce hemolytic, 
hemorrhagic, or other forms of anemia, or to affect RBC physiology or 
metabolism (George-Gay and Parker, 2003).  Further, white blood cell and 
leukocyte differentials were found to be quantitatively and morphologically 
similar between NSP-treated and untreated animals, suggesting that the clay is 
unlikely to impair immunity or inflammatory processes, increase incidence of 
infections, or cause alterations to bone marrow (Goodnough et al., 1999; 
George-Gay and Parker, 2003).  Finally, serum and hepatic VA and vitamin E 
(VE) and micronutrients Fe and Zn did not appear to be adversely impacted by 
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NSP ingestion.  Overall, this study indicated that chronic ingestion of NSP at 
levels as great as 2.0% (w/w) in the diet does not produce overt toxicity.  
The information gained in the second objective increases the feasibility 
for dietary inclusion of NSP in humans in order to reduce foodborne AF 
exposure and improve quality of life in high risk populations.  Future studies will 
test this product in healthy human volunteers in order to reduce potential   
confounding variables (i.e., malnourishment, hepatitis B and C viral infection, 
liver and kidney problems, HIV/AIDS, and immune suppression) before 
translating dietary NSP intervention to susceptible populations.  
Although future research may be designed to characterize the efficacy of 
NSP to protect humans from AF contamination, biomarker exposure data are 
first needed to identify high risk populations.  Thus, the third main objective of 
this research was to establish representative baseline data for human AF 
exposure in four communities in the Ejura district of Ghana.  Individuals in this 
area of the world are frequently exposed to AFs and have the potential to greatly 
benefit from clay-based dietary intervention strategies/therapies.   
Research for this objective was accomplished by analyzing urinary AFM1 
as a biomarker for AF exposure in volunteers within these communities.  
Measurement of urinary AFM1 is a non-invasive method of AFB1 exposure 
characterization, as it is not only prevalent but also exhibits dose-dependent 
excretion with dietary AFB1 ingestion (Groopman et al 1992a; Hsieh and Wong, 
1994).   
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The results of a survey of 91 subjects in Ghana, revealed high urinary 
AFM1 levels (71.1% contained moderate to very high levels), indicating 
substantial AF exposure in the selected study population.  With the identification 
of this high risk population, future intervention trials in Ghana will be designed to 
characterize the efficacy of NSP to decrease AF exposure from contaminated 
food.  However, since urinary AFM1 levels reflect short-term exposure status 
(over the previous 24 hr period) (Groopman, 1993; Wild, 1998) all volunteers will 
also be screened for aflatoxin-albumin adducts, which reflect chronic exposure 
to the toxin. 
In order to make this technology more accessible to people who 
frequently ingest contaminated foods, efforts should be made to educate 
Ghanaians in the use of NSP clay for AF prevention.  This would involve the 
participation and collaborations with the ruling government, community leaders 
(e.g. the chief and his entourages), and district health professionals.  It would 
also require the development and implementation of a comprehensive, 
layperson-oriented, and culturally acceptable educational curriculum for effective 
translation of this clay-based approach for the prevention of aflatoxicosis.  
Perhaps, the most efficient and effective methods to facilitate the AF prevention 
educational process could be to train some community leaders and the district 
health professionals who will in turn convey the message to their counterparts.  
The media will also play a vital role in reaching the majority of the people in the 
country.  
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Additionally, future research should investigate local clay minerals for 
efficacy and specificity for AFs.  For instance, clays that are commonly sold in 
Ghanaian marketplaces and considered “edible”, as well as those from clay 
mining sites can be tested for their ability or lack thereof, to selectively sorb AFs 
in vitro and in vivo.  It will be useful to collaborate with mineralogists in any 
country or area of interest to explore the possibilities of identifying clay minerals 
with properties comparable to those of NSP with Qmax > 0.3 mol AFB1/kg sorbent 
and Kd > 1.0 x 105.  Also, the enthalpy of sorption should be > -30 KJ/mol to 
predict tight sorbent-ligand chemisorption.  Although imported clay minerals 
such as NSP appear to be cost effective, success will be contingent upon 
affordability.  Based on this and previously described methodology (Phillips et 
al., 1988; Grant and Phillips, 1998; Lemke, 2000), efficacy and specificity of 
each clay may be investigated in a relatively short period of time.  It must be 
noted that, although NSP has been shown to significantly protect against 
aflatoxicosis, the effects of other clay minerals are ill-defined in the scientific 
literature which spells out the essentiality of thorough investigation before 
application to humans. 
Future studies may also focus on the identification of populations that 
exhibit genetic sensitivity to AFs.  Genes that code for synthesis of drug 
metabolizing enzymes, such as epoxide hydrolases (EH) and glutathione s- 
transferase (GST), which are involved in detoxification of AFs and other 
xenobiotics, may be defective or mutated.  Gene mutations may lead to 
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enhanced susceptibility due to alterations in the levels and/or activities of these 
AF-metabolizing enzymes.  Therefore, the proposed clay-based intervention 
strategy for the reduction of AF bioavailability may be highly beneficial to 
individuals possessing a genetically defective allele in an enzyme involved in its 
metabolism.   
Of particular significance is the fact that this technology is relatively cost 
effective, culturally acceptable, environmentally friendly, and has a high potential 
for sustainability.  However, delivery methods that will not destroy or alter the 
structural integrity of the clay and/or affect the taste of foods need to be further 
explored.  Thus far, dietary inclusion of NSP for animals has been shown to be 
effective against AFB1 and the chronic toxicity study showed that the amounts of 
feed consumption in rats that ingested dietary NSP were similar to those of the 
controls.  In the case of humans, the following are pertinent questions that need 
to be addressed regarding NSP usage.  For example, will encapsulating NSP be 
an appropriate delivery option for humans?  What about making NSP slurries 
that can be consumed before each meal?  Does dietary inclusion of NSP affect 
the palatability of finished food products?  What about the effects of cooking 
temperature and pH changes?  These are some of the questions that need to be 
answered in future research of NS clay. 
Dietary NSP studies should be conducted utilizing several local and 
imported foodstuffs to determine not only the delivery method but also the 
minimal effective concentration and the impact of the selected amount on 
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palatability.  One possibility is the use of capsules, like vitamin supplements, to 
encase selected amounts of the clay mineral that may then be ingested with 
food.  However, the efficacy of capsule delivery, mechanisms and kinetics of 
release, hydration and ligand sorption by NS will require verification. 
It is well-established that AF contamination of foods/feeds presents both 
economic and public health burdens worldwide, resulting in an increase in 
research initiatives to address the problem.  Clay-based enterosorption of the 
toxin within the GI tract has shown promise for the prevention of the AF burden 
in multiple animal species.  The overall goal of this research was to investigate 
the suitability of NSP for human use through in vitro characterization followed by 
in vivo evaluation of not only AFB1 sorption but also parent clay safety.  In these 
studies, NSP demonstrated high affinity, capacity, and specificity for AFs without 
affecting anatomical or physiological parameters at dietary inclusion levels as 
great as 2.0% (w/w) following long-term ingestion. The overall findings of this 
research suggest that NSP may be feasible and appropriate for the 
management of aflatoxicosis in high risk populations.   
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